FHIR IG Statistics (3422 ms)

• Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
• Authority: All | hl7 | ihe | national
• Realm: All | au | be | BNW | br | ca | ch | cl | cr | cz | de | dk | ee | efss | essilux | eu | examples | fi | fr | il | in | it | jp | nl | no | nume | nz | pt | rdsuwearme | sami | se | sl | stt | test | tw | uk | us | uv | vn
• View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

18333 resources

By Version

• R2: 52
• R2B: 0
• R3: 522
• R4: 17321
• R4B: 0
• R5: 438
• R6: 0

By Authority

• none: 2071
• hl7: 16260
• national: 2

Start Prev Rows 8000 - 8200 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-country-code	RTPBC Country Code Value Set	active	2020-05	hl7
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-error-code	RTPBC Error Code Value Set	active	2020-05	hl7
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-event-type	RTPBC Event Type Value Set	active	2020-05	hl7
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-patient-pay-type	RTPBC Patient Pay Type Value Set	active	2020-05	hl7
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-pharmacy-type	RTPBC Pharmacy Type Value Set	active	2020-05	hl7
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-prescribable-product-code	RTPBC Prescribable Product Code Value Set	active	2020-05	hl7
hl7.fhir.us.carin-rtpbc	R4	ValueSet/rtpbc-state-and-province-code	RTPBC Two Letter State and Province Code Value Set	active	2020-05	hl7
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.1	Facility Location NICU (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.10	Seizure or Serious Neurologic Dysfunction (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.100	Third Degree Perineal Laceration (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.101	Fourth Degree Perineal Laceration (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.102	Ruptured Uterus (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.103	Unplanned Hysterectomy (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.104	Facility Location OR (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.105	Unplanned Operation (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.106	Attempted Forceps Procedure (NCHS)	draft	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107	Attempted Vacuum Procedure (NCHS)	draft	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108	Fetal Presentation at Birth- Breech (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109	Fetal Presentation at Birth- Cephalic (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11	Newborn Given Surfactant Replacement (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110	Fetal Presentation at Birth- Other (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111	Route and Method of Delivery - Spontaneous (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112	Route and Method of Delivery - Forceps (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113	Route and Method of Delivery - Vacuum (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114	Route and Method of Delivery - Cesarean (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115	Route Method of Delivery - Trial of Labor (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116	Route and Method of Delivery - Scheduled C (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.117	Measured Height (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.118	Pre-Pregnancy Weight (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119	Problem Status Active (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.12	5 Min Apgar Score (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.120	Mothers Delivery Weight (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.121	Previous Other Pregnancy Outcomes (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.122	Number of Previous Live Births Now Dead (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.123	Number of Previous Live Births Now Living (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.124	Obstetric Estimate of Gestation (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125	Cervical Cerclage (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127	External Cephalic Version (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128	Tocolysis (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129	Premature Rupture (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.13	10 Min Apgar Score (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130	Precipitous Labor (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131	Prolonged Labor (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.132	Birth Plurality of Delivery (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.133	First Prenatal Care Visit (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.135	Number Prenatal Care Visits (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136	Prepregnancy Diabetes (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137	Gestational Diabetes (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138	Prepregnancy Hypertension (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139	Gestational Hypertension (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14	Delivery (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140	Eclampsia (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141	Preterm Birth (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142	Poor Pregnancy Outcome History (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143	Infertility Treatment (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.144	Fertility Enhancing Drugs (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145	Artificial or Intrauterine Insemination (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146	Assistive Reproductive Technology (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147	Listeria (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.148	Number of Previous Cesareans (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149	Neonatal Death (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15	Physician (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150	Hysterotomy Hysterectomy (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.151	Fetus Weight (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153	Fetal Autopsy (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154	Karyotype Determination (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.155	Education Level 8th (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.156	Education Level - 9 - 12 No Diploma (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.157	Education Level - High School (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.158	Education Level Some College (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.159	Education Level Associate (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16	Doctor of Osteopathic Medicine (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.160	Education Level Baccalaureate (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.161	Education Level Graduate Degree (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.164	Number of Fetal Deaths This Delivery (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166	Group B Streptococcus (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167	Cytomegalovirus (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168	Parvovirus (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169	Toxoplasmosis (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.17	Certified Midwife (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.170	Married (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.171	Never Married (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.172	Previously Married (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176	Transferred for Maternal Medical or Fetal Indicat	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.177	Transfer In (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178	Antibiotic Administration Procedure (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.179	Stated Height (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.18	Midwife (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.180	Conception Date (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.184	Birthplace Setting (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.185	Time of Death (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.187	Number of Preterm Births (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188	ICU Care (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189	Cleft Palate Alone (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.19	U.S. Territories (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190	Transfer to Facility (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.191	Institution Referred To (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192	Birth Place Hospital (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193	Birth Place Home Intended (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194	Birth Place Home Unintended (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.195	Birth Place Home Unknown Intention (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196	Birth Place Freestanding Birthing Center (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197	Birth Place Clinic Office (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198	NICU Care (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.2	Facility Location ICU (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.20	Birth Weight (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22	Augmentation of Labor - Procedure (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.23	Augmentation of Labor - Medication (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24	Chorioamnionitis During Labor (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25	Fever Greater Than 100.4 (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.26	Epidural Anesthesia - Medication (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27	Epidural Anesthesia - Procedure (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.28	Spinal Anesthesia - Medication (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29	Spinal Anesthesia - Procedure (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.3	Antibiotics (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30	Fetal Intolerance of Labor (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31	In-utero Resuscitation (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32	Further Fetal Assessment (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33	Operative Delivery (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34	Induction of Labor (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35	Spontaneous Onset of Labor (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36	Meconium Staining (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37	Non-vertex presentation in active phase of (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.38	Glucocortico Steroids (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39	Immature Fetus (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.4	IV Medication Administration Route (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40	Inflammation Indication (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41	Breastfed Infant (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.42	Male Gender (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.43	Female Gender (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.5	IM Medication Administration Route (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53	Anencephaly of the Newborn (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54	Cyanotic Congenital Heart Disease (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55	Congenital Diaphragmatic Hernia (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56	Karyotype Confirmed (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57	Suspected Chromosomal Disorder (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58	Cleft Lip with or without Cleft Palate (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.59	Karyotype Result (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6	Neonatal Sepsis (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60	Cleft Lip without Cleft Palate (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61	Down Syndrome (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62	Gastroschisis of the Newborn (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63	Hypospadias (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65	Meningomyelocele/Spina Bifida - Newborn (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66	Omphalocele of the Newborn (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.67	Date of Last Live Birth (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.68	Number of Live Births (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.69	Date of Last Menses (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.70	Date of Last Other Pregnancy Outcome (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.71	Number of Prior Pregnancies (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.72	Hispanic Ethnicity - Mexican (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.73	Hispanic Ethnicity - Puerto Rican (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.74	Hispanic Ethnicity - Cuban (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.75	Other Hispanic Ethnicity (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.76	Not Hispanic Ethnicity (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.77	Father (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.81	Race - Asian Indian (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9	Significant Birth Injury (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93	Chlamydia (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95	Pregnant (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96	Hepatitis B (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97	Hepatitis C (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98	Syphilis (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99	Transfusion Whole Blood or Packed Red Bld (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11	JCIH-EHDI Hearing Loss Risk Factors	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12	JCIH-EHDI Hearing Loss Risk Factors - Procedures	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.13	JCIH-EHDI NICU Service Delivery Location	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14	JCIH-EHDI Newborn Hearing Loss Diagnosis	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15	JCIH-EHDI Reason for no Hearing Loss Diagnosis	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16	JCIH-EHDI Newborn Hearing Loss Referrals	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17	JCIH-EHDI Newborn Hearing Procedure	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.2	JCIH-EHDI Outpatient Encounter	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20	JCIH-EHDI Procedure Declined	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7	JCIH-EHDI Reason for no Follow-up - Patient Reason	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.8	JCIH-EHDI Hearing Screen Left	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.9	JCIH-EHDI Hearing Screen Right	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1	Autopsy Performed (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13	Family History (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14	Mother Breastfeeding (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.17	Laboratory Tests (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19	Associated Conditions (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2	Autopsy Not Performed (NCHS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.4	Discharge Death (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6	Death Certification (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7	Interventions (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8	Dietary Behavior (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9	Physical Activity Behavior (HW)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.75	Joint Commission Medical Reason	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.11222.4.11.5025	Original Specimen Type Modifier PHLIP	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9	Substance Other Than Clinical Drug (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98	Route of Administration	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.1	Administrative Gender (HL7 V3)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10267	Participation Function (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10416	Financially Responsible Party Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10637	Postal Address Use (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12199	Language Ability Proficiency (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12212	Marital Status Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12249	LanguageAbilityMode Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.14914	Race Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.15913	Entity Name Use (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.159331	Act Status	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16866	Act Priority (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16926	Basic Confidentiality Kind (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.18877	Coverage Role Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19185	Religious Affiliation Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19563	Personal Relationship Role Type Value Set	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19579	Family Member Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19601	x_ServiceEventPerformer (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19717	No Immunization Reason Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2	Advance Directive Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.78	Observation Interpretation (HL7)	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.1	Amniotic Fluid Conditions (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.10	Type of Twin (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.11	Twin Placenta (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.12	Umbilical Cord Complication (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.13	Infant Fetal Complications (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.14	Placental Measurement (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.2	Cord Insertion Type (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.3	Hospital Care-Setting (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.4	Maternal Exposures (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.5	Intended Newborn Feeding Type (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.6	Placenta Type (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.7	Placental Conditions (HL7)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.9	Type of Recreational Drug (HL7)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.91	Birth Defects Diagnostic Confirmation (HL7)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.93	Birth Defects Laterality at Diagnosis (HL7)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.10	eICR Processing Status Reason Detail Type (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.11	eICR Initiation	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.3	Determination of Reportability (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.4	External Resource Type (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.5	Reportability Priority (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.6	Location Relevance (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.7	eICR Processing Status Reason (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.8	eICR Processing Status (eCR)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.19465	Healthcare Provider Taxonomy Code (NUCC)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.12.1	Personal And Legal Relationship Role Type (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.18	MoodCodeEvnInt (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.20	Telecom Use - US Realm Header (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.21	AgePQ_UCUM	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.22	Procedure Act Status Code (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.23	Planned moodCode - Act/Encounter/Procedure (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.24	Planned moodCode - SubstanceAdministration/Supply	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.25	Planned moodCode - Observation (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.26	Entity Person Name Part Qualifier (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.33	Role Class Codes (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.34	Patient Education	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.38	Current Smoking Status (NAACCR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.41	Tobacco Use	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.49	Residence and Accommodation Type	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.60	Priority Level (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.19	Healthcare Service Location (NHSN)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.277	Birth Defect Diagnosis	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.1	Immunization Funding Source Excluding Nulls	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.2	Pt Immunization Registry Status Excluding Nulls	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.3	Race Category Excluding Nulls	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.4	Immunization Refusal Reason Excluding Nulls	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.5.20.1	USDA Subject Descriptor	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.5.20.2	USDA Subject Function	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.1	NAACCR Laterality at Diagnosis	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.10	NAACCR TNM Clinical Stage Descriptor	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.11	NAACCR Cancer Status	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.12	NAACCR Quality of Survival	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.13	NAACCR Screening Result	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.14	NAACCR Behavior Code	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.15	NAACCR Grade	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.16	NAACCR ICD-9-CM Cancer Reportability List	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.21	TNM Pathologic Stage Descriptor (NAACCR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.22	Laterality (NAACCR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.25	Radiation Rx and Boost Radiation ICD10-PCS (NAACCR	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.26	Radiation Rx and Boost Radiation SNOMEDCT (NAACCR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.27	NAACCR TNM Pathologic Staged By (NAACCR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.29	NAACCR SNOMEDCT Cancer Reportability List	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.3	NAACCR Diagnostic Confirmation	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.4	NAACCR TNM Clinical Staged By	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.5	NAACCR TNM Edition Number	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.3.2	Contact Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.4.2	Provider Role Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2	Allergy/Adverse Event Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8	Problem Severity	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2	Problem Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4	Problem Value Set	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.11	Medication Product Form Value Set	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.19	Medication Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.7	Medication Route FDA Value Set	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9	Body Site Value Set	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.16	Medication Brand Name Value Set	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.18	Medication Drug Class Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.21	Medication Vehicle Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.39	Immunization Information Source	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.46	Document Class Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.47	Document Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60	Social History Type Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.62	Vital Sign Result Value Set	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.64	Medication Fill Status Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.65	V3 Result Status Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.66	Patient Class Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68	Problem Status	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.2.11.7101	VPD Reason for Study	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1000	Identity Reliability Code (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1002	Lab Test Result Name	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1003	Observation Method	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1004	Ordered Test	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1006	Type of Long Term Care Facility	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1007	Major Site of Disease (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1009	Microorganism	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1010	Microscopic Exam Culture Site (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1011	Data Subtype	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1012	Type of Data	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1013	Missing Lab Result Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1014	Modifier or Qualifier	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1015	Nationally Notifiable Disease Surveillance System (NNDSS) & Other Conditions of Public Health Importance	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1016	Nationally Notifiable Infectious Disease reportable to the Nationally Notifiable Disease Surveillance System	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1017	Nature of Abnormal Test (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1018	Non Paint Lead Source	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1019	Non-paint lead source - hobby related	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1021	Number Of Lesions (VZ)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1022	Occupation Risk Category (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1023	Response Flag (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1024	Extended Priority Codes (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1025	Order Status (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1026	Pregnancy Trimester	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1027	Previous Vaccine History	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1028	Processing ID (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1029	Processing Mode (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1031	Public Health Case Record Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1032	Rash Distribution (VZ)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1033	Rash Location First Noted (VZ)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1035	Reason Therapy Stopped (TB)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1036	Referral Status (CRA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1037	Risk Category	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1038	Sex (MFU)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1039	Specimen Appropriateness (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1040	Specimen Child Role (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1041	Specimen Collection Method (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1042	Specimen Condition	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1043	Specimen Quality (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1044	Specimen Reject Reason (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1045	Specimen Risk	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1046	Specimen Role	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1047	Specimen Treatment	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1048	Strain Type (VZ)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1049	Substance Administered (CRA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1050	Batch Deactivation Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1051	Substance Treatment Refusal Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1052	Transmission Setting (NND)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1053	Volume Units	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1054	Volume Mass Units	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1055	Universal ID Type (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1056	Vaccination Location (CRA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1057	Vaccine Contraindications	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1058	Vaccine Purchased With Funds	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1059	Value Type (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1060	Abnormal Chest X-ray Condition Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1061	PHIN Questions (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1062	PHIN Questions (Varicella)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1063	PHIN Questions (Lead Case)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1064	PHIN Questions (Lead Laboratory Report)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1065	PHIN Questions (Lead Environmental)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1066	Healthcare Provider Taxonomy (HIPAA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1067	Body Substance	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1068	Event	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1069	Material	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1071	Drug Susceptibility Test Result Name	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1073	Microbiology Test Result Name	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1074	Animal	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1075	Physical Object	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1076	Situation with Explicit Context	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1089	Botulism-like Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1090	Fever Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1091	Gastrointestinal Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1092	Hemorrhagic Illness Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1093	Localized Cutaneous Lesion Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1094	Lymphadenitis Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1095	Neurological Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1096	Rash Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1097	Respiratory Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1098	Severe Illness Or Death Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1099	Specific Infection Syndrome (BT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1100	Industry (NAICS)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1102	Drug Active Ingredients	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1103	Semantic Clinical Drug (Ingredient plus strength and dose form)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1104	Semantic Clinical Drug Form (Ingredient plus dose form)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1105	Drug Product (NDC)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1106	Drug Manufacturers (NDC)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1107	Notification Section Header	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1108	Drug Classes (NDF-RT)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1109	Procedure by Site (SNOMED)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3000	PHLIP Questions (Flu)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3014	Source of Comment (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3015	Ethnicity Group including Unknown	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3016	Lab Test Order (PHLIP Flu)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3017	Lab Test Result (PHLIP Flu)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3018	Patient Location Status at Specimen Collection	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3019	Resulted Lab Test Name (PHLIP Flu)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3020	Specimen Source (PHLIP)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3021	Preferred Method of Contact (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3022	PHIN Questions (Hepatitis)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3023	Immunization Body Site	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3024	Blood Contact Frequency (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3025	Case Confirmation Method	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3026	Case Detection Method	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3027	Case Transmission Mode	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3028	Contact Type (Hepatitis A)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3029	Contact Type (Hepatitis B and C)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3030	Disease Acquired Jurisdiction	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3031	Incarceration Type (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3032	Notifiable Condition (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3033	Number Of Sex Partners (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3034	Outbreak Type (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3035	Reason For Test (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3036	Reporting Source Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3037	Tattoo Obtained From (Hepatitis)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3038	Vaccine Dose Number (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3039	Isolate Availability EIP Testing	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3040	Isolate Not Available EIP Test Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3041	Isolate Not Received Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3042	Isolate Not Sent To NARMS Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3043	Lab Test Result Name (Hepatitis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3044	Microbiology strain	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3045	Microorganism (Hepatitis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3046	Specimen Reshipment Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3047	Specimen Shipped	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3048	Lab Test Interpretation	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3049	Lab Test Result Qualitative	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3050	PHIN Questions (Animal Rabies)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3051	PHIN Questions (ArboNet)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3052	PHIN Questions (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3053	PHIN Questions (Generic)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3054	PHIN Questions (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3055	ECOTOX Chemicals (EPA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3056	STORET Chemicals (EPA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3057	TRI Chemicals (EPA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3058	Cancer Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3059	Clinical Syndrome (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3060	Immunosuppressed Condition	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3061	Public Private Lab	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3062	Transplant Organ	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3063	Virus Type (Arboviral Disease)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3064	Yes No Unknown No Answer	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3065	Age Category (Animal)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3066	Bat Species (Animal Rabies)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3067	Virus Variant Type (Animal Rabies)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3068	Animal Species (Animal Rabies)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3069	Yes No Unknown Not Done	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3070	Botulism Food Source Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3071	Pregnancy Outcome (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3072	Animal Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3073	Botulinum Toxin Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3074	Case Traced to Carrier	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3075	Cholera Risk Factor (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3076	Cholera Sequelae (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3077	Cholera Signs Symptoms (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3078	Cyclosporiasis Signs Symptoms (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3079	Day Care Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3080	Eosin Units (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3081	Fetal Neonatal Infection Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3082	Fetal Neonatal Specimen Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3083	Food Cooking Method (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3084	Food Processing Method (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3085	Fresh Berries (FDD)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3086	Fresh Herbs (FDD)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3087	Fresh Produce (FDD)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3088	Information Source	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3089	Interview Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3090	Lettuce Type (FDD)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3091	Maternal Infection (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3092	Meat Purchase Info (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3093	Non Pork Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3094	Other Related Cases	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3095	Outbreak Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3096	Pork Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3097	Present Absent Unknown Not Examined	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3098	Recreational Water (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3099	Seafood Purchase Info (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3100	Seafood Type (FDD)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3101	Skin Exposure (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3102	Skin Exposure Activity (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3103	Suspected Food Consumed (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3104	Swimming Pool Type (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3105	Tap Water Source (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3106	Travel Destination Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3107	Travel Mode	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3108	Travel Purpose	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3109	Travelers Health Info Source	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3110	Trichinellosis Signs Symptoms (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3111	Typhoid Signs Symptoms (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3112	Underlying Conditions	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3113	Water Salinity (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3114	Well Water Treatment (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3115	Wound History	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3116	Notifiable Condition (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3117	Body Site (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3118	Medication Treatment (FDD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3119	Acute Convalescent IgG Difference (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120	Antibiotic Received (Pertussis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3121	Birth Attendees (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3122	Birth Location (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3123	Birth Outcome (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3124	Body Region (Tetanus)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3125	Case Classification Exposure Source	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3126	Genotype (Measles)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3127	Genotype (Rubella)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3128	Immunization Information Source (CRS)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3129	Injury Occurred Environment (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3130	Injury Type (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3131	Lab Result (Pertussis)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3132	Lab Result (Rubella)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3133	Live Birth Outcome (Rubella)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3134	No Case Reason (CRS)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3135	Non-Live Birth Outcome (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3136	PCR Performed Lab Location (VPD)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3137	Prenatal Care Provider (Rubella)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3138	Relationship (VPD)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4010	Lab Result (California serogroup virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4011	Lab Result (Campylobacteriosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4012	Lab Result (Chagas)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4013	Lab Result (Chancroid)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4014	Lab Result (Chlamydia trachomatis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4015	Lab Result (Cholera)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4016	Lab Result (Clostridium perfringens)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4017	Lab Result (Clostridium perfringens Epsilon Toxin)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4018	Lab Result (Coccidioidomycosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4019	Lab Result (Colorado Tick Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4020	Lab Result (Creutzfeldt-Jakob disease)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4021	Lab Result (Cryptococcosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4022	Lab Result (Cryptosporidiosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4023	Lab Result (Cyclosporiasis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4024	Lab Result (Cysticercosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4025	Lab Result (Dengue)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4026	Lab Result (Diphtheria)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4027	Lab Result (Eastern equine encephalitis virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4028	Lab Result (Ebolavirus)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4029	Lab Result (E. coli STEC)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4030	Lab Result (Ehrlichia chaffeensis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4031	Lab Result (Ehrlichia ewingii)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4032	Lab Result (Ehrlichiosis Anaplasmosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4033	Lab Result (Genital Warts)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4034	Lab Result (Giardiasis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4035	Lab Result (Glanders)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4036	Lab Result (Gonorrhea)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4037	Lab Result (Granuloma Inguinale)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4038	Lab Result (Haemophilus influenzae)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4039	Lab Result (Hansen's Disease)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4040	Lab Result (Hantavirus Pulmonary Syndrome)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4041	Lab Result (Hendra virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4042	Lab Result (Hepatitis A)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4043	Lab Result (Hepatitis B)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4044	Lab Result (Hepatitis C)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4045	Lab Result (Hepatitis D)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4046	Lab Result (Hepatitis E)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4047	Lab Result (Herpes Simplex)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4048	Lab Result (Histoplasmosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4049	Lab Result (HIV)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4050	Lab Result (Influenza A virus, H1N1 2009 strain)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4051	Lab Result (Jamestown Canyon virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4052	Lab Result (Legionellosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4053	Lab Result (Leptospirosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4054	Lab Result (Listeriosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4055	Lab Result (Lyme disease)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4056	Lab Result (Lymphogranuloma Venereum)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4057	Lab Result (Malaria)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4058	Lab Result (Marburgvirus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4059	Lab Result (Measles)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4060	Lab Result (Melioidosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4061	Lab Result (Meningococcal Disease)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4062	Lab Result (Monkeypox Orthopox)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4063	Lab Result (MRSA)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4064	Lab Result (Mumps)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4065	Lab Result (Nipah Virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4066	Lab Result (Nongonococcal Urethritis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4067	Lab Result (Nontuberculous Mycobacteria)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4068	Lab Result (Norovirus)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4069	Lab Result RCMT (Pertussis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4070	Lab Result (Plague)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4071	Lab Result (Polio)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4072	Lab Result (Powassan virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4073	Lab Result (Prion Disease)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4074	Lab Result (Psittacosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4075	Lab Result (Q Fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4076	Lab Result (Rabies)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4077	Lab Result (Relapsing Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4078	Lab Result (Respiratory Syncytial Virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4079	Lab Result (Rickettsial infection, other)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4080	Lab Result (Rift Valley Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4081	Lab Result (Rotavirus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4082	Lab Result RCMT (Rubella)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4083	Lab Result (Salmonellosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4084	Lab Result (SARS)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4085	Lab Result (Shigella)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4086	Lab Result (Smallpox)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4087	Lab Result (Spotted fever rickettsiosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4088	Lab Result (Staphylococcus aureus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4089	Lab Result (Staphylococcus aureus enterotoxin B)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4090	Lab Result (Staphylococcus aureus food poisoning)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4091	Lab Result (Staphylococcal TSS)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4092	Lab Result (St. Louis encephalitis virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4093	Lab Result (Streptococcus pneumoniae)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4094	Lab Result (Streptococcal TSS)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4095	Lab Result (Streptococcus, group A)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4096	Lab Result (Streptococcus, group B)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4097	Lab Result (Syphilis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4098	Lab Result (Tetanus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4099	Lab Result (Toxoplasmosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4100	Lab Result (Trichinellosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4101	Lab Result (Tuberculosis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4102	Lab Result (Tularemia)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4103	Lab Result (Typhoid Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4104	Lab Result (Typhus group rickettsiosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4105	Lab Result (Vaccinia)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4106	Lab Result (Vancomycin resistant Enterococcus)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4107	Lab Result (Varicella)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4108	Lab Result (Vesicular Stomatitis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4109	Lab Result (Vibriosis, non-cholera)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4110	Lab Result (Viral Hemorrhagic Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4111	Lab Result (VISA)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4112	Lab Result (VRSA)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4113	Lab Result (Western equine encephalitis virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4114	Lab Result (West Nile virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4115	Lab Result (Yellow Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4116	Lab Result (Yersiniosis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4117	Lab Test Name (Amebiasis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4118	Lab Test Name (Anaplasma)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4119	Lab Test Name (Anthrax)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4120	Lab Test Name (Arbovirus)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4122	Lab Test Name (Babesiosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4123	Lab Test Name (Bartonellosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4124	Lab Test Name (Blastomycosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4125	Lab Test Name (Botulism)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4126	Lab Test Name (Brucellosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4127	Lab Test Name (California serogroup virus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4128	Lab Test Name (Campylobacteriosis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4129	Lab Test Name (Chagas)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4130	Lab Test Name (Chancroid)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4131	Lab Test Name (Chlamydia trachomatis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4132	Lab Test Name (Cholera)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4133	Lab Test Name (Clostridium perfringens)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4134	Lab Test Name (Coccidioidomycosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4135	Lab Test Name (Colorado Tick Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4137	Lab Test Name (Cryptococcosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4138	Lab Test Name (Cryptosporidiosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4139	Lab Test Name (Cyclosporiasis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4140	Lab Test Name (Cysticercosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4141	Lab Test Name (Dengue)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4142	Lab Test Name (Diphtheria)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4143	Lab Test Name (Eastern equine encephalitis virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4145	Lab Test Name (E. coli STEC)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4146	Lab Test Name (Ehrlichia chaffeensis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4147	Lab Test Name (Ehrlichia ewingii)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4148	Lab Test Name (Ehrlichiosis Anaplasmosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4149	Lab Test Name (Giardiasis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4150	Lab Test Name (Glanders)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4151	Lab Test Name (Gonorrhea)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4152	Lab Test Name (Granuloma Inguinale)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4153	Lab Test Name (Haemophilus influenzae)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4155	Lab Test Name (Hantavirus Pulmonary Syndrome)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4157	Lab Test Name (Hepatitis A)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4158	Lab Test Name (Hepatitis B)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4159	Lab Test Name (Hepatitis C)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4160	Lab Test Name (Hepatitis D)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4161	Lab Test Name (Hepatitis E)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4162	Lab Test Name (Herpes Simplex)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4163	Lab Test Name (Histoplasmosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4164	Lab Test Name (HIV)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4165	Lab Test Name (Influenza A virus, H1N1 2009 strain)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4166	Lab Test Name (Jamestown Canyon virus)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4167	Lab Test Name (Legionellosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4168	Lab Test Name (Leptospirosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4169	Lab Test Name (Listeriosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4170	Lab Test Name (Lyme disease)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4171	Lab Test Name (Lymphogranuloma Venereum)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4172	Lab Test Name (Malaria)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4174	Lab Test Name (Measles)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4175	Lab Test Name (Melioidosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4176	Lab Test Name (Meningococcal Disease)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4177	Lab Test Name (Monkeypox Orthopox)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4178	Lab Test Name (MRSA)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4179	Lab Test Name (Mumps)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4181	Lab Test Name (Nongonococcal Urethritis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4182	Lab Test Name (Nontuberculous Mycobacteria)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4183	Lab Test Name (Norovirus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4184	Lab Test Name (Pertussis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4185	Lab Test Name (Plague)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4186	Lab Test Name (Polio)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4187	Lab Test Name (Powassan virus)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4188	Lab Test Name (Prion Disease)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4189	Lab Test Name (Psittacosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4190	Lab Test Name (Q Fever)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4191	Lab Test Name (Rabies)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4192	Lab Test Name (Relapsing Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4193	Lab Test Name (Respiratory Syncytial Virus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4194	Lab Test Name (Rickettsial infection, other)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4195	Lab Test Name (Rift Valley Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4196	Lab Test Name (Rotavirus)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4197	Lab Test Name (Rubella)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4198	Lab Test Name (Salmonellosis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4199	Lab Test Name (SARS)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4200	Lab Test Name (Shigella)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4201	Lab Test Name (Smallpox)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4202	Lab Test Name (Spotted fever rickettsiosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4203	Lab Test Name (Staphylococcus aureus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4204	Lab Test Name (Staphylococcus aureus enterotoxin B)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4205	Lab Test Name (Staphylococcus aureus food poisoning)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4206	Lab Test Name (Staphylococcal TSS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4207	Lab Test Name (St. Louis encephalitis virus)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4208	Lab Test Name (Streptococcus pneumoniae)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4210	Lab Test Name (Streptococcus, group A)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4211	Lab Test Name (Streptococcus, group B)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4212	Lab Test Name (Syphilis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4213	Lab Test Name (Tetanus)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4214	Lab Test Name (Toxoplasmosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4215	Lab Test Name (Trichinellosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4216	Lab Test Name (Tuberculosis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4217	Lab Test Name (Tularemia)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4218	Lab Test Name (Typhoid Fever)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4219	Lab Test Name (Typhus group rickettsiosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4220	Lab Test Name (Vaccinia)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4221	Lab Test Name (Vancomycin resistant Enterococcus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4222	Lab Test Name (Varicella)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4223	Lab Test Name (Vesicular Stomatitis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4224	Lab Test Name (Non-Cholera Vibrio)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4225	Lab Test Name (Viral Hemorrhagic Fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4228	Lab Test Name (Western equine encephalitis virus)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4229	Lab Test Name (West Nile virus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4230	Lab Test Name (Yellow Fever)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4231	Lab Test Name (Yersiniosis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4239	Lab Test Name (Diabetes, hemoglobin A1c)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4240	Lab Test Name (Asbestosis)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4241	Lab Test Name (Berylliosis)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4242	Lab Test Name (Ricin poisoning)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4243	Lab Test Name (Mushroom poisoning)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4244	Lab Test Name (Carbon monoxide poisoning)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4245	Lab Test Name (Pesticide poisoning)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4246	Lab Test Name (Arsenic poisoning)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4247	Lab Test Name (Cadmium poisoning)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4248	Lab Test Name (Lead poisoning)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4249	Lab Test Name (Mercury poisoning)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4250	Lab Test Name (Acid fast stain)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4251	Lab Test Name (Bacteria)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4252	Lab Test Name (Fungus)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4253	Lab Test Name (Microorganism)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4254	Lab Test Name (Mycobacteria)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4255	Lab Test Name (Parasite)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4256	Lab Test Name (Virus)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4257	Lab Test Name (Antimicrobial susceptibility tests)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4258	Lab Test Name (TB Antimicrobial susceptibility test)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4275	Lab Result (Cancer Morphology)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4276	Lab Result (Pesticide)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5000	Universal Identifier (HL7) (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5001	Specimen Type PHLIP	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5002	Order Control Codes (HL7) (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5004	Specimen Reject Reason (SCT) (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5005	Lab Test Order (PHLIP Sal)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5006	Value Type (HL7) (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5007	Specimen Related Observations (PHLIP Sal)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5013	Suspected Agent (PHLIP Sal)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5014	Observation Result Status (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5015	Role (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5016	Organization Unit (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5017	Resulted Lab Test Name PHLIP Salmonella	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5020	Acknowledgment Code (HL7) (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5021	Original Specimen Source Site PHLIP (PLT212)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5022	Original Specimen Source Site Modifier PHLIP	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5023	Original Specimen Collection Method PHLIP	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5024	Original Specimen Type PHLIP	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5026	Lab Test Result PHLIP Salmonella	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5027	Identifier Type (HL7) (PHLIP for PID3.5)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5028	Method Detail (PHLIP)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6000	Problem Goal Action Code (HL7)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6001	Certifier Types (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6002	Manner of Death (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6003	Pregnancy Status (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6004	Contributory Tobacco Use (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6005	Transportation Relationships (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6006	Legacy Reporting Jurisdiction (CDS)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6013	Lab Test Type (Hepatitis)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6014	Lab Test Type Enzymes (Hepatitis)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6027	Smoking Status (PI)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6036	Occupation (Census)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6037	Industry (Census)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6038	Morphology of Neoplasms ICD-9-CM	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6039	Funding Eligibility Observation Method (IIS)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6040	VIS Vaccines (IIS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6041	VIS Bar Codes (IIS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6046	Specimen Type (HL7)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6047	Message Structure (Syndromic Surveillance)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6048	Event Type (Syndromic Surveillance)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6049	Message Type (Syndromic Surveillance)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6050	Universal ID Type (Syndromic Surveillance)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6053	Lab Test Name (Reportable Conditions)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6054	Lab Test Result (Reportable Conditions)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6055	Lab Test Name (HEDIS)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6056	Name Type (Syndromic Surveillance)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6057	Value Type (Syndromic Surveillance)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6062	Observation Result Status Interpretation Codes	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6063	Universal ID Type (IIS)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6064	Value Type (ELR)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6065	Race (HL7)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6066	Ethnic Group (HL7)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6067	Universal ID Type (ELR)	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6069	NAACCR ICD-10-CM Cancer Reportability List	active	2012-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6070	Infections During Pregnancy - Live Birth (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6071	Gonorrhea (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6072	Trachoma (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7055	Antituberculosis Drugs (TB)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7102	VPD Lab Test Identifiers	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103	VPD Laboratory Coded Observation	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7104	VPD Specimen Type	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7105	VPD Specimen Collection Method	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7106	VPD Specimen Source Body Site	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7107	VPD Specimen Role	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7108	VPD Specimen Condition	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7109	VPD Lab Order Identifier	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7110	VPD Specimen Reject Reason	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7111	Birth Attendant Titles (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7112	Fetal Death Time Points (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7113	Fetal Presentations (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7115	Karyotype Suspected Chromosomal Disorder (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7116	Karyotype Down Syndrome (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7117	Labor and Delivery Characteristics (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7118	Delivery Routes (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7119	Maternal Morbidities (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7121	Newborn Abnormal Conditions (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7122	Newborn Congenital Anomalies (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7123	Onset Labor (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7124	Birth or Delivery Occurred (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7126	Pregnancy Risk Factors (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7129	Employment Status (ODH)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7130	Work Schedule (ODH)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7135	Infections During Pregnancy Fetal Death (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7136	Obstetric Procedures (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7137	Autopsy Examination (NCHS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7138	Histological Placental Examination (NCHS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7140	Autopsy Planned (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7142	Non-Vertex Presentation (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7143	Steroids For Fetal Lung Maturation (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7144	Assisted Ventilation Minutes After Birth (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7145	Assisted Ventilation More Than Six Hours (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7153	Estimated Time of Death No Labor Ongoing (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7154	Fetal Presentation at Birth- Unknown (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7155	Height (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7156	Assisted Ventilation (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7157	Binational Reporting Criteria	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7158	State or Province of Exposure	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7159	Mexican Health Jurisdictions (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7162	Country (GEC)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7163	Birth and Fetal Death Financial Class (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7164	Birth and Fetal Death Report Event Reason (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7165	Previous Cesarean (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7166	Binational Reporting Criteria (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7167	Case Transmission Mode (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7168	Notifiable Event Disease Condition (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7169	US Mexico States (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7170	Specimen Site (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7171	Salmonella Serogroup (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7172	Shigella Serogroup (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7173	Campylobacter Species (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7174	Campylobacter Nonculture Test Type (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7175	E. coli Culture Isolate Id Serotype (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7176	STEC Nonculture Test Type (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7177	E. coli Shiga Toxin Test Type (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7178	E. coli Shiga Toxin (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7179	Vibrio Culture Species (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7180	Vibrio Serotype (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7181	Vibrio Biotype (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7182	Vibrio Cholera Toxin Test Type (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7183	Listeria Culture Species (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7184	Occupation CDC Census 2002	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7185	Industry CDC Census 2002	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7186	Occupation CDC Census 2010	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7187	Industry CDC Census 2010	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7188	Travel Reason (Hepatitis A)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7189	Specimen Source (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7190	Current Sex (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7191	Syphilis Neurologic Involvement (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7192	HIV Status (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7193	YNRD (CDC)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7194	Drugs Used (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7195	Clinician Observed Lesions (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7196	Non Treponemal Serologic Test (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7197	Treponemal Serologic Test (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7198	Transmission Category (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7199	Detection Method (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7200	Lab Results (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7201	Lab Tests (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7202	Country Imported From (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7203	Quantitative Syphilis Test Result (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7204	Race Category including Refused	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7205	Race Category including Null Flavor	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7206	Lab Test Result Qualitative (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7208	Newborn Vital Signs (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7209	Maternal Vital Signs (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7210	Apgar Assessments (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7211	Influenza Transmission Zones (PHLIP)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7212	Certifier Titles (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7213	PHIN Questions (BIDS)	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7216	Place of Death (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7217	Lab Test Reactivity (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7218	Syphilis Clinical Stage (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7219	Syphilis Surveillance Stage (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7220	Pregnancy Treatment Stage (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7221	Syphilis Treatment Mother (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7222	Serologic Response (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7223	Birth Status (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7224	Darkfield DFA Result (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7225	Signs Symptoms (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7226	X-Ray Result (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7227	VDRL Test Result (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7228	CSF WBC Protein Result (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7229	Syphilis Treatment Infant (CS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7231	Result Status (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7234	Qual Lab Result Positive (Reportable Conditions)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7235	Qual Lab Result Negative (Reportable Conditions)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7236	Qual Lab Result Inconc (Reportable Conditions)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7243	Lab Test Name (Ebolavirus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7244	History of Disease as Evidence Of Immunity (IIS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7245	Serological Evidence Of Immunity (IIS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7246	Vital Signs (Syndromic Surveillance)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7247	Symptoms (EVD Triage)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7248	Countries Widespread Transmission (EVD)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7249	Exposure Risk (EVD)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7250	Observation Identifiers (EVD Triage)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7256	Morphologic Abnormalities of Neoplasms	draft
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7257	Abdominal Pain (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7258	Weakness (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7259	Fever (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7260	Headache (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7261	Hemorrhage (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7262	Muscle Pain (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7263	Vomiting (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7264	Diarrhea (CDS - EHR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7265	Duration Unit	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7267	Death Report Observation Identifier (NCHS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7268	Data Elements (NND Gen V2)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7269	Reason for Missing Test (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7270	Lab Test Result Interpretation (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7271	Case Notification Specification Version (NND)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7272	Case Notification MMG Version (NND)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7273	Death Pronouncement Finding (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7274	Death Pronouncement Procedure (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7275	Nationally Notifiable Event Code (Hepatitis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7276	Nationally Notifiable Event Code (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7277	Transport Mode to Hospital (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7278	Lab Test Performed Modifier (CS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7279	Non-Treponemal Test Result (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7282	Complications (Mumps)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7283	Signs and Symptoms (Mumps)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7284	Signs and Symptoms (Pertussis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7285	Complications (Pertussis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7328	1 Min Apgar Score (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7329	Type of Testing at CDC (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7330	Performing Laboratory Type (VPD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7331	Vaccine Administered (MMR)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7332	Setting of Further Spread	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7333	Timing of Maternal Treatment (NND)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7334	Lab Test Interpretation (Pertussis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7335	Vaccine Administered (Pertussis)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7336	Lab Test Type (Mumps)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7337	Lab Test Type (Pertussis)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7339	Lab Test Name (Chikungunya virus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7340	Lab Test Name (Junin Hemorrhagic fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7341	Lab Test Name (Lassa fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7342	Lab Test Name (Marburgvirus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7343	Lab Result (Chikungunya virus)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7344	Lab Result (Crimean-Congo hemorrhagic fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7345	Lab Result (Guanarito hemorrhagic fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7346	Lab Result (Junin hemorrhagic fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7347	Lab Result (Lassa fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7348	Lab Result (Lujo virus)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7349	Lab Result (Machupo hemorrhagic fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7350	Lab Result (Sabia virus hemorrhagic fever)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7351	Lab Test Performed Modifier (NND)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7352	No Prenatal Care Visit (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7354	Part/line Number	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7356	Diagnosis (ICD-10 CM)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7357	Hysterectomy (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7358	Hysterotomy (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7359	Point of Origin (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7360	Discharge Disposition IP (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7361	Disposition OPD (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7362	Follow-up Attempt Outcome (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7363	Specialty Unit Type (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7364	Type of clinic/location (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7365	Priority (Type) of Admission or Visit (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7366	Relationship (NND)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7367	Exposure Time Frame (NND)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7369	Present on Admission (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7370	Activity Type (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7371	Procedure (ICD-10 PCS)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7372	Time Units (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7373	Race (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7374	Place of Injury (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7375	Ethnicity Group (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7376	Ethnicity Detail (NCHS)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7377	Bridged Race (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7378	Death Reporting Name Type Code (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7379	Methods of Disposition (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7380	Marital Status (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7382	Death Reporting Identifier Type (HL70203) (NCHS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7383	Death Reporting Event Reason (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7385	Decedent Education Level (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7386	Death Reporting Profiles (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7387	Edit Flags (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7388	Education Level Edit Flags (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7389	Intentional Reject Edit Flags (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7390	Marital Status Edit Flags (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7391	Pregnancy Edit Flags (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7392	Race Coding Flag (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7393	Source Flags (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7395	System Reject Codes (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7396	Transax Conversion Flag (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7397	Void Flags (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7398	Nationally Notifiable Event Code (Syphilis)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7401	Triage System (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7402	Patient Residence (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7403	Injury or Poisoning (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7404	Major reason for visit (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7405	Co-morbid Conditions (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7419	Provider ED (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7421	Body Weight (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7422	Fetal Death Cause or Condition (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7423	Pregnancy Resulting From Fertility Enhancing Drugs	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7426	Estimated Time Of Fetal Death (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7430	Histological Placental Exam Performed (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7431	Surfactant Replacement Therapy (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7432	Asthma (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7433	Condition Control (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7436	Disposition (NCHS)	active	2014-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7437	Disposition ED (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7438	Application Error Code (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7439	Episode of Care (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7440	Hospital Discharge Status (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7441	Neurological Manifestation (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7442	Death Reporting Event Type (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7443	Death Reporting Message Structure (NCHS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7444	Death Reporting Message Type (NCHS)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7446	States Territories Provinces (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7447	Nationally Notifiable Event Code (Generic)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7448	Vaccine Type (NND)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7449	Qualitative Lab Result (RCMT)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7450	Vaccine Event Information Source (NND)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7451	Type of Testing at CDC (VZ)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7452	Age Unit (NND)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7453	Body Region(s) of Rash	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7454	Character of Lesions	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7456	Lab Test Type (Varicella)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7457	Zika-affected areas	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7458	Transmission Mode (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7459	Signs Symptoms (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7460	Signs Symptoms (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7462	Prenatal Diagnostic Procedures	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7463	Specimen Type (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7464	Insect Repellant	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7465	Vector (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7466	Complications (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7467	Drug Disease Interaction (Dengue)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7468	Length of Gestation in Weeks	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7469	Microcephaly Causes	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7470	Head Circumference Findings	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7472	Lab Test Type (Arbovirus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7473	Diagnostic Lab Test Findings (NND)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7474	Type of Complication (VZ)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7475	Epidural/Spinal Anesthesia - Medication (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7476	Positive Negative Equivocal Not Done	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7477	Positive Negative 4 Fold Rise Not Done	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7478	Serotype (Dengue)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7479	Lab Result (Zika virus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7480	Lab Test Name (Zika virus)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7481	Signs Symptoms (Dengue)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7482	Signs Symptoms (Chikungunya)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7483	Signs Symptoms Dengue ICD-10 CM	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7484	Signs Symptoms Chikungunya ICD-10 CM	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7485	Signs Symptoms Zika ICD-10 CM	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7486	Yes No Not Applicable (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7487	Reason for Hospitalization (VZ)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7488	Specimen Type (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7489	Transmission Mode (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7490	Clinical Syndrome - Secondary (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7491	Pregnancy Complications (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7492	Newborn Complications (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7493	Performing Lab Type (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7494	Pregnancy Outcome	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7495	Serotype (Arbovirus)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7496	Death Reporting Observation Result Status (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7497	Death Reporting Value Type (NCHS)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7512	City Places (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7513	Message Error Condition Codes (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7515	Data Elements (NND Hep Core)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7516	Data Elements (NND Hep A Acute)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7517	Data Elements (NND Hep B Acute)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7518	Data Elements (NND Hep B Perinatal)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7519	Data Elements (NND Hep B Chronic)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7520	Data Elements (NND Hep C Acute)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7521	Data Elements (NND Hep C Chronic)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7522	Data Elements (NND Mumps)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7523	Data Elements (NND Pertussis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7524	Data Elements (NND STD)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7525	Data Elements (NND CS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7526	Method of Delivery VaginalSpon Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7527	Method of Delivery Cesarean Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7528	Method of Delivery Vaginal Forceps Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7529	Method of Delivery Vaginal Vacuum Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7530	Scheduled Cesarean Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7531	Induction of Labor Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7532	Augmentation of Labor Finding (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7536	Height Unit (CDC)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7537	Duration Unit (1)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7538	Type of Complication (Babesiosis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7539	Medication Treatment (Babesiosis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7540	Blood Product	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7541	Clinical Manifestations (Babesiosis)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7542	Lab Test Name (Hantavirus Infection)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7543	Lab Result (Hantavirus Infection)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7544	Outdoor Activities	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7545	Lab Test Type (Babesiosis)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7546	NAT Tests (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7547	IgM Ab Tests (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7548	Neutralizing Ab Tests (Zika)	active	2016-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7549	Test Type (Syphilis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7550	Lab Test Type (STD)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7551	Test Result Coded Qualitative	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7552	Organism Identified AST (STD)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7553	Specimen Type AST (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7554	Specimen Collection Site AST (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7555	Susceptibility Test Type (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7556	Susceptibility Test Method (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7557	Susceptibility Test Interpretation (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7558	Susceptibility Test Result Units (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7559	Susceptibility Test Result Quantitative (STD)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.756	Gender Identity	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7563	Sexual Orientation	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7564	Birth Reporting Address Type (NCHS)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7565	Birthdate Edit Flags (NCHS)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7566	Pregnancy Report Edit Flags (NCHS)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8033	Frequency Duration Unit (Hansen)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8034	Medication Duration Unit (Hansen)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8035	Subject of Medication Received (Hansen)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8036	Antibiotic Dose Units (Brucellosis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8037	Test Type (Brucellosis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8038	Specimen Source Site (Brucellosis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8039	Test Results (Leptospirosis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8040	Pregnancy Outcome (Leptospirosis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8041	Lab Test Type (Leptospirosis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8042	Test Result (Hepatitis A)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8043	HBeAg Test Result (Hepatitis B Perinatal)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8044	Infant Nucleic Acid Test Result (Hepatitis C)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8045	Infant HCV Antigen Test Result (Hepatitis C)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8046	Mother Nucleic Acid Test Result (Perinatal Hep)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8047	Common-Source Outbreak (Hepatitis A)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8048	Common-Source Outbreak (Hepatitis B)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8049	Common-Source Outbreak (Hepatitis C)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8050	Other Case Hepatitides (Hepatitis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8051	Patient Epidemiological Risk Factors (Hepatitis A)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8052	Patient Epidemiological Risk Factors (Hepatitis B)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8053	Patient Epidemiological Risk Factors (Hepatitis C)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8054	Alanine aminotransferase (ALT) Result (Hepatitis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8055	Source of Laboratory Test (Hepatitis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8056	HBsAg Test Result (Hepatitis B Perinatal)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8057	Infant Anti-HCVTest Result (Hepatitis C Perinatal)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8058	Nucleic Acid Viral Load Test Result (Hepatitis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8059	Signs and Symptoms (Hepatitis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.806	Allergen Type (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8060	Test Result (Hepatitis)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8061	HBV DNA Test Result (Hepatitis B Perinatal)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8062	Gender Identity (USCDI)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8063	Sexual Orientation (USCDI)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8064	Travel Purpose (CDC)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8065	Occupation CDC Census 2018	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8066	Industry CDC Census 2018	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8067	Industry CDC NAICS 2017	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8068	Occupation CDC SOC 2018	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.807	Allergy Severity (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.808	Degree License Certification (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.809	Marital Status (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.810	Name Type (HL7)	active	2011-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.811	Observation Result Status (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.812	Production Class (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.813	Relationship (HL7)	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.814	Religion (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.815	Result status (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.816	Route of Administration (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.817	Telecommunication Equipment Type (HL7)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.818	Telecommunication Use Code (HL7)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.819	Yes No Indicator (HL7)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.820	Expanded Yes No (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.821	Treatment Completion Status (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.822	Referral Priority (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.823	Referral Reason (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.825	Referral Disposition (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.826	Manufacturers of vaccines (MVX)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.827	Diagnosis Type (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.828	Country	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.829	County	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.830	State	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.831	Language	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.834	Allergen	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.836	Race Category	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.837	Ethnicity group	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.838	Units of Measure	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.856	Diagnosis (ICD-9 CM)	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.875	Null Flavor (HL7 V3)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.876	Detailed Race	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.877	Detailed Ethnicity	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.878	Age unit	active	2015-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.879	Weight Unit	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.883	PHIN Questions	active	2013-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.887	Occupation	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.888	Yes No Unknown (YNU)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.891	Height Unit	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.909	Disease	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.912	Admission Level of Care (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.913	Admission Type (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.914	Diagnosis Priority (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.915	Discharge Disposition (HL7)	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.916	Medical Specialty (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.917	Patient Class (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.918	Admission Source (HL7)	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.919	Temperature Unit	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.920	Blood Pressure Unit	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.921	Emergency Department Acuity	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.922	Diagnostic service section ID (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.923	Order Control Code (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.925	Pharmacy Order Type (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.927	Administrative Sex (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.928	True False (TF)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.929	Positive Negative Unknown Not Done	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.930	Chest XRay Result	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.931	Vaccine Not Given Reason	active	2021-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.934	Vaccines administered (CVX)	active	2022-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.941	Susceptibility Result	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.945	Industry (SIC)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.946	Specimen	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.950	Passed Failed Unknown	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.954	BioSense Observations	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.957	Abnormal Chest X-Ray Finding (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.958	Acknowledgment Code (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.959	Additional Site of Disease (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.960	Specimen Additive or Preservative (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.961	Address Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.962	Procedure (ICD-9 CM)	active	2010-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.963	Consequence of Adverse Event	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.964	Adverse Event Previously Reported	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.965	Amplification and Extraction Kit	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.967	Body site	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.968	Case Classification Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.969	Case investigation closure reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.970	Case Investigation Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.972	Case Verification (TB)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.973	City	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.974	Message Error Condition Codes (HL7)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.975	Comment Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.976	Confidentiality Code (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.977	Contact Role	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.979	Type of Correctional Facility	active	2019-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.980	Diagnosed by (VZ)	active	2017-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.981	Diagnosed Pneumonia By (VZ)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.982	Directly Observed Therapy (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.983	Sites of Directly Observed Therapy (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.984	Dwelling Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.985	Employment Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.986	Encoding Type (HL7)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.988	Countermeasure Encounter Purpose	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.989	Countermeasure Encounter Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.990	Specimen Handling Code	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.991	Environmental Investigation Reason	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.992	Epilinked Case Type (VZ)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.993	Error Severity (HL7)	active	2018-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.994	General Condition Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.995	Health Care Practice Type (TB)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.996	History Source (CRA)	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.997	HIV Diagnosis Based On	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.998	HIV Status	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.999	Identifier Type	active	2008-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.3.20	Specimen Source Site (Anthrax)	active	2020-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.5.301	Immunization Service Funding Eligibility Value Set	active	2009-01
us.cdc.phinvads	R4	http://phinvads.cdc.gov/fhir/ValueSet/6.1.4.1.19376.1.7.3.1.1.13.8.64	Limb Reduction Defect (NCHS)	active	2014-01
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/qualification	Qualification	active	2022-04	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/region	SignalRegion	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceReferred	SignalServiceReferred	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestAuthorizedAmount	SignalServiceRequestAuthorizedAmount	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestDateOfReferral	SignalServiceRequestDateOfReferral	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestGuardian	SignalServiceRequestGuardian	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestNoOfUnits	SignalServiceRequestNoOfUnits	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFee	SignalServiceRequestParentFee	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFlatRate	SignalServiceRequestParentFlatRate	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestPatient	SignalServiceRequestPatient	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestProvider	SignalServiceRequestProvider	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestReferringOrg	SignalServiceRequestReferringOrg	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsClientID	SignalServiceRequestTrailsClientID	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsCountyHouseholdID	SignalServiceRequestTrailsCountyHouseholdID	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsID	SignalServiceRequestTrailsID	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/StateActivityStatus	SurveyStateActivityStatus	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo	Patient Adoption Info	draft	2023-06	hl7
signal.core.r4	R4	http://hl7.org/fhir/StructureDefinition/no-fixed-address	Patient No Fixed Address	draft	2023-05	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/documentreference	DocumentReference Profile	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/account	Account Profile	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/encounter	Encounter Profile	active		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/episodeofcare	EpisodeOfCare Profile	active		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/healthcareservice	HealthcareService Profile	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/invoice	Invoice	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/location	Location Profile	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/organization	Organization Profile	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/patient	Patient Profile	draft	2023-06	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/practitionerrole	PractitionerRole Profile	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/SignalQuestionnaireResponse	SignalQuestionnaireResponse	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/StructureDefinition/servicerequest	ServiceRequest Profile	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/omb-race-category	OMB Race Categories	active	2022-09	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/contact-attempt-results	Contact Attempt Results	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-category	Signal Healthcare Service Category	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/signal-program	Signal Program	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-type	Signal Healthcare Service Type	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/signal-organization-license	Signal Organization License	active	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/us/core/CodeSystem/signal-organization-type	Signal Organization Type	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/place-of-service	Place Of Service	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/progress-made-towards-goals	Progress Made Towards Goals	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/provider-taxonomy-na	Provider Taxonomy NA	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-action-types	Questionnaire CCARS Action Types	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-activity-involvement-rating	Questionnaire CCARS Overall Activity Involvement Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-aggression-danger-to-others-rating	Questionnaire CCARS Aggression Danger To Others Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-alcohol-use-rating	Questionnaire CCARS Alcohol Use Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-cognition-rating	Questionnaire CCARS Cognition Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-considerations-for-providers	Questionnaire CCARS Considerations For Providers	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-issues	Questionnaire CCARS Current Issues	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-living-arrangement	Questionnaire CCARS Current Living Arrangement	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-non-prescription-substance-use	Questionnaire CCARS Current Non-Prescription Substance Use	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-primary-role	Questionnaire CCARS Current Primary Role	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-depressive-issues-rating	Questionnaire CCARS Depressive Issues Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-disabilities	Questionnaire CCARS Disabilities	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-drug-use-rating	Questionnaire CCARS Drug Use Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-empowerment-rating	Questionnaire CCARS Empowerment Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-enrollment-payer	Questionnaire CCARS Enrollment Payer	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-ethnicity	Questionnaire CCARS Ethnicity	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-existence-presenting-problem	Questionnaire CCARS Existence Presenting Problem	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-family-rating	Questionnaire CCARS Family Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-gender	Questionnaire CCARS Gender	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-highest-education-level	Questionnaire CCARS Highest Education Level	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-current-victimization	Questionnaire CCARS History Current Victimization	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-issues	Questionnaire CCARS History Of Issues	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-mental-health-services	Questionnaire CCARS History Of Mental Health Services	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-hope-rating	Questionnaire CCARS Hope Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-interpersonal-rating	Questionnaire CCARS Interpersonal Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-rating	Questionnaire CCARS Legal Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-status	Questionnaire CCARS Legal Status	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-marital-status	Questionnaire CCARS Marital Status	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-medication-psychiatric-service	Questionnaire CCARS Medication Psychiatric Service	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-mental-health-services-program	Questionnaire CCARS Mental Health Services Program	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-multiple-issues-rating	Questionnaire CCARS Multiple Issues Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-level-of-functioning-rating	Questionnaire CCARS Overall Level Of Functioning Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-recovery-rating	Questionnaire CCARS Overall Recovery Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-symptom-severity-rating	Questionnaire CCARS Overall Symptom Severity Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-physical-health-rating	Questionnaire CCARS Physical Health Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-place-of-residence	Questionnaire CCARS Place Of Residence	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-previous-concurrent-services	Questionnaire CCARS Previous Concurrent Services	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-psychosis-rating	Questionnaire CCARS Psychosis Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-race	Questionnaire CCARS Race	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-rae-aso-identification-codes	Questionnaire CCARS RAE ASO Identification Codes	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-reason-for-discharge	Questionnaire CCARS Reason For Discharge	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-role-performance-rating	Questionnaire CCARS Role Performance Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-development	Questionnaire CCARS School Development	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-problems	Questionnaire CCARS School Problems	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-security-supervision-rating	Questionnaire CCARS Security Supervision Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-self-care-basic-needs-rating	Questionnaire CCARS Self Care Basic Needs Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-sexual-orientation	Questionnaire CCARS Sexual Orientation	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-social-support-rating	Questionnaire CCARS Social Support Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-socialization-rating	Questionnaire CCARS Socialization Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-suicide-danger-to-self-rating	Questionnaire CCARS Suicide Danger To Others Rating	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-tobacco-use	Questionnaire CCARS Tobacco Use	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-discharge	Questionnaire CCARS Type Of Discharge	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-update	Questionnaire CCARS Type Of Update	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-na	Questionnaire CCARS Yes No NA	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-unable-to-assess	Questionnaire CCARS Yes No Unable To Assess	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no	Questionnaire CCARS Yes No	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-admission-route-of-administration	Questionnaire DACODS Admission Route Of Administration	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-client-disability	Questionnaire DACODS Client Disability	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-clinician-diagnostic-impression	Questionnaire DACODS Clinician Diagnostic Impression	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals	Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-route-of-administration	Questionnaire DACODS Discharge Route Of Administration	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-status	Questionnaire DACODS Discharge Status	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-drug-type-code	Questionnaire DACODS Drug Type Code	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-education-employment-problems	Questionnaire DACODS Education Employment Problems	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-employment-status	Questionnaire DACODS Employment Status	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-family-issues-and-problems	Questionnaire DACODS Family Issues And Problems	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-health-insurance-status	Questionnaire DACODS Health Insurance Status	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-living-situation	Questionnaire DACODS Living Situation	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-marital-status	Questionnaire DACODS Marital Status	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-medical-physical-problems	Questionnaire DACODS Medical Physical Problems	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-reason-for-discharge	Questionnaire Dacods Reason For Discharge	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-secondary-tertiary-drug-type-code	Questionnaire DACODS Secondary Tertiary Drug Type Code	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-sexual-orientation	Questionnaire DACODS Sexual Orientation	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-socialization-problems	Questionnaire DACODS Socialization Problems	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-illicit-drugs	Questionnaire DACODS Source Of Illicit Drugs	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-income	Questionnaire DACODS Source Of Income	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-payment-for-treatment	Questionnaire DACODS Source Of Payment For Treatment	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-statutory-commitment	Questionnaire DACODS Statutory Commitment	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-tobacco-use	Questionnaire DACODS Tobacco Use	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-transfer-referral-source	Questionnaire DACODS Transfer Referral Source	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-na	Questionnaire DACODS Yes No NA	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unable-to-assess	Questionnaire DACODS Yes No Unable To Assess	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unknown	Questionnaire DACODS Yes No Unknown	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no	Questionnaire DACODS Yes No	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/reason-for-discharge	Reason For Discharge	draft	2023-08	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-classification	Signal FileRepo Classification	draft	2019-11	hl7
signal.core.r4	R4	http://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-docreviewstatus	Signal FileRepo Doc Review DocStatus	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/CodeSystem/signal-region	Signal Region	active	2023-09	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/us/core/CodeSystem/signal-state-activity-status	Signal State Activity Status	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-observation-category	US Core Screening Assessment Observation Category	active	2023-03	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/account-status	AccountStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/account-type	Account Types	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/fips-county-co	CO FIPS Counties	draft	2023-06	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/address-type	AddressType	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/address-use	AddressUse	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/birthsex	Birth Sex	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/chargeitem-status	ChargeItemStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/composition-status	CompositionStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/condition-clinical	Condition Clinical Status Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/condition-severity	Condition/Diagnosis Severity	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/condition-ver-status	ConditionVerificationStatus	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/contact-attempt-results	Contact Attempt Results	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/coverage-class	Coverage Class Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/coverage-copay-type	Coverage Copay Type Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/coverage-financial-exception	Example Coverage Financial Exception Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/data-absent-reason	DataAbsentReason	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/days-of-week	DaysOfWeek	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/detailed-ethnicity	Detailed ethnicity	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/detailed-race	Detailed Race	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/device-action	Procedure Device Action Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/device-kind	FHIR Device Types	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/diagnosis-role	DiagnosisRole	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/document-classcodes	Document Class Value Set	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/document-reference-status	DocumentReferenceStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/document-relationship-type	DocumentRelationshipType	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-admit-source	Admit source	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-diet	Diet	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-location-status	EncounterLocationStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-participant-type	Participant type	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-special-arrangements	Special arrangements	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-special-courtesy	Special courtesy	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/encounter-status	EncounterStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/episode-of-care-status	EpisodeOfCareStatus	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/episodeofcare-type	Episode of care type	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/event-status	EventStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/c80-facilitycodes	Facility Type Code Value Set	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/fm-status	Financial Resource Status Codes	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/formatcodes	DocumentReference Format Code Set	active	2019-11	hl7
signal.core.r4	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32	Gender Identity	active	2022-03	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-category	Signal Healthcare Service Category	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/healthcare-service-procedure-code-cpt	HealthCare Service Procedure Code CPT	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/signal-program	Signal Program	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-type	Signal Healthcare Service Type	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/identifier-use	IdentifierUse	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/invoice-priceComponentType	InvoicePriceComponentType	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/invoice-status	InvoiceStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/languages	Common Languages	draft	2016-08	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/location-mode	LocationMode	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/location-physical-type	Location type	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/location-status	LocationStatus	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/observation-category	Observation Category Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/observation-status	ObservationStatus	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/omb-ethnicity-category	OMB Ethnicity Categories	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/organization-role	Organization Affiliation Role	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/signal-organization-license	Signal Organization License	draft	2023-07	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/us/core/ValueSet/signal-organization-type	Signal Organization Type	draft	2023-07	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/performer-role	Procedure Performer Role Codes	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/place-of-service	Place Of Service	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/procedure-category	Procedure Category Codes (SNOMED CT)	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/procedure-followup	Procedure Follow up Codes (SNOMED CT)	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/procedure-not-performed-reason	Procedure Not Performed Reason (SNOMED-CT)	active	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/procedure-outcome	Procedure Outcome Codes (SNOMED CT)	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/progress-made-towards-goals	Progress Made Towards Goals	draft		hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/provider-taxonomy	Provider Taxonomy Codes	draft	2023-03	hl7
signal.core.r4	R4	http://terminology.hl7.org/ValueSet/v2-2.7-0360	v2 table 0360, Version 2.7	active		hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/questionnaire-answers-status	QuestionnaireResponseStatus	draft	2019-10	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-action-types	Questionnaire CCARS Action Types	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-activity-involvement-rating	Questionnaire CCARS Overall Activity Involvement Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-aggression-danger-to-others-rating	Questionnaire CCARS Aggression Danger To Others Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-alcohol-use-rating	Questionnaire CCARS Alcohol Use Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-cognition-rating	Questionnaire CCARS Cognition Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-considerations-for-providers	Questionnaire CCARS Considerations For Providers	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-issues	Questionnaire CCARS Current Issues	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-living-arrangement	Questionnaire CCARS Current Living Arrangement	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-non-prescription-substance-use	Questionnaire CCARS Current Non-Prescription Substance Use	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-primary-role	Questionnaire CCARS Current Primary Role	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-depressive-issues-rating	Questionnaire CCARS Depressive Issues Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-disabilities	Questionnaire CCARS Disabilities	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-drug-use-rating	Questionnaire CCARS Drug Use Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-empowerment-rating	Questionnaire CCARS Empowerment Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-enrollment-payer	Questionnaire CCARS Enrollment Payer	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-ethnicity	Questionnaire CCARS Ethnicity	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-existence-presenting-problem	Questionnaire CCARS Existence Presenting Problem	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-family-rating	Questionnaire CCARS Family Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-gender	Questionnaire CCARS Gender	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-highest-education-level	Questionnaire CCARS Highest Education Level	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-current-victimization	Questionnaire CCARS History Current Victimization	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-issues	Questionnaire CCARS History Of Issues	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-mental-health-services	Questionnaire CCARS History Of Mental Health Services	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-hope-rating	Questionnaire CCARS Hope Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-interpersonal-rating	Questionnaire CCARS Interpersonal Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-rating	Questionnaire CCARS Legal Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-status	Questionnaire CCARS Legal Status	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-marital-status	Questionnaire CCARS Marital Status	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-medication-psychiatric-service	Questionnaire CCARS Medication Psychiatric Service	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-mental-health-services-program	Questionnaire CCARS Mental Health Services Program	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-multiple-issues-rating	Questionnaire CCARS Multiple Issues Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-level-of-functioning-rating	Questionnaire CCARS Overall Level Of Functioning Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-recovery-rating	Questionnaire CCARS Overall Recovery Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-symptom-severity-rating	Questionnaire CCARS Overall Symptom Severity Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-physical-health-rating	Questionnaire CCARS Physical Health Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-place-of-residence	Questionnaire CCARS Place Of Residence	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-previous-concurrent-services	Questionnaire CCARS Previous Concurrent Services	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-psychosis-rating	Questionnaire CCARS Psychosis Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-race	Questionnaire CCARS Race	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-rae-aso-identification-codes	Questionnaire CCARS RAE ASO Identification Codes	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-reason-for-discharge	Questionnaire CCARS Reason For Discharge	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-role-performance-rating	Questionnaire CCARS Role Performance Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-development	Questionnaire CCARS School Development	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-problems	Questionnaire CCARS School Problems	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-security-supervision-rating	Questionnaire CCARS Security Supervision Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-self-care-basic-needs-rating	Questionnaire CCARS Self Care Basic Needs Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-sexual-orientation	Questionnaire CCARS Sexual Orientation	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-social-support-rating	Questionnaire CCARS Social Support Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-socialization-rating	Questionnaire CCARS Socialization Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-suicide-danger-to-self-rating	Questionnaire CCARS Suicide Danger To Others Rating	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-tobacco-use	Questionnaire CCARS Tobacco Use	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-discharge	Questionnaire CCARS Type Of Discharge	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-update	Questionnaire CCARS Type Of Update	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-na	Questionnaire CCARS Yes No NA	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-unable-to-assess	Questionnaire CCARS Yes No Unable To Assess	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no	Questionnaire CCARS Yes No	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-admission-route-of-administration	Questionnaire DACODS Admission Route Of Administration	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-client-disability	Questionnaire DACODS Client Disability	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-clinician-diagnostic-impression	Questionnaire DACODS Clinician Diagnostic Impression	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals	Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-route-of-administration	Questionnaire DACODS Discharge Route Of Administration	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-status	Questionnaire DACODS Discharge Status	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-drug-type-code	Questionnaire DACODS Drug Type Code	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-education-employment-problems	Questionnaire DACODS Education Employment Problems	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-employment-status	Questionnaire DACODS Employment Status	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-family-issues-and-problems	Questionnaire DACODS Family Issues And Problems	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-health-insurance-status	Questionnaire DACODS Health Insurance Status	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-living-situation	Questionnaire DACODS Living Situation	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-marital-status	Questionnaire DACODS Marital Status	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-medical-physical-problems	Questionnaire DACODS Medical Physical Problems	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-reason-for-discharge	Questionnaire Dacods Reason For Discharge	draft	2023-09	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-secondary-tertiary-drug-type-code	Questionnaire DACODS Secondary Tertiary Drug Type Code	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-sexual-orientation	Questionnaire DACODS Sexual Orientation	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-socialization-problems	Questionnaire DACODS Socialization Problems	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-illicit-drugs	Questionnaire DACODS Source Of Illicit Drugs	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-income	Questionnaire DACODS Source Of Income	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-payment-for-treatment	Questionnaire DACODS Source Of Payment For Treatment	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-statutory-commitment	Questionnaire DACODS Statutory Commitment	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-tobacco-use	Questionnaire DACODS Tobacco Use	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-transfer-referral-source	Questionnaire DACODS Transfer Referral Source	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-na	Questionnaire DACODS Yes No NA	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unable-to-assess	Questionnaire DACODS Yes No Unable To Assess	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unknown	Questionnaire DACODS Yes No Unknown	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no	Questionnaire DACODS Yes No	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/reason-for-discharge	Reason For Discharge	active	2023-06	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/referencerange-appliesto	Observation Reference Range Applies To Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/referencerange-meaning	Observation Reference Range Meaning Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/service-provision-conditions	ServiceProvisionConditions	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/service-referral-method	ReferralMethod	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/request-intent	RequestIntent	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/servicerequest-orderdetail	Service Request Order Details Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/request-priority	RequestPriority	draft	2016-07	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/request-status	RequestStatus	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/service-type	Service type	draft	2019-11	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-classification	Signal FileRepo Classification	draft	2023-09	hl7
signal.core.r4	R4	http://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-docreviewstatus	Signal FileRepo DocStatus	draft	2023-09	hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/signal-organization-qualification	Signal Organization Qualification	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/ValueSet/signal-region	Signal Region	draft		hl7
signal.core.r4	R4	https://signalbhn.org/fhir/us/core/ValueSet/signal-state-activity-status	Signal State Activity Status	draft	2023-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/subscriber-relationship	SubscriberPolicyholder Relationship Codes	draft	2019-11	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/contact-point-system	ContactPointSystem	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/ValueSet/contact-point-use	ContactPointUse	draft	2019-10	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-discharge-disposition	US Core Discharge Disposition	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-encounter-type	US Core Encounter Type	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-problem-or-health-concern	US Core Problem or Health Concern	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-condition-category	US Core Screening Assessment Condition Category	active	2023-04	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category	US Core ServiceRequest Category Codes	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-simple-observation-category	US Core Simple Observation Category	active	2022-09	hl7
signal.core.r4	R4	http://hl7.org/fhir/us/core/ValueSet/us-core-usps-state	USPS Two Letter Alphabetic Codes	active	2022-09	hl7
tiga.health.clinical	R4	http://tigahealth.com/SearchParameter/tiga-allergyintolerance-encounter	TigaAllergyIntoleranceEncounter	active	2022-09
tiga.health.clinical	R4	http://tigahealth.com/SearchParameter/tiga-immunization-encounter	TigaImmunizationEncounter	active	2022-10
tiga.health.clinical	R4	https://www.ama-assn.org/cdt	CDT, The Code on Dental Procedures and Nomenclature, produced by American Dental Association (ADA)	active
tiga.health.clinical	R4	http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx	HL7 Table 0292, Vaccine Administered (CVX) is a product of the National Center of Immunization and Respiratory Diseases (NCIRD). NCIRD is part of the Centers for Disease Control and Prevention (CDC).	active
tiga.health.clinical	R4	http://dicom.nema.org/	DICOM defines how to format images and image quality requirements that aid the exchange of images for clinical use.	active
tiga.health.clinical	R4	http://tigahealth.com/fhir/ConceptMap/cpt-hcpcs		active
tiga.health.clinical	R4	http://tigahealth.com/fhir/ConceptMap/dicom-loinc		active
tiga.health.clinical	R4	http://tigahealth.com/fhir/ConceptMap/hcpcs-cpt		active
tiga.health.clinical	R4	http://tigahealth.com/fhir/ConceptMap/loinc-dicom		active
tiga.health.clinical	R4	http://tigahealth.com/fhir/ConceptMap/snomed-dicom		active
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/CapabilityStatement/client	Argonaut Provider Directory Client	draft	2016-11	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/CapabilityStatement/server	Argonaut Provider Directory Server	draft	2017-04	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/ImplementationGuide/ig	Argonaut Provider Directory Implementation Guide	draft		hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-endpoint	Argonaut Provider Directory Endpoint	draft	2016-11	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-location	Argonaut Provider Directory Location	draft	2016-11	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-organization	Argonaut Provider Directory Organization	draft	2016-11	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-practitioner	Argonaut Provider Directory Practitioner	draft	2016-11	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-practitionerrole	Argonaut Provider Directory PractitionerRole	draft	2016-11	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/ValueSet/provider-role	Argonaut Provider Directory Provider Role (NUCC)	draft	2016-08	hl7
fhir.argonaut.pd	R3	http://fhir.org/guides/argonaut-pd/ValueSet/provider-specialty	Argonaut Provider Directory Provider Speciality (NUCC)	draft	2016-08	hl7
hl7.fhir.us.patient-reported-outcomes	R4	CapabilityStatement/server	Server	draft	2017-03	hl7
hl7.fhir.us.patient-reported-outcomes	R4	ImplementationGuide/ig	Patient Reported Outcomes	draft		hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ConceptMap/ndc-cvx	Argonaut NDC to CVX Code Mapping	active	2016-06	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ImplementationGuide/ig	Implementation Guide Template	draft		hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/OperationDefinition/docref	Argonaut Get DocumentReferences	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/SearchParameter/ethnicity	ArgonautEthnicity	draft	2016-12	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/SearchParameter/race	ArgonautRace	draft	2016-12	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-allergyintolerance	Argonaut AllergyIntolerance Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-birthsex	Sex of patient assigned at birth	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-careplan	Argonaut CarePlan Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-careteam	Argonaut CareTeam Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-condition	Argonaut Condition Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-device	Argonaut Device Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-diagnosticreport	Argonaut DiagnosticReport Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-documentreference	Argonaut DocumentReference Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-ethnicity	Argonaut ethnicity Extension	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-goal	Argonaut Goal Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-immunization	Argonaut Immunization Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-medication	Argonaut Medication Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-medicationorder	Argonaut MedicationOrder Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-medicationstatement	Argonaut MedicationStatement Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-observationresults	Argonaut Observation Results Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-patient	Argonaut Patient Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-procedure	Argonaut Procedure Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-profile-link	Profile-Resource Association	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-race	Argonaut Race Extension	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-resource-documentation	Resource level Documentation	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-smokingstatus	Argonaut Smoking Status Observation Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/StructureDefinition/argo-vitalsigns	Argonaut Vital Signs Observation Profile	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/argo-codesystem	Argonaut Extension Codes	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/condition-category	Argonaut Condition Category Codes	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/detailed-ethnicity	US-Core Detailed ethnicity	draft	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/detailed-race	US-Core Detailed Race	draft	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/device-kind	Argonaut Device Types	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/languages	All Languages	draft	2016-11	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/medication-codes	Medication Clinical Drug (RxNorm)	draft	2016-05	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/narrative-status	Narrative Status	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/ndc-vaccine-codes	Vaccine National Drug Code (NDC)	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/observation-ccdasmokingstatus	Smoking Status	active	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/observation-ccdavitalsignresult	Argonaut Vital Sign Codes	active	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/observation-value-codes	Observation Value Codes (SNOMED-CT)	draft	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/omb-ethnicity	OMB Ethnicity Categories	draft	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/omb-race	OMB Race Categories	active	2016-05	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/procedure-icd10pcs	Argonaut Procedure Type ICD-10-PCS Codes	draft	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/procedure-type	Argonaut ProcedureType	draft	2016-05	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/provider-role	Care Team Provider Roles	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/substance-ndfrt	DAF Substance ND-FRT codes	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/substance-rxnorm	DAF Substance RxNorm Codes	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/substance-sct	DAF SNOMED CT Substances Other Than Clinical Drugs	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/substance	Argonaut Substance-Reactant for Intolerance and Negation Codes	draft	2016-10	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/ucum-vitals-common	Argonaut Vital Signs Units	draft	2016-05	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/ucum	UCUM units	draft	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/usrealm-birthsex	USRealm Birth Sex Value Set	active	2016-08	hl7
fhir.argonaut.r2	R2	http://fhir.org/guides/argonaut/ValueSet/vacc-status	Argonaut Immunization Status	draft	2016-10	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-datamart	Data Mart	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-datasource	Data Source	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-research-queryrequester	Research Query Requester	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-research-queryresponder	Research Query Responder	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/CodeSystem/daf-research-data-models	DAF Research Data Models	draft	2017-04	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/CodeSystem/daf-research-query-formats	DAF Research Query Formats	draft	2017-04	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/ImplementationGuide/ig	Implementation Guide Template	draft		hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-execute-query	Execute Query	draft	2016-07	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-extract	Extract Data	draft	2016-07	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-load	Load Data	draft	2016-07	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-capabilitystatement	U.S. Data Access Framework (DAF) Capability Statement Profile	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-data-model	Data Models	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-operationdefinition	U.S. Data Access Framework (DAF) OperationDefinition Profile	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-provenance	U.S. Data Access Framework (DAF) Provenance	draft	2014-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-query-format	Query Formats	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-queryresults	U.S. Data Access Framework (DAF) Query Results	draft	2014-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-task	U.S. Data Access Framework (DAF) Task Profile	draft	2016-08	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-data-models	DAF Research Data Models	active	2016-07	hl7
hl7.fhir.us.daf	R3	http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-query-formats	DAF Research Query Formats	active	2016-07	hl7
fhir.tx.support.r4	R4	urn:oid:2.16.840.1.113883.3.1937.98.5.8	TemplateStatusCode LifeCycle	active	2013-12	hl7
fhir.tx.support.r4	R4	https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats	Australian Immunisation Register Vaccine	active	2021-03	hl7
fhir.tx.support.r4	R4	http://cap.org/eCP	College of American Pathologists Electronic Cancer Protocol (eCP) Codes	active	2023-03	hl7
fhir.tx.support.r4	R4	http://terminology.hl7.org/CodeSystem/ICHContextOfUse	ICH Context of Use	active	2025-05	hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/CodeSystem/MDC-concept-status	MDC Concept Status	active		hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/CodeSystem/MDC-designation-use	MDC Designation Use	active		hl7
fhir.tx.support.r4	R4	http://standardterms.edqm.eu	EDQM Standard Terms	active	2019-03	hl7
fhir.tx.support.r4	R4	http://terminology.hl7.org/CodeSystem/hl7-document-format-codes	HL7 Document Format Codes	active	2019-07	hl7
fhir.tx.support.r4	R4	urn:oid:2.16.840.1.113883.2.9.6.2.7	International Standard Classification of Occupations (ISCO)	active	2007-12	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/spdx-license	SPDXLicense	draft	2021-01	hl7
fhir.tx.support.r4	R4	https://www.usps.com/	US State Codes	active	2013-12	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/resource-names-r2-r3	Resource Names R2 to R3	active	2019-01	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/resource-names-r2-r4	Resource Names R2 to R4	active	2019-01	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/resource-names-r3-r2	Resource Names R3 to R2	active	2019-01	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/resource-names-r3-r4	Resource Names R3 to R4	active	2019-01	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/resource-names-r4-r2	Resource Names R4 to R2	active	2019-01	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/resource-names-r4-r3	Resource Names R4 to R3	active	2019-01	hl7
fhir.tx.support.r4	R4	http://fhir.org/packages/fhir.tx.support.r4/ImplementationGuide/fhir.tx.support.r4	FHIR Terminology Support Package	active		hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/ValueSet/MDC-dimension	MDC Unit of Measurement	active		hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/ValueSet/MDC-metric	MDC Metric nomenclature	active		hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/ValueSet/MDC-object	MDC Object infrastructure and Device nomenclature	active		hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/ValueSet/MDC-partition	MDC Partition codes	active		hl7
fhir.tx.support.r4	R4	http://devices.fhir.org/ValueSet/MDC	MDC Nomenclature	active		hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-gps-uv-ips	Allergy-intolerance substance-product - GPS - IPS	active	2021-05	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-snomed-extended-uv-ips	Allergy intolerance substance product - SNOMED CT extended - IPS	active	2021-05	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/ValueSet/covid-19-cond	COVID-19 related Condition codes	draft	2020-03	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/ValueSet/covid-19-obs	COVID-19 related Observation codes	draft	2020-03	hl7
fhir.tx.support.r4	R4	http://hl7.org/fhir/ValueSet/jurisdiction-common	Common Jurisdiction Codes	active	2020-09	hl7
fhir.tx.support.r4	R4	http://terminology.hl7.org/ValueSet/snomed-intl-ips	SNOMED CT® International Patient Set (IPS)	active	2022-06	hl7
fhir.tx.support.r4	R4	https://www.iana.org/time-zones	IANA Timezones	draft	2021-01	hl7
hl7.fhir.us.sdcde	R3	CapabilityStatement/sdc-de-curator	SDC Data Element Curator	draft	2014-07	hl7
hl7.fhir.us.sdcde	R3	CapabilityStatement/sdc-de-registry	SDC Data Element Manager	draft	2014-07	hl7
hl7.fhir.us.sdcde	R3	ImplementationGuide/sdcde	Structured Data Capture - Data Element Exchange	draft		hl7
hl7.fhir.us.sdcde	R3	StructureDefinition/sdcde-codesystem	Structured Data Capture Code System	draft	2014-07	hl7
hl7.fhir.us.sdcde	R3	StructureDefinition/sdcde-dataelement	Structured Data Capture Data Element Exchange	draft	2014-04	hl7
hl7.fhir.us.sdcde	R3	StructureDefinition/sdcde-valueset	Structured Data Capture Data Element Exchange Value Set	draft	2014-07	hl7
hl7.fhir.us.sdcde	R3	ValueSet/dataelement-sdccode	DataElement SDC Concept	draft	2017-04	hl7
hl7.fhir.us.immds	R4	CodeSystem/ForecastReason	Forecast Reason	active	2021-06	hl7
hl7.fhir.us.immds	R4	CodeSystem/ForecastStatus	Forecast Status	active	2021-06	hl7
hl7.fhir.us.immds	R4	CodeSystem/StatusReason	Evaluation Status Reason	active	2021-06	hl7
hl7.fhir.us.immds	R4	ImplementationGuide/hl7.fhir.us.immds	Immunization Decision Support Forecast (ImmDS) Implementation Guide	active	2021-06	hl7
hl7.fhir.us.immds	R4	OperationDefinition/ImmDSForecastOperation	Immunization Decision Support Forecast	draft	2021-06	hl7
hl7.fhir.us.immds	R4	StructureDefinition/immds-immunization	ImmDS Immunization	active	2021-06	hl7
hl7.fhir.us.immds	R4	StructureDefinition/immds-immunizationevaluation	ImmDS Immunization Evaluation	active	2021-06	hl7
hl7.fhir.us.immds	R4	StructureDefinition/immds-immunizationrecommendation	ImmDS Immunization Recommendation	active	2021-06	hl7
hl7.fhir.us.immds	R4	StructureDefinition/immds-patient	ImmDS Patient	active	2021-06	hl7
hl7.fhir.us.immds	R4	ValueSet/ForecastReason	Forecast Reason	active	2021-06	hl7
hl7.fhir.us.immds	R4	ValueSet/ForecastStatus	Forecast Status	active	2021-06	hl7
hl7.fhir.us.immds	R4	ValueSet/StatusReason	Evaluation Status Reason	active	2021-06	hl7
hl7.fhir.us.immds	R4	ValueSet/targetDisease	Vaccine Target Disease	active	2021-06	hl7
us.nlm.vsac	R4	ImplementationGuide/us.nlm.vsac	US VSAC Package	active
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.1280649	Sneezing and Itching Grouping	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.15972546	Conditions Indicating Appropriate Sinonasal Imaging	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16432390	Cerumen Impaction	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16929355	Allergic Rhinitis Grouping	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.18316962	Severe Asthma	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.19613338	Immunoglobulin G Testing Grouping	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.23618223	Hearing Aids Grouping	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.24927846	Specific IgE testing	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.26050446	Ear Surgery Affecting the Tympanic Membrane	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.26878039	Specific IgE Testing	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.29996863	Immunoglobulin G testing	active	2017-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.4352590	Benign Prostatic Hyperplasia	active	2017-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.8867.26816.649902	Office or Outpatient Encounter	active	2017-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.12009.10.2.5	LOINC Imaging Document Codes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45	Comfort Measures	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1	Selected non pharmaceutical therapies for moderate to severe chronic pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3	selected first line medications for pain control	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3	selected muscle relaxants for pain control	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3	Selected topical agents for pain control	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2	selected non opioids for moderate to severe pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2	Selected opioids for moderate to severe pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1	pain medication action plan	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1	Selected urine drug screens for opioids indicating testing is complete	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1	selected follow up visit intervals for opioid monitoring	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2	Selected urine screening for patients receiving opioid therapy	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1	Opioids used for pain control	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2	All prescribable opioids used for pain control including Inactive Medications	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.1	malignant neoplasms and cancer pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.2	malignant neoplasms and cancer pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7	malignant neoplasms and cancer pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9	malignancy or cancer related pain	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150	Cerumen on Otoscopy	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151	Cerumen on Otoscopy	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152	Cerumen on Otoscopy	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172	Hearing Loss	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173	Hearing Loss	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174	Hearing Loss	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175	Tinnitus	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176	Tinnitus	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177	Tinnitus	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178	Ear Congestion	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179	Ear Pruritus	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180	Otalgia	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181	Otalgia	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182	Otalgia	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96	Initial Encounter with Otolaryngologist or undefined clinician	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204	Hearing Aids	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205	Hearing Aids	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206	Hearing Aids	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81	Cerumen Impaction	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82	Cerumen Impaction	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188	Radiotherapy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189	Radiotherapy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190	Radiotherapy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191	Head and Neck Anatomic Locations	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192	Conditions Associated with Head and Neck Radiotherapy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193	Conditions Associated with Head and Neck Radiotherapy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194	Ear Canal Stenosis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195	Ear Canal Stenosis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196	Ear Canal Stenosis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197	Exostoses	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198	Exostoses	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199	Exostoses	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200	Non intact Tympanic Membrane	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201	Non Intact Tympanic Membrane	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202	Non Intact Tympanic Membrane	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246	Hearing Aids	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250	DO NOT USE	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251	Cerumenolytics	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252	Irrigation	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253	Irrigation	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288	Otoscopy performed on exam	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291	Otolaryngologist as a Clinician or Service	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123	Cerumen Impaction	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275	Dermatologic Diseases of the Ear	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20	Keratoses Obturans	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221	Tympanoplasty	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222	Tympanoplasty	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223	Myringoplasty	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224	Myringoplasty	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225	Mastoidectomy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229	Mastoidectomy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227	Ear Surgery, Other	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228	Ear Surgery, Other	active	2018-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334	Sleep Apnea	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335	Sleep Apnea	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336	Sleep Apnea	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237	Allergic Rhinitis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238	Allergic Rhinitis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239	Allergic Rhinitis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263	Uncontrolled or severe asthma	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264	Uncontrolled or severe asthma	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265	Uncontrolled or severe asthma	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300	Rhinosinusitis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301	Rhinosinusitis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302	Rhinosinusitis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303	Nasal Polyposis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304	Nasal Polyposis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305	Nasal Polyposis	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306	Suspected Nasal Neoplasm	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307	Suspected Nasal Neoplasm	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308	Suspected Nasal Neoplasm	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309	Other sinus conditions potentially requiring imaging	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310	Other sinus conditions potentially requiring imaging	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319	Intranasal Antihistamines	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320	Mast Cell Stabilizers	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321	Ophthalmic Antihistamines	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215	Sneezing as a finding	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216	Sneezing as a Clinical Condition	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217	Pruritus Unspecified or Other Location	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218	Pruritus Unspecified or Other Location	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272	Specific IgE Testing for Allergies	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273	Immunoglobulin G Testing	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274	Total IgE Testing	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290	Clinicians who perform allergy testing	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279	Radiography of face, head or neck	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315	Intranasal Corticosteroids	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316	Eustachian Tube Dysfunction	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317	Eustachian Tube Dysfunction	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318	Eustachian Tube Dysfunction	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287	Oral Second Generation and Less Sedating Antihistamines	active	2017-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266	Leukotriene antagonist	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267	Immunotherapy that is not Identified as Subcutaneous	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268	Immunotherapy	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653	Fidaxomicin	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654	Proton Pump Inhibitors not including for H. pylori treatment	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655	Clostridium difficile infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656	Clostridium difficile infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657	Clostridium difficile infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594	Complete Blood Count (with Diff)	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662	Metronidazole Systemic	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663	Vancomycin non injectable	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665	Creatinine	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722	Ileus due to infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723	Ileus due to infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724	Ileus due to infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725	Vomiting potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726	Vomiting potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727	Vomiting potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728	Toxic Megacolon in adults	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729	Toxic Megacolon in adults	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730	Toxic Megacolon in adults	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731	Abdominal Distension	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732	Abdominal Distension	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688	Septic Shock due to C. Diff	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689	Septic Shock due to C. Diff	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690	Septic Shock due to C. Diff	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658	Antiperistaltic agents to avoid in C. diff	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734	Systemic Antimicrobial Medications not used for CDI	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659	Recurrent Clostridium difficile infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660	History of CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661	Consult Infectious Disease	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691	Abdominal Xrays for CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692	CT of abdomen with contrast for fulminant CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693	Surgical consult for CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694	Fecal microbiota transplantation	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645	Hospitalist	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697	Positive result indicator	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698	Clostridium Difficile Test	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646	Body Temperature	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647	Body Temperature	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648	Diarrhea Potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649	Diarrhea Potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650	Diarrhea Potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651	Leukocyte count	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652	Inpatient Setting	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1	ONC Administrative Sex	active	2015-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1	Substance Reactant for Intolerance	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2	Clinical Substance	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.4	Medication Clinical Drug	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.5	Medication Clinical Brand specific Drug	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6	CVX Vaccines Administered Vaccine Set	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.7	Clinical Drug Ingredient	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8	Vaccine Clinical Drug	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9	Substance Other Than Clinical Drug	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240	SNOMED CT CORE Problem List	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98	Route of Administration	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101	Gender Identity USCDI core	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.102	Unknown or did not answer	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.103	Other or unknown or refused to answer	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12	Low Molecular Weight Heparin for VTE prophylaxis ingredient specific	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120	Patient Sex for Quality Measurement	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121	Federal Administrative Sex	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14	Published test VS	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.24	Birth Sex	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.30	AdministrationUnitDoseForm	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33	Sexual Orientation	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40	MDP Test Intensional	active	2019-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.41	MDP Test HL7 Intensional	active	2019-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.46	Device Magnetic resonance (MR) Safety	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.47	Device Latex Safety	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.48	Implantable Device Status	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56	Medical Reason Not Done SCT	active	2019-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.119	Phototherapy	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120	Phototherapy	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121	Phototherapy	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.122	Neonatal Jaundice	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123	Neonatal Jaundice	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124	Neonatal Jaundice	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125	Maternal Drug Use	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126	Maternal Drug Use	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127	Maternal Drug Use	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.128	Fetal Conditions	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129	Fetal Conditions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130	Fetal Conditions	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.131	Congenital Malformations	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132	Congenital Malformations	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133	Congenital Malformations	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.134	Social Indications	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135	Social Indications	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136	Social Indications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.137	Neonatal Severe Birth Trauma	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138	Neonatal Severe Birth Trauma	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139	Neonatal Severe Birth Trauma	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.140	Neonatal Severe Hypoxia or Asphyxia	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141	Neonatal Severe Hypoxia or Asphyxia	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142	Neonatal Severe Hypoxia or Asphyxia	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.143	Neonatal Severe Shock and Resuscitation	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144	Neonatal Severe Shock and Resuscitation	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145	Neonatal Severe Shock and Resuscitation	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.146	Neonatal Severe Respiratory Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147	Neonatal Severe Respiratory Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148	Neonatal Severe Respiratory Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.149	Neonatal Severe Infection	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150	Neonatal Severe Infection	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151	Neonatal Severe Infection	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.152	Neonatal Severe Neurological Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153	Neonatal Severe Neurological Complications	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154	Neonatal Severe Neurological Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.155	Neonatal Severe Shock and Resuscitation Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156	Neonatal Severe Shock and Resuscitation Procedures	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157	Neonatal Severe Shock and Resuscitation Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.158	Neonatal Severe Respiratory Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159	Neonatal Severe Respiratory Procedures	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160	Neonatal Severe Respiratory Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.161	Neonatal Severe Neurological Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162	Neonatal Severe Neurological Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163	Neonatal Severe Neurological Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.164	Neonatal Severe Septicemia	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165	Neonatal Severe Septicemia	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166	Neonatal Severe Septicemia	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.167	Neonatal Moderate Birth Trauma	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168	Neonatal Moderate Birth Trauma	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169	Neonatal Moderate Birth Trauma	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.170	Neonatal Moderate Respiratory Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171	Neonatal Moderate Respiratory Complications	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172	Neonatal Moderate Respiratory Complications	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.173	Neonatal Moderate Respiratory Complications Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174	Neonatal Moderate Respiratory Complications Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175	Neonatal Moderate Respiratory Complications Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176	Neonatal Moderate Birth Trauma with LOS	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177	Neonatal Moderate Birth Trauma with LOS	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178	Neonatal Moderate Birth Trauma with LOS	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179	Neonatal Moderate Respiratory Complications with LOS	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180	Neonatal Moderate Respiratory Complications with LOS	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181	Neonatal Moderate Respiratory Complications with LOS	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182	Moderate Neurological Complications with LOS Procedures	active	2019-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183	Neonatal Moderate Neurological Complications with LOS Procedures	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184	Neonatal Moderate Neurological Complications with LOS Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185	Neonatal Moderate Respiratory complications with LOS Procedures	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186	Neonatal Moderate Respiratory complications with LOS Procedures	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187	Neonatal Moderate Respiratory complications with LOS Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188	Single Liveborn Newborn Vaginal	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189	Single Liveborn Newborn Vaginal	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190	Single Liveborn Newborn Vaginal	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191	Single Liveborn Newborn Cesarean	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192	Single Liveborn Newborn Cesarean	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193	Single Liveborn Newborn Cesarean	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194	Birth Weight	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195	Neonatal Moderate Infection with LOS	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196	Neonatal Moderate Infection with LOS	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197	Neonatal Moderate Infection with LOS	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203	Neonatal Intensive Care Unit	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204	Intensive Care Unit	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205	Neonatal Intensive Care Unit	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206	Intensive Care Unit	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208	Blood Transfusion Administration	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209	Blood Transfusion Administration	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213	Blood Transfusion	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214	Acute Respiratory Distress Syndrome	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217	Amniotic Fluid Embolism	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219	Aortic Aneurysm	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220	Aortic Aneurysm	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221	Cardiac Arrest Ventricular Fibrillation	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223	Disseminated Intravascular Coagulation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225	Eclampsia	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227	Heart Failure Cardiac Arrest Related to Procedure or Surgery	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228	Heart Failure Cardiac Arrest Related to Procedure or Surgery	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229	Puerperal Cerebrovascular Disorder	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231	Pulmonary Edema	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233	Acute Heart Failure	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235	Severe Anesthesia Complications	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237	Sepsis	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239	Shock	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24	Blood Transfusion Administration	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241	Sickle Cell Disease with Crisis	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243	Air and Thrombotic Embolism	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245	Blood Transfusion	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246	Blood Transfusion	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247	Conversion of Cardiac Rhythm	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248	Conversion of Cardiac Rhythm	active	2021-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249	Hysterectomy	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250	Hysterectomy	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251	Tracheostomy	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252	Tracheostomy	active	2021-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253	Ventilation	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254	Ventilation	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255	Severe Maternal Morbidity Diagnoses	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256	Severe Maternal Morbidity Procedures	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267	Gestational Diabetes	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269	Gestational Diabetes	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271	HIV in Pregnancy Childbirth and Puerperium	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272	HIV in Pregnancy Childbirth and Puerperium	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274	Preexisting Diabetes	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275	Preexisting Diabetes	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277	Previous Cesarean	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278	Previous Cesarean	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279	Pulmonary Hypertension	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281	Pulmonary Hypertension	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282	Multiple Pregnancy	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284	Multiple Pregnancy	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286	Bleeding Disorder	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287	Bleeding Disorder	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289	Morbid or Severe Obesity	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290	Morbid or Severe Obesity	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291	Economic Housing Instability	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292	Economic Housing Instability	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295	Thyrotoxicosis	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296	Thyrotoxicosis	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297	Preterm Birth	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299	Preterm Birth	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300	Placenta Accreta	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302	Placenta Accreta	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303	Placental Abruption	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305	Placental Abruption	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306	Neuromuscular Disease	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308	Neuromuscular Disease	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309	Autoimmune Disease	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311	Autoimmune Disease	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312	Mental Health Disorder	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314	Mental Health Disorder	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315	Bariatric Surgery	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317	Bariatric Surgery	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318	Substance Abuse	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320	Substance Abuse	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321	Anemia	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323	Anemia	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324	Severe Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326	Mild or Moderate Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327	Severe Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329	Mild or Moderate Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330	Hypertension	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332	Hypertension	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333	Renal Disease	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335	Renal Disease	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336	Gastrointestinal Disease	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338	Gastrointestinal Disease	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339	Cardiac Disease	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341	Cardiac Disease	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344	Aortic Aneurysm	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357	Conversion of Cardiac Rhythm	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358	Hysterectomy	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359	Tracheostomy	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360	Ventilation	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361	Venous Thromboembolism in Pregnancy	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363	Venous Thromboembolism in Pregnancy	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364	Long Term Anticoagulant Use	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366	Long Term Anticoagulant Use	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368	Preadmission Observation Undelivered Mother	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369	ED Visit and OB Triage	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370	Present on Admission is No or Unable To Determine	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371	COVID 19 Confirmed	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372	COVID 19 Confirmed	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373	COVID 19 Confirmed	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374	Respiratory Conditions Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375	Respiratory Conditions Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376	Respiratory Conditions Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377	Respiratory Support Procedures	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378	Respiratory Support Procedures	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379	Respiratory Support Procedures Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387	Placenta Increta or Percreta	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388	Placenta Increta or Percreta	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67	Other Health Care Facility	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10	Non essential Hypertension SNOMEDCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102	Suicide Attempt	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11	Cirrhosis ICD9CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12	Cirrhosis ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13	Cirrhosis SNOMEDCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14	Cirrhosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151	Polycystic Ovary Syndrome	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16	Low Intensity Statin Therapy/Branded	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17	Moderate Intensity Statin Therapy/Branded	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18	High Intensity Statin Therapy/Branded	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21	ALT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230	Gestational Diabetes SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231	Gestational Diabetes ICD10CM	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233	All Results of High Risk HPV Test	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234	High Risk HPV Positive Results	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248	Suicide Attempt SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26	Nonopioid pain medications	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263	High Risk Positive HPV Results Without HPV16 or HPV18	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264	CDS Pregnancy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265	CDS Pregnancy Intensional	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266	Rhabdomyolysis Intensional	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267	CDS Rhabdomyolysis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268	HPV Negative Results	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27	Non pharmacologic treatments for chronic pain ICD10PCS	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28	Urine drug screen for pain management	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29	Non pharmacologic treatments for chronic pain SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292	Non pharmacologic treatments for chronic pain NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296	SCT Findings 202209	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298	Cervical Cytology Test	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299	HPV 16 Tests	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300	HPV 18 Tests	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302	Test Cervical Excision Procedures	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303	Statin Combinations	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305	Counseling for Physical Activity CPT	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306	Counseling for Physical Activity ICD10CM	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307	Counseling for Physical Activity CDS	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308	Cardiovascular disease 10Y risk	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309	SCT Findings 202309	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311	SCT Procedures 202209	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312	SCT Procedures 202309	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313	Statin Allergen Grouping	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319	Steward Transfer Test	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320	Opioids ATCPROD N02A	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322	Test 123	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34	Opioid pain medications	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36	Non pharmacologic treatments for chronic pain	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40	Suicide attempt	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42	Naloxone and Nalmefene medications	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43	Benzodiazepine medications	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44	Stool softeners and laxatives	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50	Sleep disordered breathing	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51	Sleep disordered breathing	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53	Sleep disordered breathing	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54	Adjuvant pain medications	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55	Risk assessments relevant to pain management	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6	Non essential Hypertension ICD9CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7	Non essential Hypertension ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79	Behavioral Counseling for Nutrition and Activity Referral	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85	Impaired Glucose Tolerance	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87	Fasting Plasma Glucose	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88	Waist Circumference	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9	Hypertension	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90	Gestational Diabetes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92	First Degree Family Member	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94	Glucose Tolerance Test Results	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96	Dependence on dialysis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99	Gestational Diabetes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460	Cluster Headache (ICD10CM)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461	Cluster Headache (ICD9CM)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464	Cluster Headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467	Medication Therapy for Cluster Headache (RXNORM)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555	Patient Declines Treatment for Cluster Headache (SNOMEDCT)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558	Acute Cluster Headache Medication (RXNORM)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559	Long Term Preventive Medication for Cluster Headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561	Oral Steroid for Cluster Headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569	Migraine Preventive Medication	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601	Acute Migraine Attack Medication	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605	NSAID OTC Migraine Attack Medication	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606	NSAID Prescribable Migraine Attack Medication	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640	Neurologic Disorders	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641	Neuromodulation for migraine	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642	No pain with headache	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643	Antiplatelets	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644	Anticoagulants	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645	Statin Medications	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646	Anxiety Disorders (ICD10 and SNOMED)	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648	Depression Diagnosis (ICD10 and SNOMED)	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649	Psychosis (ICD10 and SNOMED)	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650	Cluster Headache (SNOMED)	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651	Galcanezumab (RxNorm)	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652	Lithium (RxNorm)	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653	Verapamil	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654	Long term preventive medications for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655	Short term preventive medication for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656	Zolmitriptan	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657	Sumatriptan	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658	Dihydroergotamine	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659	Acute cluster headache medication	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660	Acute cluster headache treatment	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661	Short term preventive treatment for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662	Long term preventive treatment for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663	Migraine diagnosis (ICD)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664	Prescribable NSAIDs and Acute Migraine Attack Medication	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103	Abnormal Presentation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105	Abnormal Presentation	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114	Hematocrit Lab Test	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117	Potassium Lab Test	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119	Sodium Lab Test	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127	Platelet Count Lab Test	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129	White Blood Cells Count Lab Test	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130	Respiratory Rate	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134	Glucose Lab Test	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139	Bicarbonate Lab Test	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15	Intravenous Thrombolytic tPA Therapy	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151	Oxygen Saturation by Pulse Oximetry	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152	Body Temperature	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159	Body Weight	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16	Intraarterial Thrombolytic tPA Therapy	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163	Systolic Blood Pressure	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171	Abnormal Presentation	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173	Delivery of Singleton	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21	Intravenous or Intraarterial Thrombolytic tPA Therapy	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26	Estimated Gestational Age at Delivery	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27	Cornual Ectopic Pregnancy	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38	General Or Neuraxial Anesthesia	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39	Low Dose Unfractionated Heparin for VTE Prophylaxis	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41	Glycoprotein IIb IIIa Inhibitors	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55	Oxytocin	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56	Dinoprostone	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58	Delivery Procedures	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59	Delivery Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66	PCI	active	2017-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67	PCI	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68	Endotracheal Intubation	active	2018-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69	Endotracheal Intubation	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98	Delivery of Singleton	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99	Delivery of Singleton	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225	Opioid Medication Assisted Treatment (MAT) SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241	Schedule II, III and IV Opioid Medications	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242	Opioid Use Disorder	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243	Opioid Use Disorder	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265	Inpatient, Emergency, and Observation Locations	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269	Medications for Opioid Use Disorder (MOUD)	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274	NHSN Inpatient Encounter Class Codes	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277	Emergency Department Location	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278	Emergency Department Treatment Location	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279	Triage	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283	Emergency Department Location	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284	Emergency Department Location	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285	Mental Health Diagnosis without Substance Use Disorders	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286	Decision to Transfer	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35	Healthcare Agent or Proxy Choices	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10	Breastfeeding	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100	Familial Hypercholesterolemia	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102	Rhabdomyolysis	active	2017-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107	Low Intensity Statin Therapy	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12	Liver Disease	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13	Rhabdomyolysis	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21	Atherosclerosis and Peripheral Arterial Disease	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22	Liver Disease ICD9	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37	Stable and Unstable Angina	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39	Cerebrovascular Disease Stroke or TIA	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.41	Ischemic Heart Disease or Related Diagnoses	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42	Liver Disease	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.43	Liver Disease	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44	Cerebrovascular Disease Stroke or TIA	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46	Ischemic Heart Disease or Related Diagnoses	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47	Stable and Unstable Angina	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.501	Overweight or Obese	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502	Overweight or Obese	active	2018-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.512	Elevated Blood Pressure Reading	active	2019-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513	Elevated Blood Pressure Reading	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514	Finding of Elevated Blood Pressure or Hypertension	active	2019-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.515	Bariatric Procedures	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.517	Age related macular degeneration intermediate dry	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.518	Ophthalmologist visit	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.519	Posterior vitreous detachment (PVD)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.521	Ophthalmoscopic exam	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.523	Opthalmoscopic exams with Scleral Depression	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525	Referral (ophthalmology)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.526	Retina Ultrasound	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527	Retina visualization inadequate	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528	Refusal or Noncompliance with treatment	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.529	Vitreous hemorrhage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530	Vitreous hemorrhage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.536	Macula examination	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.539	Fluorescein angiography	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.541	Optical coherence tomography (OCT)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.542	Intravitreal injection	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543	Bevacizumab injection	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544	Ranibizumab injection	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545	Aflibercept injection	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.552	Uveitis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553	Uveitis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.554	Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.555	Macular edema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556	Corticosteroids for Injection	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557	Corticosteroids for Injection	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560	Tonometry	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.561	Intraocular pressure	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.571	Retinal Vein Occlusion Related Macular Edema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576	Vitreous hemorrhage	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580	Intravitreal and Periocular Injections	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581	Intravitreal and Periocular Injections	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582	Corticosteroids for Injection	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.583	Endophthalmitis in the Right Eye	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.584	Endophthalmitis in the Left Eye	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.585	Panophthalmitis in the Right Eye	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.586	Panophthalmitis in the Left Eye	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587	Lost to follow up	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588	Uveitis	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.610	Scleral depressed exam	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611	3 Mirror Goldmann exam	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612	Scleral depressed exam	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615	Physical Disability	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616	Financial difficulty	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.617	Vitreous exam findings	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619	Scleral depressed exam	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.629	Post operative follow up	active	2020-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.67	Breastfeeding	active	2017-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69	Stable and Unstable Angina	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70	Ischemic Heart Disease or Related Diagnoses	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71	Cerebrovascular Disease Stroke or TIA	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73	Breastfeeding	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85	Familial Hypercholesterolemia	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.89	Rhabdomyolysis	active	2017-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9	Outpatient Encounters for Preventive Care	active	2019-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.91	Familial Hypercholesterolemia	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.93	Hypercholesterolemia ICD 9	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97	High Intensity Statin Therapy	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98	Moderate Intensity Statin Therapy	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.50	HIV Lab Tests	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.51	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.71	Human Immunodeficiency Virus (HIV) Viral Load	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.10	ARBs (Angiotensin Receptor Blockers)	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1000	OIA_V2_GLP1s_RxNorms	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1001	OIA_V2_PCSK9s_RxNorms	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1002	OIA_RFs_Secondary_Prevention_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003	OIA_RFs_Secondary_Prevention_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1004	OIA_RFs_Secondary_Prevention_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005	OIA_RFs_Secondary_Prevention_ICD_SM_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1006	OIA_Asthma_COPD_Combo_Meds	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1007	OIA_Asthma_COPD_Combo_Meds_SABA_SAMA	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1008	OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009	PAE_Patient_Conditions	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012	PAE Conditions Short	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1016	OIA_TEST_VS	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1017	Triptan Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1018	NSAID Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1019	Statin Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1021	Penicillin Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1022	Macrolide Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1023	Quinolone Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1025	Beta blocker Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026	ACE inhibitor Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1027	ARB Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1028	Sulfonylurea Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1030	DPP4i Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1031	GLP1RA Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1032	Beta blocker allergy intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033	SGLT2i Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1034	MRA Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1036	Meglitinide Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1037	Alpha glucosidase inhibitor Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1038	TZD Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1041	Hemoglobin	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1042	Hematocrit	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043	Anemia for Erythropoesis Simulating Agents I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044	Anemia for Erythropoesis Simulating Agents SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045	Anemia for Erythropoesis Simulating Agents	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1046	AZT Meds	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1047	Ferritin	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1048	Knee pain I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049	Knee pain SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105	conditions_heartfailure	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050	Knee pain	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051	Knee decreased ROM SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1052	Knee effusion I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1054	Knee effusion	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055	Knee crepitus SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1056	OIA_Antiemetics	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1057	OIA_PDE5is	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1058	OIA_Vitamins	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1059	OIA_Plavix	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1061	OIA_Oral_Contraceptives	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1063	OIA_Topical_Steroids	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1064	OIA_Cough_Cold_Meds	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1065	Antiperspirant aluminum salts	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1066	Antiperspirant anticholinergics	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1067	Antieplieptic medications	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1068	Antidepressant medications	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069	Urinary incontinence SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1070	Urinary incontinence I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071	Urinary incontinence	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073	Hemifacial spasm SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1074	Hemifacial spasm I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075	Hemifacial spasm	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076	Spasmodic dysphonia SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077	Physical therapy procedure SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078	Occupational therapy SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079	Hyperhidrosis SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1080	Hyperhidrosis I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081	Hyperhidrosis	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1082	Tic disorder I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083	Tic disorder SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084	Tic disorder	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085	Esophageal achalasia SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1086	Esophageal achalasia I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087	Esophageal achalasia	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1088	ET propanolol or primidone	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1089	ET topiramate alprazolam or gabapentin	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.109	CKD stage4above I10	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090	Blephraospasm SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1091	Blepharospasm I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092	Blepharospasm	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093	Strabismus SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1094	Strabismus I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095	Strabismus	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096	Overactive bladder SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1097	Overactive bladder I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098	Overactive bladder	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099	Movement disorders SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110	CKD stage4above SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1100	Movement disorders I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101	Movement disorders	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102	Lateral epicondylitis SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1103	Lateral epicondyltisis I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104	Lateral epicondylitis	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105	Plantar fasciitis SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1106	Plantar fasciitis I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107	Plantar fasciitits	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108	Cardiac CT SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1109	Cardiac CT CPT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111	CKD stage4above	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111	Cardiac CT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112	Cardiac MRI SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1113	Cardiac MRI CPT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114	Cardiac MRI	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115	CT Angiography of Coronary Artery SCT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1116	CT Angiography of Coronary Artery CPT	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117	CT Angiography of Coronary Artery	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.112	Chronic kidney disease I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113	Chronic kidney disease SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.116	DigTx Cognitive Impairment I10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117	DigTx Cognitive Impairment SCT	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120	Diabetic ketoacidosis SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121	Diabetic ketoacidosis	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124	DKD	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147	HFrEF SCT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.148	HFrEF I10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.15	Kidney tansplant	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.150	History of Hypoglycemia I10	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151	History of Hypoglycemia SCD	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.153	Hyperlipidemia	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.159	conditions_COPD I10	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168	medications_COPD	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17	Atrial fibrillation	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.173	Asthma I10	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175	Asthma	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186	Beta blockers GDMT for heart failure	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.188	medications_heart failure	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189	SGLT2i	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.193	relatedconditions_COPD I10	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.197	Blood (Serum and Plasma) Potassium	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.202	Serum Creatinine	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21	Thoracic aorta disease	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214	Type 1 Diabetes Mellitus SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.224	Systolic Heart Failure I10	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226	Systolic Heart Failure	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238	MRA mineralocorticoid receptor antagonists	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.252	relatedconditions_Heart failure I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260	UACR SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.263	Pregnancy I10	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281	Statins Allergy SCT	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282	Statin Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.292	Metabolic syndrome I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.3	Delivery I10	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.314	relatedconditions_hyperlipidemia I10	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.322	Angina I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.325	Tachyarrhythmia I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.337	Migraine I10	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.34	Blood pressure panel	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.35	Systolic Blood Pressure	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.350	Coronary artery disease I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.367	Trandolapril	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369	Candesartan	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37	relatedconditions_hypertension SCT	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377	Valsartan	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.38	relatedconditions_hypertension I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.397	eGFR	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.409	Hypertension I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412	Statin Moderate Intensity	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.415	LDL Cholesterol	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.43	Urinalysis	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.434	Insulin	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.437	TZD Thiazolidinediones	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438	medications_T2DM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.439	relatedconditions_T2DM I10	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440	relatedconditions_T2DM SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.442	Blood Glucose	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45	ACE inhibitor allergy RXNORM	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.455	Metabolic acidosis I10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459	Liver cancer	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47	ACE inhibitor allergy SCT	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473	Tetanus toxoid, diphtheria (Td) Vaccine	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474	Allergy to Tdap Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475	Allergy to Td Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476	Allergy To Vaccine Component	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478	Allergy to HPV Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.481	medications_hypertension	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492	Inhaled Corticosteroids Allergy	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498	Metformin AllergyIntolerance SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5	Delivery - Procedure	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.508	Abdominal aortic imaging CPT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516	Allergy to Herpes Zoster Vaccine SCT	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.517	Hemoglobin A1c	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.518	Drug hypersensitivity I10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519	Drug hypersensitivity SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520	Drug hypersensitivity	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.521	Diabetic Kidney Disease I10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.523	Diabetic kidney disease	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524	Chronic Hepatitis SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525	Chronic Hepatitis	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527	OCS_Prednisone	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528	High Dose Non Combo ICS Adult	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529	Medium Dose Non Combo Asthma ICS Adult	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530	Low Dose Non Combo ICS	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531	Anti IgE Medications	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532	IL5 Antagonists	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533	Mast cell stabilizers for asthma	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.534	Vasospastic disease I10	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535	Vasospastic disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536	Vasospastic disease	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.537	Hemiplegic and basilar migraine I10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538	Hemiplegic and basilar migraine SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539	Hemiplegic and basilar migraine	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.540	Peptic ulcer disease I10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541	Peptic ulcer disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542	Peptic ulcer disease	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.544	Bleeding disorder I10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545	Bleeding disorder SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548	Electronic cigarettes or Vaping	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549	Bleeding disorder	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.551	Heart Rate	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552	Triptans	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553	CGRP receptor antagonists	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554	Ditans	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555	Ergots	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556	Migraine specific NSAIDs	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557	OTC migraine analgesics	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558	Butalbital analgesics	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559	medications_migraine_acute	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.560	relatedconditions_migraine I10	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561	conditions_migraine	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562	relatedconditions_migraine SCT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563	relatedconditions_migraine	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564	Triptan Allergy Intolerance SCT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565	Triptan Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566	Ischemic bowel disease SCT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.567	Ischemic bowel disease I10	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568	Ischemic bowel disease	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569	Allergen Immunotherapy	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570	Allergy to house dust mites SCT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.571	Allergy to house dust mites I10	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572	Allergy to house dust mites	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.573	conditions_hyperlipidemia I10	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574	conditions_hyperlipidemia SCT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575	conditions_hyperlipidemia	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578	PIM_Schedule V	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580	PIM_Acarbose	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581	PIM_Avandamet	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582	PIM_Dulaglutide	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583	PIM_Glimepiride	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585	PIM_Glucophage	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587	PIM_Glucovance	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588	Glyburide PIM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590	Alpha glucosidase inhibitors	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.592	Azotemia	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594	Intolerance to ARB SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595	ICS Low	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596	ICS Medium	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597	ICS High	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598	Low Dose ICS Formoterol	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.599	PIM_Vitamin B12 Level_LOINC_CPT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.600	PIM_Vitamin B12 Level_LOINC	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.601	PIM_Vitamin B12 Level_CPT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604	PIM_Glyburide	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605	PIM_Pioglitazone	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606	PIM_Semaglutide	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607	PIM_Linagliptin	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609	Macrolide_Azithromycin	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61	Secondary antihypertensives	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610	Long Acting Beta Agonists (LABA) Non_Formoterol	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.611	relatedconditions_Asthma I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612	Wolff Parkinson White SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.613	Wolff Parkinson White I10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614	Wolff Parkinson White	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615	medications_Asthma	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617	HighICS_LABA_NonFormoterol	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618	relatedconditions_Asthma SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619	ICS_LABA_LAMA	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620	Low Dose ICS_LABA_Non Formoterol	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621	Medium ICS_LABA Non Formoterol	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622	relatedconditions_Asthma	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623	LAMA Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624	LABA Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625	BetaBlock NonCS Secondary Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626	Eplerenone Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627	Spironolactone Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628	SGLT2 Inhibitors Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.629	PIM_Refill_Request_Antilipemics_LFTs	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631	Pneumococcal Vaccine Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632	Meglitinides Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633	DPP4i Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635	Alpha_glucosidase inhibitors allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636	Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637	Insulins Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638	TZD Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639	T2DM_Medications Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642	T2DM_Medications Allergy RXNORM	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643	T2DM_Medications Allergy SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646	T2DM_Medication Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647	Statins Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649	ACE Inhibitors Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650	ARB Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652	Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653	Long Acting Beta Agonists (LABA) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654	BetaBlocker NonCS Secondary Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656	MRA Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657	Eplerenone Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658	Spironolactone Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659	SGLT2i Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661	Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665	Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666	Human Papillomavirus (HPV) vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667	Herpes Zoster Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670	Pneumococcal Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671	Inhaled Corticosteroids(ICS) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672	LABA(Formoterol only)	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674	PIM_Tirzepatide	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675	GLP1RA Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.676	PIM_Diabetes_Testing_Supplies	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677	PIM_H2_Antagonists	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678	SGLT2i DM CKD	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679	SGLT2i DM ASCVD	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680	GLP1RA DM ASCVD	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683	OIA_Gout_Medications	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684	GlumetzaSubstitution	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685	MetforminER500mg	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686	PIM_Metformin	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687	PIM_Glipizide	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689	PIM_Glipizide_Glyburide_Glimepiride	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690	PIM_Insulin_Meglitinides	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691	PIM_Glyxambi	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692	PIM_Farxiga	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693	PIM_Invokana	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694	PIM_Jardiance	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695	PIM_Invokana_Jardiance	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696	Reclast	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697	LAMA_LABA Combination 1 Inhaler	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698	PIM_Contraceptives	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699	Selected Oral Antiemetics for Migraine	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.700	PIM_DEXA_Scan	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.701	PIM_DEXA_Scan_CPT_LOINC	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702	PIM_SSRIs	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703	PIM_SNRIs	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704	PIM_NRIs	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705	PIM_TCAs	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706	PIM_Citalopram	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707	PIM_Hydroxyzine	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708	PIM_Buspirone	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709	PIM_Bupropion	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710	PIM_Mirtazapine	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711	PIM_Trazodone	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.712	PIM_IHD_CHD_CAD_ICD10	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713	PIM_IHD_CHD_CAD_SNOMED	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714	PIM_Gabapentin	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715	PIM_Allergy_Nasal_Sprays	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716	PIM_Allergy_Oral_Meds	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717	PIM_Allergy_Nasal_Oral	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719	OCS_Prednisolone	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72	Inhaled corticosteroids (IC)	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720	COPD_Ofloxacin	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721	COPD_Ciprofloxacin	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722	COPD_Doxycycline	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723	Macrolide Allergy SCT	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724	Macrolide Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725	Prednisone Allergy SCT	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727	Tetracycline Allergy SCT	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728	Tetracycline Allergy Intolerance	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729	Fluoroquinolones Allergy SCT	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730	Fluoroquinolone Allergy Intolerance	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731	Penicillin Allergy RXNORM	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732	Penicillin Allergy SCT	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733	Penicillin Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734	PIM_Metformin_Single_Ingredient_Only	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735	PIM_Metformin_Combo_Ingredient_Only	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.736	Pneumonia I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737	Pneumonia SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738	Pneumonia	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.739	Pulmonary Embolism I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742	Pulmonary Embolism SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743	Pulmonary Embolism	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.744	Influenza I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745	Influenza SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.746	Influenza (Tests for influenza A or B virus Antigen)	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747	Influenza	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.748	COVID 19 I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749	COVID19 SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750	COVID19	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.752	RSV I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753	RSV SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754	RSV	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755	Respiratory Rate SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.756	Respiratory Rate LOINC	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757	Respiratory Rate	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.758	Acute Respiratory Failure I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759	Acute Respiratory Failure SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760	Acute Respiratory Failure	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761	Dyspnea SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.762	Dyspnea I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763	Dyspnea	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.764	Confusion I10	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765	Confusion SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766	Confusion	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767	Drowsiness SCT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.768 us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234	Reason Medication Discontinued Lack of Effectiveness	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235	Reason Medication Discontinued Safety Issue Occurred	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236	Reason Medication Discontinued Compliance Issue other than cost	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237	Recommendation to Resolve Medication Therapy Problem	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239	Reason Medication Discontinued Patient Unable to Afford	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.240	Medication Lists	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3	Findings Related to Medication Management, Transitions Between Health Care Settings	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35	Interventions Related to Medication Management, Comprehensive Medication Review	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5	Reasons for Interventions Related to Medication Management, Unnecessary Therapy	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53	Reasons for Interventions Related to Medication Management, Adverse Events	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55	Reasons for Interventions Related to Medication Management, Adherence	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56	Findings Related to Medication Management, Multiple Providers	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58	Findings Related to Medication Management, Chronic Disease Present	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59	Findings Related to Medication Management, Taking Medication for Chronic Disease	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6	Reasons for Interventions Related to Medication Management, New or Additional Therapy Required	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60	Findings Related to Medication Management, Health Literacy	active	2021-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61	Findings Related to Medication Management	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7	Reasons for Interventions Related to Medication Management, Ineffective Therapy	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8	Reasons for Interventions Related to Medication Management, Dose Too Low	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83	Assessments Related to Medication Management, General Assessments	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84	Assessments Related to Medication Management	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85	Assessments Related to Medication Management, Assessments Using Assessment Scales	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86	Interventions Related to Medication Regimen, Monitoring	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87	Interventions Related to Care Coordination, Consultations	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88	Interventions Related to Care Coordination, Referrals to Other Providers	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89	Interventions Related to Care Coordination, Referrals for Specific Services	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9	Reasons for Interventions Related to Medication Management, Dose Too High	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90	Recommendations Related to Medication Regimen, Continue Medication	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91	Recommendations Related to Medication Regimen, Initiate Medication	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92	Recommendations Related to Medication Regimen, Change Medication	active	2021-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93	Recommendations Related to Medication Regimen, Change Medication Dose	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94	Recommendations Related to Medication Regimen, Change Medication Dosage Form	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95	Recommendations Related to Medication Regimen, Change Medication Course	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97	Recommendations Related to Medication Regimen, Change Medication Dosing Interval	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98	Recommendations Related to Medication Regimen, Discontinue Medication	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99	Recommendations Related to Medication Regimen, Monitoring	active	2021-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.10	Care Plan Document Type	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.11	Medication Status	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12	Medication Route	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24	Extended Pregnancy Status	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27	Care Team Member Function (SNOMEDCT)	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.28	Problem Type (LOINC)	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29	Allergy Clinical Status	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30	Care Team Member Function	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.33	External Cause of Injury/Morbidity	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35	Arthritis Feedback Types (SNOMED)	active	2019-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.36	Arthritis Feedback Types (LOINC)	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.4	DIRSectionTypeCodes LOINC	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45	Bidirectional Services eReferral Type	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46	Bidirectional Services eReferral Reason	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.49	Disability Status Assessment	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50	Transport vehicle type	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53	Sex	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54	Specimen type	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.55	At Home In Vitro Patient Questions	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57	Advance Directives Content Type	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58	Acute COVID 19 Diagnosis	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59	Medication Adherence SCT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.1	Case Management for Behavioral Health	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.63	Case Management for Behavioral Health	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.64	Case Management for Behavioral Health	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.10	Medicare FFS Payer	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.12	Medicare Advantage Payer	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101	Myocardial Infarction	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124	Follow Up Within 6 Months	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125	Follow Up Within 6 Months	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.126	Bone Scan	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.127	Bone Scan	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15	Hospice Care Ambulatory	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175	Office and Wellness Visits for General Screening	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.176	Office and Wellness Visits for General Screening	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.177	Office and Wellness Visits for General Screening	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178	Office and Wellness Visits for General Screening	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179	Hypertensive disorders in pregnancy	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.180	Outpatient Prenatal Visit	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182	Eclampsia	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183	Gestational Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184	Preexisting Hypertension in Pregnancy	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185	Postpartum Encounter	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.186	Postpartum Encounter	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187	Postpartum Encounter	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188	Preexisting Hypertension in Pregnancy	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.189	Spontaneous or Elective Abortion	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190	Spontaneous or Elective Abortion	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191	Preeclampsia or Eclampsia	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.192	Spontaneous or Elective Abortion Procedure	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193	Spontaneous or Elective Abortion	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.28	Non Acute Encounter Codes CPT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.29	Non Acute Encounter Codes HCPCS	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.31	Bleeding Event Diagnosis Codes ICD9	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.78	Statin Associated Muscle Symptoms	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84	Statin Associated Muscle Symptoms	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85	Statin Associated Muscle Symptoms	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.99	Underweight	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.11	Cornual Ectopic Pregnancy	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12	Cornual Ectopic Pregnancy	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.13	Perforation of Uterus	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14	Perforation of Uterus	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.15	Uterine Rupture	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16	Uterine Rupture	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.17	Transabdominal Cerclage	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18	Transabdominal Cerclage	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2	Transabdominal Cerclage	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.21	Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23	Intensive Care Unit	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24	Uterine Horn	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25	Metroplasty	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.3	Medical Induction of Labor	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.35	Placenta Previa	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36	Placenta Accreta Spectrum Previa or Vasa Previa	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37	Placenta Accreta Spectrum Previa or Vasa Previa	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38	Outpatient Surgery Service	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41	Statin Allergen	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42	Statin Allergen	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50	Rivaroxaban for VTE Prophylaxis	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.51	Prasugrel	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52	Pharmacological Contraindications For Antithrombotic Therapy	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.53	Acute Renal Failure	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54	Total Parenteral Nutrition	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.55	Intravenous Thrombolytic tPA Therapy	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.56	Intraarterial Thrombolytic tPA Therapy	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57	Ischemic Stroke Thrombosis	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.58	Ischemic Stroke Thrombosis	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.59	Ischemic Stroke Other	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60	Ischemic Stroke Other	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61	Antithrombotic Therapy Antiplatelet	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62	Antithrombotic Therapy for Ischemic Stroke	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.63	Present On Admission is Yes or Exempt	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64	Application of Venous Foot Pumps	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65	Application of Intermittent Pneumatic Compression Devices	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66	Application of Graduated Compression Stockings	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67	20 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68	37 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69	37 to 38 Weeks Gestation	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.70	20 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71	20 to 42 Plus Weeks Gestation	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.72	37 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73	37 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.74	37 to 38 Weeks Gestation	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75	37 to 38 Weeks Gestation	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76	History of Atrial Ablation	active	2022-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.77	Placenta Accreta Spectrum Previa or Vasa Previa	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.78	Placenta Previa	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126	Hospital Settings	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143	Observation Services	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.146	Buprenorphine	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.159	All Primary and Secondary Cancer	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161	All Primary and Secondary Cancer	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.163	Emergency Department Evaluation	active	2020-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164	Admit Inpatient	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.166	Codeine Schedule II and III	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.167	Alfentanil	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.168	Remifentanil	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.169	Sufentanil	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171	Opioid Use Disorder	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173	Sickle Cell Disease with and without Crisis SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.174	Sickle Cell Disease with and without Crisis ICD	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175	Sickle Cell Disease with and without Crisis	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.176	Opioid Medication Assisted Treatment (MAT) HCPCS	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177	Opioid Medication Assisted Treatment (MAT)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.178	Cancer Related Pain ICD 10	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179	Cancer Related Pain SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180	Cancer Related Pain	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14	Medication drug class for allergen intolerance SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.10	Care Experience Preferences at End of Life LOINC	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.11	Care Experience Preferences Grouping	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12	Healthcare Agent Ordinality	active	2020-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.13	Healthcare Agent Powers or Limitations Indicator	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.14	ADIClauseTypeVS	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.15	Upon Death Preferences	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.17	Preconditions for Treatment Preferences	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.18	Treatment Intervention Preferences at End of Life Ordinal LOINC	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19	Obligation or Prohibition Instruction Type Grouping	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.2	InstructionActStatus	active	2017-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.20	Advance Healthcare Directive Witness roleCode	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.21	Witness Categories	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.22	Advance Directive Document Types	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.23	AD Conditions and Prognosis Scenarios	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.26	Healthcare Agent or Advisor Indicator	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.27	Initial Treatment portable medical order options	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.28	Cardiopulmonary Resuscitation Order Options	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30	Cardiopulmonary Resuscitation Order Procedures	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31	Cardiopulmonary Resuscitation Procedures Grouping	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32	Additional Portable Medical Order Procedures	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33	Initial Treatment Portable Medical Order Procedures Grouping	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34	Additional portable medical order Procedures Grouping	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.35	Medically Assisted Nutrition Order Options	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.36	Medically Assisted Nutrition Portable Medical Order Procedures Grouping	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.37	Healthcare Agent Powers	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.38	Personal Health Goal Options LOINC	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.39	Personal Health Goal Options Grouping	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.40	Portable Medical Order Document Types	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.41	Advance Healthcare Directive Document Types Grouper	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5	Advance Directive Content Type SCT	active	2022-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.6	Personal Health Goals LOINC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.7	Health Goals Grouping	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.8	Treatment Intervention Preferences at End of Life LOINC	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.9	Treatment Intervention Preferences Grouping	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.1	Rituximab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100	Pathological M Stage M1c	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101	Pathological N Stage N3	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102	N Stage pN1a	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103	N Stage pN1b	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105	Pathological N Stage pN1mi	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106	Pathological N Stage N2b	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107	Pathological N Stage N2a	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108	Pathological N Stage N2	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109	Pathological N Stage N1b	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110	Pathological N Stage N1a	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112	Pathological N Stage N0	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114	Pathological T Stage T4d	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115	Pathological T Stage T4c	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116	Pathological T Stage T4b	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117	Pathological T Stage T4a	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118	Pathological T Stage T4	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120	N Stage N2C	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121	T Stage T3c	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122	T Stage T3b	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123	T Stage T3a	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124	Pathological T Stage T3	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125	T Stage T2c	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126	T Stage T2b	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127	T Stage T2a	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128	Pathological T Stage T2	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129	Pathological T Stage T1c	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132	Pathological T Stage T1b	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135	Pathological T Stage T1a	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136	Pathological T Stage T1	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137	Pathological T Stage T1mic	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139	Pathological T Stage T0	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142	Cancer Stage III	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143	Cancer Stage IIIA	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144	Cancer Stage IIIB	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145	Cancer Stage IIIC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146	Cancer Stage IV	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147	Cancer Stage IVA	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148	Cancer Stage IVB	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149	Cancer Stage IVC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.151	Cisplatin Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.153	Vinorelbine Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.154	Gemcitabine Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.155	Docetaxel	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.156	Pemetrexed Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.158	Vinblastine Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160	ECOG Performance Status	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.161	ECOG Performance Status	active	2020-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162	ECOG Performance Status	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164	Karnofsky Performance Status	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.165	Carboplatin Injectable	active	2020-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.166	Paclitaxel	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168	Doxorubicin Injectable	active	2022-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169	Irinotecan Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179	Bevacizumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.181	Methotrexate	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.184	Breast Cancer	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185	Breast Cancer	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191	Cancer Stage II	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192	Cancer Stage IIA	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193	Cancer Stage IIB	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.194	Pertuzumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.196	Ixabepilone Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.197	Goserelin	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200	Epirubicin Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.202	Ramucirumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.204	Letrozole	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.206	Exemestane	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.209	Fluorouracil	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210	Capecitabine Oral	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222	Aprepitant Oral	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223	Fosaprepitant Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.255	Colorectal Cancer	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256	Colorectal Cancer	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.257	Colorectal Cancer Chemotherapy	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280	Cancer Stage IA	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281	Cancer Stage IB	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286	Cancer Stage IIC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.291	Positive Result	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292	Negative Result	active	2015-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300	Pathological N Stage N1C	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332	Daunorubicin Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336	Palonosetron Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.341	External Beam Radiotherapy	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.349	Metastatic Cancer	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365	Hospice Care Referral or Admission	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439	T Category	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440	N Category	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441	M Category	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442	TNM Stage Group	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.449	Opioids	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.492	Pharmacological interventions for depression	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.535	Ovarian Cancer	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.536	Ovarian Cancer	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.537	Fallopian Tube Cancer	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539	Fallopian Tube Cancer	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.541	Peritoneal Cancer	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.542	Peritoneal Cancer	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547	Cancer Stage 1C	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555	Gender Female	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556	Gender Male	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557	Pathological N Stage N3a	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558	Pathological N Stage N3b	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560	Rolapitant Oral	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599	Obinutuzumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.600	Ofatumumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602	Neurokinin 1 Receptor Antagonist	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604	Serotonin Receptor Antagonist	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61	Cetuximab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.63	Panitumumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81	Palonosetron Oral	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.88	Lung Cancer	active	2015-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.89	Lung Cancer	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95	M Stage M0	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97	Pathological M Stage M1	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98	Pathological M Stage M1a	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99	Pathological M Stage M1b	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.5	Most/Moderately Effective Contraceptive Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6	Most/Moderately Effective Contraceptive SNOMED Findings	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1	Schedule IV Benzodiazepines	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.7	PROMIS Depression Assessment	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11	Sleep Apnea	active	2018-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12	Toxic Megacolon in adults	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13	Septic Shock due to C. Diff	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15	Body Temperature	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16	Diarrhea Potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17	Abdominal Distension	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18	Vomiting potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19	Ileus due to infection	active	2019-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20	Clostridium difficile infection	active	2019-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.3	Radiation Therapy Indicators from CPT	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.4	Diagnostic Radiology Surrounding Face and Sinus	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.5	Ear Surgery Affecting the Tympanic Membrane	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.6	Allergic Rhinitis Immunotherapy	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.8	Radiology to Head and Sinus	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9	Immunotherapy For Allergic Rhinitis	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1136.63	Aortic Dissection or Ruptured Aortic Aneurysm	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.564	CABG or PCI Procedure	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.565	CABG or PCI Procedure	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.566	CABG or PCI Procedure	active	2018-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.12	C2S Cannabis Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.13	C2S Cannabis Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.14	C2S Cannabis Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15	C2S Cannabis Use DIsorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.16	C2S Cocaine Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.17	C2S Cocaine Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18	C2S Cocaine Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.19	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.2	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.20	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.21	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.24	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.25	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.26	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.28	C2S Inhalants	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.29	C2S Inhalants	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.3	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30	C2S Inhalants	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.32	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.33	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.34	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.35	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.38	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.39	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.4	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.40	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43	C2S Other Psychoactive Substance Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.44	C2S Other Psychoactive Substance Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.45	C2S Other Psychoactive Substance Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.47	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.48	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.49	C2S Sexuality and reproductive health information sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.5	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.52	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.53	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.54	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.55	C2S Substance Use Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.56	C2S Substance Use Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58	C2S Sensitive Categories	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.59	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.6	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.60	C2S HIV/AIDS information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65	Test C2S Alcohol Use Disorders	active	2019-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67	Test C2S HIV/AIDS Information Sensitivity	active	2019-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.7	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.8	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.9	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.10	Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1002	Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012	S. Typhi Infection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016	S. Paratyphi Infection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1017	S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021	Dark Urine (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022	Acute Onset [Qualifier Value] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024	Acute Viral Hepatitis (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1027	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029	Listeriosis [Listeria species] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1030	Meningitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1032	Encephalitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033	Encephalitis [Unspecified Cause] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035	Indeterminate or Equivocal Lab Result Value	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037	Smoking Status [Current Nonsmoker] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1040	Organisms (Tests by Unspecified Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1041	Organisms (Tests by Culture and Identification)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1044	Candida auris Infection (Tests for Candida auris by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1045	Candida auris Infection (Tests for Candida auris Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1047	Parkinson’s disease (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048	Parkinson’s disease (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1049	Parkinsonism [Secondary] (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050	Parkinsonism [Secondary] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1053	Carbidopa Levodopa Combination (RXNORM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1065	Consciousness [Decreased Level] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071	Drug Use [IV Evidence] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072	Miosis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1076	Opioid Overdose and Poisoning (Tests for Opioids [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077	Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1078	Opioid Overdose and Poisoning (Naloxone) (RxNorm)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083	Rash [Pustular Vesicular] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084	Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090	Syphilis [Congenital] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1091	Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1092	Congenital heart disease (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1093	Hearing impairment (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1095	Microcephaly (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1096	Developmental delay (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1099	Congenital heart disease (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1100	Hearing impairment (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1104	Developmental delay (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1106	Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.112	Tetanus (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1123	COVID_19 (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1124	COVID_19 (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1130	Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1131	Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1138	Staphylococcus Aureus (Tests by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1139	VISA/VRSA (Tests for Vancomycin Resistance Gene)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1142	COVID_19 (Tests for SARS_CoV_2 Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1143	COVID_19 (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1145	Resistant Lab Result Value	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1148	Tests for Vancomycin Susceptibility [Ord]	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1149	Proteinuria (Tests for Total Protein in 24H Urine)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.115	Mumps (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1150	Thrombocytopenia (Tests for Platelets [#/volume] in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1156	Staphylococcus aureus (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1158	COVID_19 (Tests for SARS_CoV_2 Antigen)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1169	Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.117	Mumps (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1180	Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1186	Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative])	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1188	Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1189	California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative])	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1196	Anthrax (Tests for Bacillus cereus by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1197	Cervical Lymphadenitis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1207	CRE (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1210	Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1212	Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1213	NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1214	Carbapenemase resistance mechanism (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1215	Tests for carbapenemase production	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1216	Tests for carbapenemase resistance mechanism	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1217	Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem]	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1218	Tests for carbapenem susceptibility [Ertapenem]	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1219	Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1220	NU_Tests for Enterobacteriaceae species by Culture and Identification Method	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224	Therapeutic Response to Medication [Improved]	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225	Altered Mental Status (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230	Eschar (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231	Hypotension (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233	Localized Edema (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1234	Localized Edema (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237	Tachycardia (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1238	Tachycardia (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239	RCKMS Conditions (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124	Poliomyelitis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240	Maternal Condition Puerperium (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242	Non pestis Yersiniosis Infection (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244	Blastomycosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246	Blastomycosis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1249	Blastomycosis (Tests for Blastomyces species by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1250	Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1251	Blastomycosis (Tests for Blastomyces species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1252	Blastomycosis (Tests for Blastomyces species Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1253	Blastomycosis (Tests for Blastomyces species Antigen)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1265	Fatigue (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269	Tuberculosis [Latent Infection] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274	Histoplasmosis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1275	Histoplasmosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1281	Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295	Seizure [Unspecified Cause] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1298	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1299	Seizure [Unspecified Cause] (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130	Influenza (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1304	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1305	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1306	Body Temperature (Vital Sign)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1307	Respiratory Rate (Vital Sign)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309	RSV (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1310	RSV (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1312	RSV (Tests for RSV Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314	Wheezing (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1317	Bronchiolitis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325	Tobacco Use and Exposure (Social History)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1330	Tobacco Smoking Status [Current] (Social History) (LOINC)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335	Hospitalized [Inpatient] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336	Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337	Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1340	Prion Disease (Tests for 14_3_3 Protein)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1341	Prion Disease (Tests for Abnormal Prion Protein)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349	Cerebrospinal Fluid (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135	Chronic Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350	Endocervical (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351	Tissue (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352	Specimen from a Normally Sterile Site (Specimen Type)(SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353	Urethral Swab (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355	Wound (Specimen Type) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1359	Hepatitis E (Tests for hepatitis E virus IgM Antibody)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136	Invasive Pneumococcal Disease (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1360	Hepatitis E (Tests for hepatitis E virus Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1363	Epiglottitis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1364	Organisms (Tests by Microscopic Observation by Gram Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369	Serum (Specimen Type) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1378	Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379	Fish Poisoning (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388	Occupational Asthma (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389	Asthma (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1390	Asthma (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391	Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393	WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1400	Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1402	Cancer [Malignant Neoplasms] (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1403	Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1404	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407	Cancer [Malignant Neoplasms] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1409	COVID_19 (Tests for SARS_CoV_2 Genomic Sequence)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418	Alpha gal syndrome (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1420	Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative])	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422	Ptosis of Eyelid [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1423	Ptosis of Eyelid [Unspecified Cause] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424	Constipation [Unspecified Cause] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426	Intubation [Respiratory Tract] (Procedure) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430	Infant Botulism (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446	Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447	MRSA (Disorders (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449	Staphylococcus aureus infection (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145	Varicella (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1450	Staphylococcus aureus infection (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1452	MRSA (Tests by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1453	MRSA (Tests for Methicillin Resistance Gene)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1454	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1458	Tests for Cefoxitin Susceptibility [OrdQn]	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1459	Organisms (Tests in Blood by Culture and Identification)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1460	Bacteria (Tests in Blood by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1461	Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1462	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463	VRE (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464	VRE (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1465	VRE (Tests by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1466	Enterococcus species (Tests by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468	Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469	Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470	Enterococcus species (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471	Amebiasis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1473	Amebiasis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1476	Amebiasis (Tests for Entamoeba histolytica Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1482	Norovirus (Tests for Norovirus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485	Norovirus (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487	Clostridioides difficile infection (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1491	C. diff infection (Tests for C diff Toxin Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1492	C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505	Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507	Arsenic Exposure and Toxicity (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1509	Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513	Urine (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1514	Mercury Exposure and Toxicity (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1515	Cryptococcosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516	Cryptococcosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1520	Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1523	Cryptococcosis (Tests for Cryptococcus species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1524	Cryptococcosis (Tests for Cryptococcus species Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1525	Mercury Exposure and Toxicity (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1528	Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1532	Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533	Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1534	Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1538	Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154	Hepatitis C Virus Infection (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1540	Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1541	Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1542	Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1543	Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1544	Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1545	Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546	Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1551	Meningitis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552	Bacterial Meningitis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553	Fungal Meningitis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554	Parasitic Meningitis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1555	Bacterial Meningitis (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559	Photophobia (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562	Bacteria [Causing Meningitis] (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563	Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564	Viruses [Causing Meningitis] (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1565	Viruses [Causing Meningitis] (Tests for Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1566	Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1567	Bacteria [Causing Meningitis] (Tests by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1574	Invasive Group B Streptococcus (Disorders) (ICD10CM))	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1577	Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1578	Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580	Animal Bite [Dog] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581	Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582	Animal Bite [Excluding Mammals] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584	Animal Bite [Unspecified Animal] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1585	Animal Bite [Dog] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1586	Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1587	Animal Bite [Excluding Mammals] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1588	Cadmium Exposure and Toxicity (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1594	HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1595	HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1597	HIV Infection (ARV Combination Treatment for HIV) (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1598	HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600	HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1604	Vaccine Adverse Event (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605	Vaccine Adverse Event (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606	Vaccinia disease or adverse event  (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161	Vibriosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1612	Blepharitis [Unspecified Cause] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613	Keratitis [Unspecified Cause] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1614	Keratitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1618	Smallpox Vaccine (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1620	Anaphylaxis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626	Thrombocytopenic Purpura [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1634	Sofosbuvir Velpatasvir Combination (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1640	Typhus Fever (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1641	Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1642	Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1643	Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651	Chagas Disease (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1654	Chagas Disease (Tests for Trypanosoma cruzi Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661	Cervical lymphadenopathy [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662	Conjunctival injection (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663	Drying of lips (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667	Edema of hands or feet (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1676	Tests for Acinetobacter baumannii Nucleic Acid	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1677	Tests for Pseudomonas aeruginosa by Culture and Identification Method	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1678	Tests for Pseudomonas aeruginosa Nucleic Acid	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679	Pseudomonas aeruginosa (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687	NU_Gunshot Wound (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1688	NU_Gunshot Wound (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169	Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170	Chlamydia trachomatis Infection (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700	Encephalitis [Viral] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702	Encephalitis [Parasitic] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712	Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714	Parasites [Causing Encephalitis] (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715	Viruses [Causing Encephalitis] (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716	Drowning and Submersion (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1717	Drowning and Submersion (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718	Motor Vehicle Injury (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1719	Motor Vehicle Injury (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720	Enterovirus Infection [Non polio] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1721	Enterovirus Infection [Non polio] (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722	Enterovirus Infection [Non polio] (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1723	Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1725	Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1726	Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1735	Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739	Head Injury (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1740	Head Injury (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1742	Brain Injury [Traumatic] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745	Rotavirus Disease (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1746	Rotavirus Disease (Tests for Rotavirus Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748	Chemical Pneumonitis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1749	Chemical Pneumonitis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1753	Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755	Vomitus (Specimen Type) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758	Asbestosis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.176	West Nile Virus Infection (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1763	Byssinosis (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1769	Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772	Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773	CLABSI (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775	Ophthalmia neonatorum (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778	Genital herpes (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1779	Genital herpes (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1781	Herpes (Tests for Herpes simplex virus Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785	Elevated liver enzyme (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1786	Elevated liver enzyme (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1788	Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789	Granuloma Inguinale (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791	Ulcer [Genital, Perineal, or Perianal Area] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1792	Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797	Bronchial Wash (Specimen Type) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800	Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1803	Bacteria (Tests in Sputum Specimen by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181	Coccidioidomycosis (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1819	Louseborne relapsing fever (Tests for Borrelia species)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1820	Louseborne relapsing fever (Tests for Borrelia species in Blood)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823	Borrelia species (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824	Spirochetes (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829	Polyarthritis [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835	Rheumatoid nodules (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842	Ventilator associated event (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844	Leishmaniasis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1846	Leishmaniasis (Tests for Leishmania species Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1847	Leishmaniasis (Tests for Leishmania species Antibody)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1848	Leishmania species (Tests by Microscopic Observation in Tissue)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185	Brucellosis (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864	Taeniasis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866	Taeniasis (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187	Dengue Virus Infection (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1875	Cysticercosis (Tests for Taenia solium Antibody)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878	Surgical Site Infection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1880	Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1881	NU_Tests for Enterobacteriaceae species Nucleic Acid	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882	Carbapenemase production (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892	Toxoplasmosis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1893	Toxoplasmosis (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895	Toxoplasmosis (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1897	Toxoplasmosis (Tests by Microscopic Observation)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1898	Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1901	Toxoplasmosis (Tests for Toxoplasma gondii Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1902	Orthopox (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1908	Organisms (Tests by Electron Microscopic Observation)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1912	Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1913	Penicillin G [Procaine] [Injectable] (RXNORM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1919	Fungi [Causing Meningitis] (Tests by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923	Coronary artery aneurysm (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924	Coronary artery dilatation (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925	Ectatic coronary artery (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926	Left ventricular ejection fraction [Decreased Level] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1927	Coronary artery aneurysm (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928	Shock (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1929	Shock (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930	Troponin [Elevated Level] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931	Oral mucosa Inflammation (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1932	Oral mucosa Inflammation (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1933	C reactive protein (Tests by Any Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1934	Lymphocytes [Concentration] (Tests by Any Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935	Strongyloidiasis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1936	Strongyloidiasis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1937	Strongyloidiasis (Tests for Strongyloides Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1938	Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1939	Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1940	Organisms (Tests by Microscopic Observation in Stool)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941	Strongyloidiasis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942	Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943	Jamestown Canyon Virus Diseases (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1944	Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1945	Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1946	Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947	Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948	Keystone Virus Diseases (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949	La Crosse Virus Diseases (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950	Snowshoe hare Virus Diseases (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951	Trivittatus Virus Diseases (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1952	La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1953	Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1954	La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1955	Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1956	La Crosse Virus Diseases (Tests for La Crosse Virus Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1957	Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1958	Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1959	Keystone Virus Diseases (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1960	La Crosse Virus Diseases (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1961	Snowshoe hare Virus Diseases (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1962	Trivittatus Virus Diseases (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1963	Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1964	Encephalomyelitis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1965	Encephalomyelitis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1966	Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1967	Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1968	Hepatitis D Virus Infection (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1969	Hepatitis D Virus Infection (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1970	NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1971	Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1972	Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1973	Hepatitis D Virus Infection (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1974	Baylisascariasis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1975	Baylisascariasis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1976	Baylisascariasis (Tests for Baylisascaris species Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1978	Larva Migrans (Neural, Ocular, or Visceral) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1979	Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1980	California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1981	California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1982	California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1983	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1984	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1985	California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1986	Pregnant (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1987	Flank Pain (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1988	Bone Pain (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1989	Abscess (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1990	Abscess (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1991	Focal Brain Lesions (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1992	Pathologic Fractures [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1993	Pathologic Fractures [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1994	Granulomas (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1995	Granulomas (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1996	Skin Lesions (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1997	Skin Lesions (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1998	Angiostrongyliasis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1999	Lymphocytic Choriomeningitis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2000	Lymphocytic Choriomeningitis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2001	Lymphocytic Choriomeningitis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2002	Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2003	Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2004	Lymphocytic Choriomeningitis (Tests for LCMV Antibody)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2005	Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2006	Angiostrongyliasis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2007	Eosinophilic meningitis (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2009	Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2010	Eosinophils [Concentration] (Tests in CSF by Any Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2011	Eosinophils [Percentage] (Tests in CSF by Any Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2012	Mpox (Tests for mpox virus by Genomic Sequencing)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2013	Mpox (Test Panels for mpox virus by Genomic Sequencing)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2017	Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2018	Interpretation of an Observation (High)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2019	Interpretation of an Observation (Low)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.202	Trichinellosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2020	Lymphadenopathy [Acute] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2023	Tick Paralysis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2024	Bacillary angiomatosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2025	Animal Bite or Scratch [Cat] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2026	Animal Bite or Scratch [Cat] (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2027	Bartonellosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2028	Bartonellosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2029	Bartonellosis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2030	Bartonella henselae infection (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2031	Bartonella quintana infection (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2032	Bartonella bacilliformis infection (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2033	Bartonella henselae infection (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2034	Bartonella quintana infection (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2036	Bartonella henselae (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2037	Bartonella quintana (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2038	Bartonella bacilliformis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2039	Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.204	Giardiasis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2040	Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2041	Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2042	Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2043	Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2044	Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2045	Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2046	Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2047	Bartonellosis (Tests for Bartonella spp. Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2048	Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2049	Bartonella spp. (Tests by Microscopic Observation)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2050	Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2051	Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2052	Echinococcosis (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2053	Echinococcosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2054	Cystic Echinococcosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2055	Cystic Echinococcosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2056	Alveolar Echinococcosis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2057	Alveolar Echinococcosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2058	Echinococcosis (Tests for Echinococcus species Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2059	Echinococcus species (Tests by Microscopic Observation)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2060	Echinococcosis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2061	Genital Warts (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2062	Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2063	Genital Warts (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2064	Diphyllobothriasis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2065	Diphyllobothriasis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2066	Diphyllobothriasis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2067	Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2068	Angiostrongyliasis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2069	Pelvic Inflammatory Disease (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2070	Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2071	Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2072	Pelvic Inflammatory Disease (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2073	Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2074	Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2075	Lower Abdominal Tenderness (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2076	Lower Abdominal Tenderness (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2077	Tenderness with motion of the cervix (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2078	Adnexal Tenderness (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2079	Uterine Tenderness (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2080	Leukocytosis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2081	Leukocytosis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2082	Purulent material in the peritoneal cavity (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2083	Pelvic Abscess (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2084	Pelvic Abscess (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2085	Leukocytes [Concentration] (Tests in Blood by Any Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2087	Nongonococcal Urethritis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2088	Nongonococcal Urethritis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2089	Urethritis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2090	Urethritis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2091	Urethral discharge (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2092	Urethral discharge (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2093	Dysuria (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2094	Dysuria (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2095	Gonorrhea (Tests for Neisseria gonorrhoeae Antigen)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2096	Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2098	Rhinitis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2100	Rhinitis (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2101	Pleuritis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2102	Pleuritis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2103	Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2105	Methemoglobinemia (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2106	Methemoglobinemia [Non Congenital] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2107	Methemoglobinemia (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2108	Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2109	Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative])	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2110	Anencephaly (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2111	Anencephaly (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2112	Fetal Anencephaly (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2113	Fetal Anencephaly (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2114	Cleft Lip Alone (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2115	Cleft Lip Alone (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2116	Fetal Cleft Lip (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2117	Cleft Palate Alone (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2118	Cleft Palate Alone (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2119	Cleft Lip with Cleft Palate (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2120	Cleft Lip with Cleft Palate (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2121	Fetal Spina Bifida (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2122	Spina Bifida (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2123	Spina Bifida (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2124	Down Syndrome (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2125	Down Syndrome (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2126	Fetal Down Syndrome (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2127	Fetal Down Syndrome (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2128	Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2129	Bacteremia (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2130	Bacteremia (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2131	Gastroschisis (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2132	Gastroschisis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2133	Fatal Familial Insomnia (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2134	Fatal Familial Insomnia (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2135	Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2136	Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2137	Prion Disease (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2138	Prion Disease (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2139	Prion Disease (Tests for Abnormal PRNP Gene Variant)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2140	Phenylketonuria (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2141	Phenylketonuria (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2142	Linezolid (RXNORM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2143	Tuberculosis (Pretomanid) (RXNORM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2144	Tuberculosis (Bedaquiline) (RXNORM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2145	Tuberculosis [Suspected] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2146	Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2147	Limb Reduction (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2148	Limb Reduction (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2149	NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2150	Congenital Hearing Loss (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2151	Congenital Hearing Loss (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2152	Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2153	Primary Congenital Hypothyroidism (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2154	Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2155	Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2156	Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2157	Mpox (Combination Tests that include mpox virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2158	Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2159	Mpox (Test Panels for mpox virus Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.216	Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2160	Orthopox (Test Panels for orthopoxvirus Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2161	COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2163	Dengue Virus Infection [Suspected] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2164	Mumps [Suspected] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2165	Pertussis [Suspected] (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2166	Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2167	Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2168	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2169	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2170	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2171	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2172	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2173	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2174	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2175	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2176	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2177	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2178	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2179	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.218	Listeriosis (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2180	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2181	Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2183	Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2187	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2188	Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2189	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2190	Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2192	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2193	Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2194	Organisms (Combination Tests by Culture and Identification)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2195	Organisms (Combination Tests for Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2196	Lung Tissue (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2197	Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2198	Anaplasmosis (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2199	NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2200	Organisms (Tests by Animal Inoculation Method)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2201	Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2202	Abnormal Lung Sounds (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2203	Abnormal Lung Sounds (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2204	Anemia [Unspecified Cause] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2205	Anemia [Unspecified Cause] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2206	Creatinine (Tests in Serum by Any Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2207	Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2208	Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2209	Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2210	Histopathology or Cytopathology Tests by Microscopic Observation	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2211	Ehrlichiosis (Tests for Ehrlichia species IgG Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2212	Invasive Cronobacter Infection (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2213	Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2214	Necrotizing Enterocolitis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2215	Necrotizing Enterocolitis (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2216	Abscess [Brain] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2217	Abscess [Brain] (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2218	Urinary Tract Infection (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2219	Urinary Tract Infection (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2220	Amniotic Fluid (Specimen Type) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2221	Congenital Cytomegalovirus (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2222	Organisms (Tests in Amniotic Fluid by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2223	Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2224	Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2225	Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2226	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2227	Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2228	Congenital Cytomegalovirus (Tests for CMV Antigen)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2229	Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2230	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2231	Congenital Cytomegalovirus Infection (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2232	Congenital Cytomegalovirus Infection (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2233	Cytomegalovirus Disease (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2234	Cytomegalovirus Disease (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2235	Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2236	Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2237	Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2238	Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2239	Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2240	Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2241	Stillbirth (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2242	Stillbirth (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2243	Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2244	Candida species (Tests by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2245	Organisms (Tests in Extrapulmonary Specimen by Culture and Identification)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2246	Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2247	Extrapulmonary [NTM] (Specimen Type) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2248	Plasmodium species (Tests by Microscopic Observation)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2249	Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2250	Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2251	Organisms (Tests in Sputum Specimen by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2252	Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2253	Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] )	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2254	Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2255	Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2256	CP_CRE (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2257	Organisms (Tests in Stool by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2258	Loss of Consciousness (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2259	Neonatal Abstinence Syndrome (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.226	Lyme Disease (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2260	Neonatal Abstinence Syndrome (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2261	High Pitched Cry (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2262	Inability to Console (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2263	Inability to Console (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2264	Hypertonia (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2265	Hypertonia (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2266	Tremors (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2267	Tremors (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2268	Myoclonus (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2269	Myoclonus (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.227	Lyme Disease (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2270	Poor Sleep (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2271	Poor Sleep (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2272	Alterations in Feeding (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2273	Alterations in Feeding (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2274	Excoriation (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2275	Excoriation (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2276	Sneezing (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2277	Sneezing (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2278	Nasal Congestion (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2279	Nasal Congestion (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2280	Yawning (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2281	Cutaneous Mottling (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2282	Sweating (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2283	Sweating (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2284	Feeding Intolerance (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2285	Feeding Intolerance (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2286	Respiratory Distress or Nasal Flaring (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2287	Respiratory Distress or Nasal Flaring (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2288	In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2289	In Utero Substance Exposure (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2290	In Utero Substance Exposure (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2291	Childbirth (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2292	Childbirth (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2293	Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2294	NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2295	Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2296	NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2297	Exposure or suspected exposure to harmful algae or algae toxins (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2298	Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2299	Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2300	Babesia species (Tests by Microscopic Observation)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2301	Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2302	Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2303	Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2304	Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2305	Gram_negative Diplococcus (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2306	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2307	D_Transposition of the Great Arteries (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2308	L_Transposition of the Great Arteries (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2309	Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2310	Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2311	Interrupted Aortic Arch (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2312	Interrupted Aortic Arch (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2313	Coarctation of the Aorta (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2314	Coarctation of the Aorta (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2315	Ebstein Anomaly (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2316	Ebstein Anomaly (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2317	Pulmonary valve atresia (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2318	Pulmonary valve atresia (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2319	Pulmonary valve stenosis (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2320	Pulmonary valve stenosis (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2321	Fetal Pulmonary valve stenosis (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2322	Double Outlet Right Ventricle (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2323	Double Outlet Right Ventricle (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2324	Hypoplastic left heart syndrome (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2325	Hypoplastic left heart syndrome (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2326	Single Ventricle (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2327	Single Ventricle (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2328	Tetralogy of Fallot (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2329	Tetralogy of Fallot (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2330	Truncus Arteriosus (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2331	Truncus Arteriosus (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2332	Atrioventricular septal defect (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2333	Atrioventricular septal defect (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2334	Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2335	Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2336	Tricuspid valve atresia (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2337	Tricuspid valve atresia (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2338	Tricuspid valve stenosis (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2339	Tricuspid valve stenosis (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2340	Fetal Tricuspid valve stenosis (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2341	Exposure to Measles (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2342	Increased Risk for Exposure to Measles (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2343	Giardiasis (Tests by Microscopic Observation)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2344	Diphtheria (Tests for Diphtheria Toxin Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2345	Lead in Blood (Tests for Lead in Venous Blood)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2346	Lead in Blood (Tests for Lead in Capillary Blood)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2347	Opioid Overdose and Poisoning (Test Panels for Opioids)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2348	Rubella (Test Panels for rubella virus IgM Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2349	Consistent with Tuberculosis (Finding in Chest Xray Imaging Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2350	Acute Viral Hepatitis (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2351	Shigellosis (Combination Tests that include Shigella species by Culture and Identification)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2352	Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2353	Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2354	Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2355	Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2356	Skin (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2357	Organisms (Tests by Microscopic Observation in Skin)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2358	Unspecified Tissue (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2359	Organisms (Tests by Microscopic Observation in Unspecified Tissue)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2360	S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2361	S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2362	Tuberculosis (Ethambutol) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2363	Tuberculosis (Isoniazid [INH]) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364	Tuberculosis (Pyrazinamide [PZA]) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2365	Tuberculosis (Rifabutin) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2366	Tuberculosis (Rifampin) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2367	Tuberculosis (Rifapentine) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2368	Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2369	Necrotizing Fasciitis (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2370	Necrotizing Fasciitis (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2371	Renal Impairment [Acute or Unspecified] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2372	Renal Impairment [Acute or Unspecified] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2373	Coagulopathy [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2374	Coagulopathy [Unspecified Cause] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2375	Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2376	Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2377	Soft Tissue Necrosis (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2378	Soft Tissue Necrosis (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2379	Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2380	Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2381	Specimen from a Nonsterile Site (Specimen Type) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2382	Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2383	Absence of Skin Lesions (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2384	Neuralgia (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2385	Neuralgia (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2386	Peripheral Nerve Thickening (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2387	Nerve (Specimen Type) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2388	Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.239	Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.240	Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2403	NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2404	Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2405	Hepatitis D Virus Infection (Test for hepatitis D virus Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2406	Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2407	Firearm Injury (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2408	Firearm Injury (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2409	Babesiosis (Tests for B. microti IgG or Total Antibody [Titer])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2410	Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2411	Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2412	Babesiosis (Tests for Babesia species IgG or Total Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2413	Brucellosis (Tests for Brucella species IgG Antibody by ELISA)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2414	Cranial Nerve Involvement (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2415	Cranial Nerve Involvement (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2416	Unusual Change in Behavior (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2417	Radiculitis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2418	Subarachnoid Hemorrhage (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2419	Subarachnoid Hemorrhage (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2420	Discitis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2421	Discitis (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2423	Respiratory Insufficiency [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2424	Respiratory Insufficiency [Unspecified Cause] (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2425	Conjunctival Suffusion (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2426	Leptospira species (Tests by Microscopic Observation)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2427	Leptospirosis (Tests for Leptospira Antibody by Agglutination)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2428	Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2429	Conjunctival Suffusion (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2430	Pleural effusion (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2431	Pleural effusion (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2432	Abdominal swelling (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2433	Abdominal swelling (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2434	Neck swelling (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2435	Neck swelling (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2436	Diaphoresis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2437	Diaphoresis (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2438	Edema (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2439	Edema (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.244	Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2440	Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2441	Anthrax (Tests for Bacillus species by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2442	Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2443	Influenza A (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2444	Influenza B (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2445	Influenza [Unspecified] (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2446	Influenza A (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2447	Influenza [Unspecified] (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2448	Influenza (Tests for unspecified influenza virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2449	Influenza (Tests for influenza B virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2450	Influenza (Tests for unspecified influenza virus Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2451	Influenza (Tests for influenza B virus Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2452	Influenza (unspecified influenza virus in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2453	Influenza (influenza B virus in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2454	Influenza (Tests for unspecified influenza virus by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2455	Influenza (Tests for influenza B virus by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2456	Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2457	Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2458	Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2459	Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2460	Borrelia species (Tests by Microscopic Observation)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2461	Borrelia species (Tests by Microscopic Observation in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2462	Spirochetes (Tests by Microscopic Observation)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2463	Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2464	CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2465	CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2466	CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2467	CRE (Tests for Enterobacterales species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2468	CRE (Combination Tests that include Enterobacterales by Culture and Identification)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2469	Tests for Carbapenem Susceptibility [Meropenem and Doripenem]	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2470	Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2471	Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2473	Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2474	Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2475	Aortic valve stenosis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2476	Aortic valve stenosis (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2477	Anotia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2478	Microtia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2479	Microtia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2480	Anotia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2482	Anophthalmia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2483	Anophthalmia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2484	Microphthalmia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2485	Microphthalmia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2486	Atrial septal defect (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2487	Atrial septal defect (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2488	Fetal Aortic valve stenosis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2489	Congenital Posterior Urethral Valves (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2490	Congenital Posterior Urethral Valves (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2491	Bladder Exstrophy (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2492	Bladder Exstrophy (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2493	Encephalocele (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2494	Fetal Encephalocele (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2495	Encephalocele (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2496	Choanal Atresia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2497	Choanal Atresia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2498	Cloacal Exstrophy (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2499	Cloacal Exstrophy (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2500	Renal Agenesis or Hypoplasia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2501	Renal Agenesis or Hypoplasia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2502	Trisomy 13 (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2503	Trisomy 13 (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2504	Fetal Trisomy 13 (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2505	Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2506	Galactosemia (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2507	Galactosemia (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2508	Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2509	Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2510	Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2511	Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2512	Galactosemia (Tests for Galactokinase (GALK) [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2513	Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2514	Galactosemia (Tests for GALT gene allele 1)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2515	Galactosemia (Tests for GALT gene allele 2)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2516	Hypospadias (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2517	Hypospadias (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2518	Trisomy 18 (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2519	Fetal Trisomy 18 (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2520	Fetal Trisomy 18 (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2521	Trisomy 18 (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2522	Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2523	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2524	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2525	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2526	Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2527	Chlamydia species [Unspecified] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2528	Ventricular septal defect (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2529	Ventricular septal defect (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2530	Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2531	Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2532	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2533	Congenital Cytomegalovirus (Tests for CMV Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.264	Viral Hemorrhagic Fever (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.265	Viral Hemorrhagic Fever (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.268	Mumps (Tests for mumps virus IgM Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.272	Present or Positive Lab Result Value	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.282	Varicella (Tests for Varicella zoster virus by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.283	Varicella (Tests for Varicella zoster virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.285	Encephalitis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.287	Varicella (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.289	Carbon Monoxide Poisoning (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.293	Toxic Effects of Lead (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.297	Measles (Tests for measles virus Nucleic Acid)	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.299	Measles (Tests for measles virus IgM Antibody)	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.300	Meningococcal Disease (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.301	Shigellosis (Tests for Shigella species by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.304	Pesticide Related Illness (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.305	Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.307	Leptospirosis (Tests for Leptospira IgM Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.308	Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.310	Bacteria (Tests by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.311	Viruses (Tests by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.316	Rubella (Tests for rubella virus IgM Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.317	Shigellosis (Tests for Shigella species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.319	Fungi (Tests by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.322	Pesticide Related Illness (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.326	Arboviral Disease [Other] (Disorders) (ICD10CM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.329	Apnea (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.330	Apnea (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.333	Shigellosis (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.335	Influenza (Tests for influenza A virus by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.336	Influenza (Tests for influenza A or B virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.340	Influenza (influenza A or B virus in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.341	Campylobacteriosis (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.342	Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.343	Campylobacteriosis (Tests for Campylobacter species Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.344	Campylobacteriosis (Tests for Campylobacter species Antigen)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.349	Hepatitis A (Tests for hepatitis A virus IgM Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.353	Diarrhea (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.356	HIV Infection (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.359	Botulism (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.362	Hansen’s Disease (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.365	Silicosis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.366	Silicosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.371	Cryptosporidiosis (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.372	Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.375	Cyclosporiasis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.376	Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.379	Giardiasis (Tests for Giardia species Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.384	Listeriosis (Tests for Listeria monocytogenes Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.386	Vibriosis (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.388	Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.390	Trichinellosis (Tests for Trichinella species Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.395	Syphilis (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.396	Syphilis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.398	Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.399	Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.40	STEC Infection (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.400	Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.401	Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.403	Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.405	Hantavirus Infection and Diseases (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.407	Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.408	Hepatitis B Virus Infection (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.422	Tuberculosis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.427	STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.43	Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.436	Coccidioidomycosis (Tests for Coccidioides species IgM Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.437	Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.438	Coccidioidomycosis (Tests for Coccidioides species Antigen)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.44	Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.445	Legionellosis (Tests for Legionella species Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.446	Legionellosis (Tests for Legionella species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.451	Tuberculosis (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.460	HIV Infection or AIDS (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.464	Malaria (Tests for Plasmodium species Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.468	Leptospirosis (Tests for Leptospira Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.471	Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.472	Leptospirosis (Tests for Leptospira Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.476	Babesia species (Tests by Microscopic Observation in Blood)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.478	Anthrax (Tests for Bacillus anthracis by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.479	Anthrax (Tests for Bacillus anthracis Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.48	Salmonellosis (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.480	Anthrax (Tests for Bacillus anthracis Antigen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.481	Anthrax (Tests for Bacillus anthracis Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.494	Ehrlichiosis (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.496	Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.500	Q Fever (Tests for Coxiella burnetii Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.505	Toxic Shock Syndrome (TSS) (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.507	Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.512	Brucellosis (Tests for Brucella species Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.515	Brucellosis (Tests for Brucella species Antibody [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.516	Brucellosis (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.519	Dengue Virus Infection (Tests for dengue virus Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.523	Dengue Virus Infection (Tests for dengue virus Antigen)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.524	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative])	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.525	Dengue Virus Infection (Tests for dengue virus IgM Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.527	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative])	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.530	Borrelia species (Tests for Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.531	Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.532	Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.534	Smallpox (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.542	Spotted Fever Rickettsiosis (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.548	St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.550	Syphilis (Tests for Treponema pallidum Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.553	Anaplasma species (Tests by Microscopic Observation)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.555	Yellow Fever (Tests for yellow fever virus Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.557	Yellow Fever (Tests for yellow fever virus Antibody [Quantitative])	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.56	Diarrhea (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.560	West Nile Virus Infection (Tests for West Nile virus Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.569	Plague (Tests for Yersinia pestis Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.575	Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.576	Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.577	Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.578	Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.579	Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.58	Pertussis (Tests for Bordetella pertussis Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.580	Arboviral Disease [Other] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.581	Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.584	Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.586	Viral Hemorrhagic Fever (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.595	Tularemia (Tests for Francisella tularensis Nucleic Acid)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.598	Tularemia (Tests for Francisella tularensis Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.6	Diphtheria (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.605	Organisms (Tests by Microscopic Observation by Acid Fast Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.606	Tuberculosis (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.614	Pertussis (Tests for Bordetella pertussis Toxin Antibody)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.621	Inspiratory Whoop (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.632	Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.645	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.648	Vomiting (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.650	Jaundice (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.652	Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.660	Hypertonia [Excluding Congenital Hypertonia] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.662	Chest Pain (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.663	Erythema Nodosum (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.664	Congenital Zika Syndromes (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.665	Congenital Zika Syndromes (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.666	Guillain Barré syndrome (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.668	Rash (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.671	Fever (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.672	Arthralgia (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.673	Arthralgia (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.674	Conjunctivitis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.675	Conjunctivitis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.676	Pregnant (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.677	Postpartum (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.678	Postpartum (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.679	Hearing Loss (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.680	Abdominal Pain (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.681	Abdominal Pain (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.686	Erythema Multiforme (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.687	Myalgia (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.689	Periorbital Edema (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.691	Eosinophilia (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.692	Eosinophilia (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.70	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.702	Weight Loss (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.705	Syphilis (Tests for Treponemal or Non Treponemal Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.709	Cough [Non Productive] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.71	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.711	Wound Infection (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.712	Pneumonia (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.713	Sepsis [Septicemia] [Unspecified Organism] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.714	Sepsis [Septicemia] [Unspecified Organism] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.715	Meningitis (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.717	Cellulitis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.718	Cellulitis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.719	Myositis [Unspecified Cause] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.720	Myositis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.721	Otitis Media (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.722	Otitis Media (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.723	Otitis Externa (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.724	Otitis Externa (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.727	Acute Upper Respiratory Illness (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.728	HIV Infection (Tests for HIV Nucleic Acid [Qualitative])	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.730	HIV Infection (Tests for HIV Antibody)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.733	Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.741	Hepatitis B Immune Globulin (RXNORM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.744	Coccidioidomycosis (Tests for Coccidioides species IgG Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.746	Treponema pallidum (Tests by Microscopic Observation)	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.747	Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.750	Chest Pain (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.755	Acute Upper Respiratory Illness (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.756	Purpura (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.757	Muscle Spasms (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.758	Muscle Spasms (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.762	Mumps (Test Panels for mumps virus IgM IgG Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.763	Parotitis [Unspecified Cause] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.764	Mumps (Tests for mumps virus IgG Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.765	Aseptic Meningitis (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.766	Encephalitis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.767	Hearing Loss (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.770	Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.773	Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.777	Mastitis (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.779	Pancreatitis (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.780	Pancreatitis (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.782	Rubella (Test Panels for rubella virus IgM IgG Antibody)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.785	Opioid Overdose and Poisoning (Tests for Opioids [Qualitative])	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.789	Purpura (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.79	Campylobacteriosis (Disorders) (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.792	Novel Influenza A Virus Infection (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.793	Novel Influenza A Virus Infection (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.794	Sore Throat (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.795	Influenza (influenza A virus in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.796	Influenza (Novel influenza A virus in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.797	Influenza (Tests for influenza A or B virus by Culture and Identification Method)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.798	Influenza (Tests for influenza A virus Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.799	Influenza (Tests for influenza A virus Antigen)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.802	Influenza (Tests for Novel influenza A virus Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.803	Tests by Microscopic Observation in Tissue by H&E or PAS Stain	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.808	Headache (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.809	Headache (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.810	Backache (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.811	Backache (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.815	NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative])	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.816	Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.818	Measles (Tests for measles virus IgG Antibody [Ratio] in Serum)	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.820	Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.822	Pneumoconiosis (Unspecified) (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.823	Pneumoconiosis (Unspecified) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.824	Computerized Tomography of Chest (Imaging)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.830	Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.835	Lead in Blood (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.836	Lead in Blood (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.839	Acid Fast Bacilli (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.841	Tuberculosis (Interferon Gamma Release Assays)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.842	Tests by Microscopic Observation in Tissue	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.844	Tuberculosis (Second Line Drugs for Treatment) (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.846	SARS (Tests for SARS_CoV by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.847	SARS (Tests for SARS_CoV Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.86	Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.864	Nausea (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.865	Confusion (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.867	Dyspnea (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.869	Loss of Consciousness (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.87	Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.875	SARS (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.878	MERS (Tests for MERS_CoV Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.88	Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.881	Difficulty Breathing (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.884	Tests by Microscopic Observation in Blood	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.889	Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.892	Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.895	Rhinorrhea (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.896	Tests by Microscopic Observation in Blood Smear	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.897	Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.9	Xray of Chest (Imaging)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.90	Cough (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.900	Organisms (Tests by Microscopic Observation)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.902	Acute Renal Failure [Unspecified Cause] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.907	Arthritis [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.91	Cough (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.910	Epididymitis [Unspecified Cause] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.911	Epididymitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.914	Osteomyelitis [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.915	Osteomyelitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.918	Spondylitis [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.919	Arthritis [Unspecified Cause] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.92	Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.927	Thrombocytopenia [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.928	Bleeding [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.930	ECG Abnormalities [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.931	Hematemesis [Unspecified Cause] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.932	Hematemesis [Unspecified Cause] (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.934	Hematuria [Unspecified Cause] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.935	Hemoptysis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.937	Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.942	Petechiae [Non Traumatic] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.952	Thrombocytopenia [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.956	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.957	Regional Lymphadenitis [Including Bubo] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.958	Regional Lymphadenitis (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.96	Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.963	Arboviral Disease [Other] (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.965	Proteinuria [Unspecified Cause] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.969	Proteinuria [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.970	Bulbar Weakness (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.971	Bulbar Weakness (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.976	Dysphagia (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.978	Impaired Respiration [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.979	Botulism (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.98	Shigellosis (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.989	Tests for Mycobacterium species by Culture and Identification Method	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.991	Rifampin (RXNORM)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.994	Organisms (Tests for Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.998	Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.999	Chlamydia species (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.109	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.110	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.112	Pressure Injury Deep Tissue	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.113	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.119	Inpatient Falls	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.120	Major Injuries	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.122	Inpatient Falls	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.125	Bleeding at Non Critical Site	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.130	Anticoagulants for VTE Prophylaxis	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.131	Anticoagulants for Indications Other than VTE Prophylaxis	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.135	Bleeding at Critical Site	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143	Bleeding at Critical Site	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.144	Bleeding at Critical Site	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.145	Bleeding at Non Critical Site	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146	Bleeding at Non Critical Site	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.160	Abdominal or Pelvic CT Scan with Contrast	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.163	Ultrasound of Lower Extremities	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.164	Ultrasound of Lower Extremities	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.165	Ultrasound of Lower Extremities	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.171	Inpatient Falls	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.183	Anti Factor Xa Assay	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.187	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.188	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.190	Intra Aortic Balloon Pump	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.191	Intra Aortic Balloon Pump	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.193	Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.194	Pressure Injury Deep Tissue Diagnoses	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.196	Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.197	Present on Admission or Clinically Undetermined	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.198	Not Present On Admission or Documentation Insufficient to Determine	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.1	DEXA Dual Energy Xray Absorptiometry, Bone Density	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.11	Bladder Cancer Staging Ta for Urology Care	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.12	Bladder Cancer staging T1 for Urology Care	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.13	Bladder Cancer staging Tis for Urology Care	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.15	Carcinoma of urinary bladder, superficial	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.16	Injection Leuprolide Acetate	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17	High grade bladder cancer Ta for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.18	Immunocompromised state for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.19	Systemic chemotherapy for urology care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.2	Bladder Cancer in Situ	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.20	Corticosteroids for patients receiving Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21	Calcineurin inhibitors for patients receiving Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.23	Immunomodulators for patients undergoing Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.24	Monoclonal antibody for patient undergoing Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.28	Radiotherapy for patients undergoing Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.29	Plasmacytoid cell, morphologic abnormality for urology care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.3	Bladder Cancer in Situ	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.30	Sarcomatoid, morphologic abnormality for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.31	Micropapillary, morphologic abnormality, for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.32	Immunosuppressive Drugs for Urology Care	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.38	DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care	active	2017-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39	Mixed histology urothelial cell carcinoma for Urology Care	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4	BCG Bacillus Calmette Guerin, Tice	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.40	Cystectomy for Urology Care	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.44	Unavailability of Bacillus Calmette Guerin for urology care	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.45	Bladder Cancer for Urology Care	active	2017-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.48	Androgen deprivation therapy for Urology Care	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5	BCG Bacillus Calmette Guerin, Connaught	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.52	BCG Bacillus Calmette Guerin for Urology Care	active	2020-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.53	Cystectomy for Urology Care	active	2018-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.54	Acute Tuberculosis for Urology Care	active	2018-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.55	Cystectomy for Urology Care	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.56	Active Tuberculosis for Urology Care	active	2018-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.57	Bladder Cancer Staging Tis for Urology Care	active	2019-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.58	Bladder Cancer Staging Tis for Urology Care	active	2019-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.59	Hospital Services for Urology	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.6	Peripheral DXA Scan	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.60	Chemotherapy Agents for Advanced Cancer	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.8	Tuberculosis Diagnosis Prior to Urology Care	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.9	Leukemia Diagnosis Prior to Urology Care	active	2016-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.13	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.14	Intensive Lifestyle Interventions	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.15	Intensive Lifestyle Interventions	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.16	Intensive Lifestyle Interventions	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.17	Intensive lifestyle interventions	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.21	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.22	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.23	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.24	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.25	Reason for No Intensive Lifestyle Intervention	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.27	Type 2 Diabetes Diagnoses	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.28	Type 2 Diabetes Diagnoses	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.29	Type 2 Diabetes Diagnoses	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.30	Prediabetes HbA1c Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.31	Prediabetes HbA1c Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.32	Prediabetes HbA1c Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.33	Prediabetes Oral Glucose Tolerance Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.34	Prediabetes Oral Glucose Tolerance Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.35	Prediabetes Oral Glucose Tolerance Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.36	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.37	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.38	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.4	Glycemic Screening Tests	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.40	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.41	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.42	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.43	Analgesics for Acute Pain	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.49	Medication Therapy Management Services for Essential Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.5	Glycemic Screening Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.52	Remote Physiologic Blood Pressure Monitoring	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57	Aldosterone Receptor Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58	Alpha Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.59	Angiotensin Converting Enzyme Inhibitor for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.6	Glycemic Screening Tests	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.60	Angiotensin II Receptor Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.61	Beta Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.62	Calcium Channel Blocker Dihydropyridine for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.63	Calcium Channel Blocker Non Dihydropyridine for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.64	Central Acting for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65	Direct Renin Inhibitor for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.66	Loop Diuretic for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.67	Neuronal Blocking Agent for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68	Potassium Sparing Diuretic for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.69	Thiazide Diuretic for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.7	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70	Vasodilator for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.73	Analgesics for Acute Pain (Non Parenteral Route)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.74	Analgesics for Acute Pain (Parenteral Route)	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.75	Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.77	Antihypertensive Medication Classes	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.78	Medication Therapy Management Services for Essential Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.79	Medication Therapy Management Services for Essential Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.8	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.84	Renal Colic	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.85	Renal Colic	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.86	Renal Colic	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.88	Direct LDL Cholesterol	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.89	Calculated LDL Cholesterol	active	2025-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.9	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.50	Urinary retention	active	2017-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.51	Urinary retention	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.52	Urinary retention	active	2017-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.65	Morbid Obesity	active	2018-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.66	Morbid Obesity	active	2018-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.67	Morbid Obesity	active	2018-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.68	BMI greater than 40	active	2019-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.69	Morbid Obesity	active	2019-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.1	Pregnancy Status	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.10	Pap Smear Tests	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.103	Female Sterilization HCPCS Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.105	Female Sterilization ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.109	Sterilization SNOMED Findings	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.11	HIV Tests	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.110	Pregnancy Bundle Visits	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.111	Prenatal Care Specific Visits CPT	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.112	Prenatal Care Specific Visits HCPCS	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.113	Prenatal Care Specific Visits SNOMED	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.114	Prenatal Care Specific Visits	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.115	Self Identified Need for Contraception (SINC)	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.117	Syphilis Tests	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.118	Infecund Not for Contraceptive Reasons CPT Procedures	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.119	Infecund Not for Contraceptive Reasons HCPCS Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.12	Human Papilloma Virus Tests	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.120	Prenatal Care Visits CPT	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.121	Prenatal Care Visits HCPCS	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.122	Prenatal Care Visits SNOMED	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.123	Pregnancy Related Diagnoses ICD10CM	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.124	Pregnancy Related Diagnoses SNOMED	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.125	Non Live Birth Diagnoses ICD10CM	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.126	Non Live Birth Diagnoses SNOMED	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.127	Non Live Birth CPT Procedures	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.128	Non Live Birth ICD10PCS Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.129	Contraceptive Ring RXNORM Medications	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.13	Chlamydia Trachomatis Tests	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.130	Contraceptive Implants RXNORM Medications	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.131	Injectable Contraceptive RXNORM Medications	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.132	Oral Contraceptive Pills RXNORM Medications	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.133	Pregnancy Related Diagnoses	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.134	Female Sterilization SNOMED Provision Procedures	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.135	General Prenatal Care Visits	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.136	Non Live Birth Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.137	Non Live Birth Diagnoses	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.138	IUD Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.139	IUD Provision Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.14	Neisseria Gonorrhoeae Tests	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.140	IUD Devices	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.141	Contraceptive Patch SNOMED Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.142	Female Sterilization Provision Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.143	Live Birth Delivery CPT Procedures	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.144	Contraceptive Patch SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.145	Contraceptive Patch SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.146	Contraceptive Patch ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.147	Contraceptive Patch ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.148	Live Birth Delivery ICD10PCS Procedures	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.149	Contraceptive Patch HCPCS Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.15	Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.150	Contraceptive Patch LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.151	Infecund Not for Contraceptive Reasons Procedures	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.152	Live Birth Delivery Procedures SNOMED CT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.153	Contraceptive Ring SNOMED Surveillance Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.154	Contraceptive Ring SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.155	Contraceptive Ring SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.156	Contraceptive Ring ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.157	Contraceptive Ring ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.159	Contraceptive Ring HCPCS Devices	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.160	Contraceptive Ring LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.161	Contraceptive Implant SNOMED Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.162	Contraceptive Implant ICD10PCS Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.163	Contraceptive Implant SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.164	Contraceptive Implant SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.165	Infecund Not for Contraceptive Reasons SNOMED Procedures	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.167	Contraceptive Implant LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.168	Pregnancy Bundle CPT	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.169	Pregnancy Bundle HCPCS	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.17	Contraceptive Type	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.170	Contraceptive Implant ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.171	Contraceptive Implant ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.173	Contraceptive Implant HCPCS Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.174	Contraceptive Patch Devices	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.177	Live Birth Delivery Procedures	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.178	Contraceptive Ring Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.18	Contraception Not Used Reason	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.180	Contraceptive Implant CPT Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.181	Injectable Contraceptive SNOMED Surveillance Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.182	Injectable Contraceptive SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.183	Injectable Contraceptive SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.185	Injectable Contraceptive ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.186	Injectable Contraceptive ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.187	Injectable Contraceptive HCPCS Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.188	Injectable Contraceptive LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.189	Oral Contraceptive Pill SNOMED Surveillance Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.190	Oral Contraceptive Pill SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.191	Oral Contraceptive Pill SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.192	Contraceptive Implant SNOMED Surveillance Procedures	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.193	Oral Contraceptive Pill ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.194	Oral Contraceptive Pill ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.195	Oral Contraceptive Pill HCPCS Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.196	Oral Contraceptive Pill LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197	Injectable Contraceptive Provision Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198	Injectable Contraceptive Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199	Oral Contraceptive Pill Provision Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200	Oral Contraceptive Pill Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201	Contraceptive Implant Devices	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202	Contraceptive Implant Provision Procedures	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203	Contraceptive Implant Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.204	Prenatal Care Bundle CPT	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.205	Prenatal Care Bundle Visits	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.206	Infecund Not for Contraceptive Reasons ICD10PCS Procedures	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209	Yes and No Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21	Contraceptive Provision Method	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210	Pap Smear Results	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.211	Contraceptive discussion	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22	Pregnancy Intention	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24	Clinical Provider Role	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.29	Insurance Coverage Type	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3	Organism Detection	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31	English Proficiency	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.76	Contraceptive Patch RXNORM Medications	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.78	Intrauterine Devices CPT Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.79	Intrauterine Devices HCPCS Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.80	Intrauterine Devices LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.81	Intrauterine Devices HCPCS Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.83	Intrauterine Devices ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.84	Intrauterine Devices ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.85	Intrauterine Devices RXNORM Medications	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86	Intrauterine Devices SNOMED Devices	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87	Intrauterine Devices SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88	Intrauterine Device SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89	Intrauterine Devices SNOMED Surveillance Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.91	Intrauterine Devices ICD10PCS Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.93	Female Sterilization CPT Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96	Infecund Not for Contraceptive Reasons SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.97	Infecund Not for Contraceptive Reasons ICD10CM	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.98	Female Sterilization LOINC	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.99	Female Sterilization ICD10PCS Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10	ASN Screening Declined	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.11	Transportation Insecurity Diagnosis	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.12	Food Insecurity Diagnosis	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.13	Homelessness Diagnosis	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.14	Housing Instability Diagnosis	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15	Intervention for Positive Transportation Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16	Intervention for Positive Food Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.17	Intervention for Positive Food Insecurity Screen	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.18	Intervention for Positive Food Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19	Intervention for Positive Food Insecurity Screen	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2	Intracranial or Intraspinal surgery	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20	Intervention for Positive Homelessness Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21	Intervention for Positive Housing Instability Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.22	Emergency Department Observation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27	Mental Health Diagnosis without Substance Use Disorders	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.28	Mental Health Diagnosis without Substance Use Disorders	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29	Bed Assigned	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3	Malignant Intracranial Neoplasm Group	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31	Healthcare Agent & Power of Attorney Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.32	Healthcare Agent and Power of Attorney Documentation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.33	Advance Directive Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34	Advance Directive Documentation	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.35	Advance Directive Documentation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.36	Portable Medical Order(s) Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37	Portable Medical Order(s) Documentation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38	Advance Care Planning Discussion Documentation	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4	Thrombolytic medications	active	2021-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.40	Advance Care Planning Documentation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.41	Advance Care Planning Documentation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42	Healthcare Agent & Power of Attorney Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43	Advance Directive Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45	Advance Care Planning Documentation	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.46	Advance Care Planning Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47	Portable Medical Order(s) Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48	Portable Medical Order(s) Documentation	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.49	Intervention for Positive Utility Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5	Allergy to thrombolytics	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50	Intervention for Positive Utility Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.51	Intervention for Positive Transportation Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52	Intervention for Positive Transportation Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.53	Intervention for Positive Housing Instability Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54	Intervention for Positive Housing Instability Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.55	Intervention for Positive Homelessness Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56	Intervention for Positive Homelessness Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.57	Non Invasive Oxygen Therapy Device Codes	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.58	Goals, preferences, and priorities for medical treatment	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6	Thrombolytics Adverse Event	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.7	Intraspinal surgery	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8	Intervention for Positive Utility Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.9	Utility Insecurity Diagnosis	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58	Food Insecurity Screening Positive	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.1	Ezetimibe Therapy	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.10	Antihypertensive Medications	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100	Allergy or Intolerance to ACE Medication	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101	Allergy or Intolerance to ARB Medication	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102	Chronic Kidney Disease Stage 1	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103	Chronic Kidney Disease Stage 2	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104	Chronic Kidney Disease Stage 3	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105	Chronic Kidney Disease Stage 4	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106	Chronic Kidney Disease Stage 5	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.107	ICD10 CM Chronic Kidney Disease Stage 1	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.108	ICD10 CM Chronic Kidney Disease Stage 2	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111	AHA GWTG Chronic Kidney Disease Stage 2	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.112	ICD10 CM Chronic Kidney Disease Stage 3	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.113	ICD10 CM Chronic Kidney Disease Stage 4	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.114	ICD10 CM Chronic Kidney Disease Stage 5	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115	AHA GWTG Chronic Kidney Disease Stage 1	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116	AHA GWTG Chronic Kidney Disease Stage 3	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117	AHA GWTG Chronic Kidney Disease Stage 4	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.118	SNOMED CT Atrial Fibrillation	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.119	ICD10 CM Atrial Fibrillation	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.121	AHA GWTG Atrial Fibrillation	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.123	SNOMED CT Hyperlipidemia	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.124	ICD10 CM Hyperlipidemia	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.125	AHA GWTG Hyperlipidemia	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.126	SNOMED CT Hypertriglyceridemia	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.127	ICD10 CM Hypertriglyceridemia	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.129	AHA GWTG Hypertriglyceridemia	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.130	SNOMED CT Gestational Diabetes	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.131	ICD10 CM Gestational Diabetes	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.132	AHA GWTG Gestational Diabetes	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.133	SNOMED CT Hyperglycemia	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.134	ICD10 CM Hyperglycemia	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.135	AHA GWTG Hyperglycemia	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.136	SNOMED CT Nonobstructive CAD	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.137	ICD10 CM Nonobstructive Coronary Artery Disease	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.138	AHA GWTG Nonobstructive coronary artery disease	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.139	AHA GWTG Anti Obesity Pharmacotherapy	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15	Non Tobacco Smoking Product User	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.16	Antihypertensive Fixed Dose Combination Medications	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2	PCSK9 Inhibitors	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.20	CCB and Thiazide and Thiazide Like Diuretics	active	2021-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21	Referral to cardiac rehab	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22	Cardiac Rehabilitation	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.25	2 Hour Blood Glucose Test	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.26	NYHA Functional Classification	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27	ARNI Therapy	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29	MRA Therapy	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.3	Cholesterol non HDL Laboratory Test	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.30	SGLT2 Inhibitors	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.31	Heart Transplant	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32	Heart Transplant	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33	Heart Transplant	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34	Allergy to MRA Therapy	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.35	Aspirin or Clopidogrel	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.39	Cardiac Rehabilitation	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.4	Hypothyroidism	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40	Cardiac Rehabilitation	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43	SGLT2 Ingredients	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.44	MRA Ingredients	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.49	Minnesota Living with Heart Failure Questionnaire	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5	Hypothyroidism	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.50	Kansas City Cardiomyopathy Questionnaire	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.51	Cardiac Pacer	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52	Cardiac Pacer	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53	Cardiac Pacer	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.54	Heart Transplant Complications	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55	Heart Transplant Complications	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56	Heart Transplant Complications	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57	Left Ventricular Assist Device Complications	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58	Left Ventricular Assist Device Complications	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.59	Left Ventricular Assist Device Placement	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6	Hypothyroidism	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60	Left Ventricular Assist Device Placement	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61	Left Ventricular Assist Device Placement	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.62	Left Ventricular Assist Device Placement	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.63	Heart Transplant	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.65	Cardiac Pacer	active	2022-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.66	Diastolic Heart Failure	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67	Diastolic Heart Failure	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68	Diastolic Heart Failure	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69	Allergy to SGLT2 Inhibitors	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.7	Anorexia Nervosa	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70	Intolerance to SGLT2 Inhibitors	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71	Intolerance to MRA Therapy	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.72	ARNI Ingredient	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.73	Mitral Stenosis	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74	Mitral Stenosis	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75	Mitral Stenosis	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.76	Mechanical Prosthetic Heart Valve	active	2022-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77	Mechanical Prosthetic Heart Valve	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78	Mechanical Prosthetic Heart Valve	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.79	Mechanical Prosthetic Heart Valve in Situ	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8	Anorexia Nervosa	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.82	Systolic Heart Failure	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83	Systolic Heart Failure	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84	Systolic Heart Failure	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.85	Carotid Intervention	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.86	Serum Creatinine	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.87	Urine Creatinine	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.88	Urine Albumin	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9	Anorexia Nervosa	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.90	Non Steroidal Mineralcorticoid Receptor Antagonist	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.91	Glucagon like peptide 1 medications	active	2024-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96	AHA GWTG Long COVID19	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97	AHA GWTG Long COVID19 SNOMEDCT	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.98	AHA GWTG Long COVID19 ICD10CM	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1	Wound internal item and/or body structure visible value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11	Wound exudate appearance value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12	Wound exudate color value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13	Exudate odor value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14	Wound anatomic location value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16	Skin temperature value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17	Skin color enumerated value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18	Skin turgor value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19	Skin and mucous membrane integrity value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2	Periwound condition value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20	Skin moisture value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3	Wound Type Etiology value set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4	Wound episode value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.6	Wound bed appearance value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.60	Wound type reference set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.7	Wound bed color value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.74	Nonverbal pain indicators reference set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.76	Pain associated signs and symptoms reference set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.77	Pain body location reference set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.8	Wound edge description value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.80	Pain quality reference set	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.81	Pain speed of onset reference set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.9	Presence absence value set (foundation metadata concept)	active	2018-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.1	Common drug substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.2	Common drug classes for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.3	Common dietary substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.4	Common environmental substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.5	Common refutations for substance causes for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7	Common substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8	Common substances for allergy and intolerance documentation including refutations	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.10	NHSNCriterionOfDiagnosisCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.11	NHSNCriterionOfDiagnosisCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.12	NHSNInfectionConditionCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.13	NHSNInfectionConditionCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.14	NHSNInfectionTypeCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.15	NHSNInfectionTypeCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.16	NHSNInfectionFirstReportedSource(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.17	NHSNInfectionFirstReportedSource(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.18	NHSNLOS/MENDischargeDisposition(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.19	NHSNLOS/MENDischargeDisposition(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.20	NHSNPopulationSummaryReportTypeCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.21	NHSNPopulationSummaryReportTypeCode(LOINC)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.22	NHSNSameDayOutcomeMeasure(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.23	NHSNSameDayOutcomeMeasure(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.24	NHSNSignificantPathogenCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.25	NHSNSignificantPathogenCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.26	NHSNSpinalFusionApproachCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.27	NHSNSpinalFusionApproachCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.28	NHSNVascularAccessTypeCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.29	NHSNVascularAccessTypeCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.30	NHSNVascularSpecimenCollectionSite(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.31	NHSNVascularSpecimenCollectionSite(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.38	Blood Glucose Laboratory and Point of Care Tests	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.58	Diabetes Medications	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.6	NHSNPathogenCodeARO	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.62	Lab Tests for Clostridioides difficile	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.63	Bacterial and Fungal Blood Culture Tests	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.7	NHSNRoleOfPerformerCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.74	Enteral Medication Route	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.75	Intravenous Medication Route	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.76	Fidaxomicin	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.77	Vancomycin	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.78	Metronidazole	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.79	Fidaxomicin, Vancomycin, and Metronidazole	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.8	NHSNRoleOfPerformerCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.85	Baloxavir	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.86	Peramivir	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.87	Zanamivir	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.88	Digestive, Intramuscular, Intravenous Route of Administration	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.89	Maternal Diagnoses	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.9	NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)	active	2020-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.90	NHSN LTC AU Antimicrobial Agents	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.91	Long Term Care Discharge Disposition	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.94	NHSNNeurogenicBladder	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.95	NHSNSpinalCordInjury	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1139	S4G Hyperlipidemia	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1291	S4G Cardiomyopathy	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1292	S4G Tricuspid valve disorder	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1293	S4G Pompe disease	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1294	S4G Malignant hyperthermia	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1295	S4G Malignancy	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1297	S4G Intestinal polyp	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1298	S4G Hamartoma	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1299	S4G Diabetes mellitus	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1300	S4G Muscular dystrophy and weakness	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1325	S4G Hamartoma and S4G Intestinal Polyp	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1326	S4G Malignancy and S4G Intestinal Polyp	active	2022-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1344	Tests for Neisseria gonorrhoeae of unspecified site reported by presence	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1352	Body weight	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354	Cefixime preparations for oral administration	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1358	Beta lactam medicinal product SNOMED	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1370	Beta lactam ingredients for allergy determination RXNORM	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.147	SCIP Major Surgical Procedure	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158	Multiple Myeloma Regimen Drugs	active	2019-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.226	Opioids, All	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3483	Financial Insecurity Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3484	Food Insecurity Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3485	Health Literacy Screening Assessments Questions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3486	Homelessness Screening Assessments Questions	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3487	Housing Instability Screening Assessments Questions	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3488	Less Than High School Education Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3519	Health Insurance Coverage Status Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3520	Inadequate Housing Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.393	Hypoglycemics Severe Hypoglycemia	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.394	Hypoglycemics Treatment Medications	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4436	Gentamicin medications	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4437	Azithromycin medications	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4448	Lidocaine	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4466	Pharyngeal specimens	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4467	Urogenital & Anorectal Specimens	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469	Cabotegravir Injectable Products	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4470	Emtricitabine oral for HIV PrEP	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4474	HIV Laboratory Based Tests	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4502	Ceftriaxone all code types	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491	Medium Dose ICS Formoterol Preparations	active	2021-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495	ICS LABA LAMA Preparations	active	2021-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.788	Social Determinants of Health Conditions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.789	Social Determinants of Health Procedures	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.790	Social Determinants of Health Service Requests	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93	CPIC RxNORM abacavir SCDG	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.94	CPIC RxNORM allopurinol SCDG	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.95	CPIC RxNORM amitriptyline SCDG	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96	CPIC RxNORM atazanavir SCDG	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97	CPIC RxNORM atomoxetine SCDG	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99	CPIC RxNORM capecitabine SCDG	active	2019-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.1	Mechanical Complications Related To Hip and Knee Procedures	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.10	Surgical Site Bleeding and Other Surgical Site Complications	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.11	Procedures Resulted From Surgical Site Bleeding and Other Surgical Site Complications	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.12	Opioid (Oral Tablets and Patches only)	active	2019-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.13	Comorbidity Risk Factors	active	2020-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.14	Treatment of Hemorrhage or Hematoma	active	2020-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.15	General Surgery	active	2020-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.17	Coagulation Disorder Conditions	active	2020-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.18	Acute Respiratory Failure	active	2020-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.19	Anticoagulant Medications	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.2	Fracture Exclusions For Hip And Knee Procedures	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.20	Anticoagulant Medications, Oral	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.21	Anticoagulant Medications, Injection	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.28	Active Bleeding	active	2020-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.29	Fall Risk Increasing Drugs (FRIDs)	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.3	Pulmonary Embolism Complications Related To Hip and Knee Procedures	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.30	Fall Risk Factors	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.32	Total Hip Arthroplasty Surgery	active	2021-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.33	Total Knee Arthroplasty Surgery	active	2021-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.34	AbnormalityOfGaitAndMobility	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.35	Assymetry Symptoms	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.36	Hemiplegia Symptoms	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.37	Leg Weakness Symptoms	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.38	Osteopenia Symptoms	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.39	Stroke Symptoms	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.4	Sepsis Complications Related To Hip and Knee Procedures	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.40	Vestibular Symptoms	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.41	TricyclicAntidepressants	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.42	Benzodiazepines	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.43	LoopDiuretics	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.44	Antiepileptics	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.45	Antipsychotics	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.46	Opioid Medications	active	2021-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.47	Imaging Related to VTE	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.48	Anticoagulant Medication	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.49	VTE Diagnoses	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.5	Nonprimary Total Hip, Total Knee Replacement	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.50	Bisphosphonate Therapy	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.51	VTE Symptoms	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.52	Oncology Critical Care Units	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.53	Provider Types	active	2022-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56	FOBT_Lab	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.57	Colorectal Screening	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.58	Screening Mammogram (CPT)	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.59	Screening Mammogram (LOINC)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.6	Pneumonia Complications Related To Hip and Knee Procedures	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.60	Screening Mammogram (SNOMEDCT)	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.61	Screening Mammogram (Grouping)	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.62	Diagnostic Mammography (CPT)	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.63	Diagnostic Mammography (LOINC)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.64	Diagnostic Mammography (SNOMEDCT)	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.65	Diagnostic Mammography	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.66	Breast Cancer Biopsy and Surgical Excision	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.67	BI_RADS Categories 0, 4, and 5	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.68	BI_RADS Categories 1, 2, and 3	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.7	Malignant Neoplasm Complications Related To Hip and Knee Procedures	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.8	Periprosthetic Joint Infection/Wound Infection and Other Wound Complications	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.9	Procedures Resulted From Periprosthetic Joint Infection/Wound Infections	active	2019-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.101	Local Anesthetics	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.102	Ophthalmic Epinephrines	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.103	Inhaled Epinephrines	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.104	Clopidogrels	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.105	Cytochrome P450 2C19 inhibitors	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.106	Cytochrome P450 2C9 inhibitors	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.107	Aspirin Ingredient and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109	Oral Anticoagulant Ingredients and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.110	Corticosteroid Ingredients and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.111	Antidepressant Ingredients and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.112	PPI and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113	Antiplatelet Ingredients and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.114	NSAIDs Ingredients and Risk of GI Bleeding	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.115	Kratom containing compounds	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117	Clopidogrel Ingredients and Risk of GI Bleeding	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.121	Gastrointestinal bleeding episode and Risk of GI Bleeding 1	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.122	Gastrointestinal bleeding episode and Risk of GI Bleeding 2	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.123	Gastrointestinal bleeding episode and Risk of GI Bleeding	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.24	Oxycodones	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1217.2	TESTSemanticBitsValueSet	active	2020-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.1	Bronchiectasis Disorder SNOMED	active	2020-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.10	Interstitial Lung Disease ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.100	Occupational Therapy Procedure HCPCS	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.101	Occupational Therapy Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.102	Speech Language Therapy Procedure HCPCS	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.103	Speech Language Therapy Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.104	Home Health Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.105	Intermittent Skilled Nursing Home Health Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.106	pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.107	Breathing Test Procedure During Sleep	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.108	Ambulance Transport Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.109	Prefabricated Spinal Orthotic Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.11	Interstitial Lung Disease SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.110	Custom Fitted Spinal Orthotic Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.111	Custom Fabricated Spinal Orthotic Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.112	Orthotic Device Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.113	Spinal Orthotic Device or Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.115	Spine or Neck Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.116	Spine or Neck Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.117	Spine or Neck Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.118	Total Electric Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.119	Hypoventilation Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.12	Interstitial Lung Disease	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.120	Hypoventilation Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.121	Hypoventilation Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.122	Respiratory Assist Device Qualifying Condition	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.123	Apnea Hypopnea Index Rate Measurement	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.124	Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.125	Maximal Inspiratory Pressure Measurement	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.126	Forced Vital Capacity (FVC) Measurement by Spirometry	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.127	Oxygen Saturation Measurement At Rest	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.128	Respiratory Assist Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.129	Respiratory Assist Device Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.13	Cystic Fibrosis Lung Disease ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.130	Home Oxygen Therapy Accessory	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.131	Forced Vital Capacity (FVC) Measurement Prediction	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.132	Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.133	Respiratory Disturbance Index	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.134	Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.135	Past Medical History Condition Related to Need for Positive Airway Pressure Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.136	Home or Facility Care Location	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.137	Fracture of Bone Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.138	Fracture of Bone Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.139	Fracture of Bone Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.14	Cystic Fibrosis Lung Disease SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.140	Severe Obesity Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.141	Severe Obesity Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.142	Severe Obesity Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.143	Transfer from Bed Impairment SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.144	Bed Confinement Impairment	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.145	Transfer from Bed Impairment	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.146	Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.147	Mobility Impairment or Fall From Chair ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.148	Ability to Safely Sit in Chair or Wheelchair Impairment	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.149	Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.15	Cystic Fibrosis Lung Disease	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.150	Fall or Fall Risk from Wheelchair or Scooter ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.152	Muscle, Tendon or Joint Contracture Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.153	Muscle, Tendon or Joint Contracture Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.154	Muscle, Tendon or Joint Contracture Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.155	Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.156	Muscle Weakness or Myasthenia Gravis Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.158	Myocardial Infarction Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.159	Myocardial Infarction Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.16	Neoplasm of Lung or Trachea Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.160	Myocardial Infarction Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.161	Amputation Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.162	Amputation Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.164	Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.165	Lower Extremity Deep Vein Thrombosis Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.167	Spinal Cord Injury or Paralysis Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.168	Spinal Cord Injury or Paralysis Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.169	Spinal Cord Injury or Paralysis Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.17	Neoplasm of Lung or Trachea Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.170	Demyelinating Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.171	Demyelinating Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.172	Demyelinating Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.173	Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.174	Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.176	Wound Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.177	Wound Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.178	Wound Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.179	Danger to Self or Others Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.18	Neoplasm of Lung or Trachea Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.180	Danger to Self or Others Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.181	Danger to Self or Others Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.182	Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.183	Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.184	Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.185	Pain on Movement or Joint Pain Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.186	Pain in Joint Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.187	Pain on Movement or Joint Pain Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.188	Non Emergency Ambulance Transport Reason	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.189	Osteoarthritis Disorder SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.19	Secondary Erythrocytosis Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.190	Osteoarthritis Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.191	Osteoarthritis Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.192	Immunosuppressive Medication RxNorm	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.193	Medication Supporting Immunosupressive Medication RxNorm	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.194	Non Emergency Ambulance Transport Qualifying Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.197	Turalio	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.198	Hepatic Medical History	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.2	Bronchiectasis Disorder ICD10CM	active	2020-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.20	Secondary Erythrocytosis Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.21	Secondary Erythrocytosis Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.22	Acute or Chronic Heart Failure Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.23	Acute or Chronic Heart Failure Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.24	Acute or Chronic Heart Failure Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.25	Home Oxygen Therapy Qualifying Condition	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.26	Device Use Patient Activity Level	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.27	Portable Liquid Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.28	Stationary Liquid Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.29	Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.3	Bronchiectasis Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.30	Sleep Apnea or Breathing Related Sleep Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.31	Sleep Apnea or Breathing Related Sleep Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.32	Positive Airway Pressure Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.33	Diabetes Mellitus Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.34	Diabetes Mellitus Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.35	Diabetes Mellitus Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.36	Restrictive Lung Disease SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.37	Restrictive Lung Disease ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.38	Restrictive Lung Disease	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.39	Chest Wall Deformity Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.4	Chronic Obstructive Lung Disease (COPD) ICD10CM	active	2020-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.40	Chest Wall Deformity Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.41	Chest Wall Deformity Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.42	Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.43	Motor Neuron Disease or Spinal Muscular Atrophy Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.44	Motor Neuron Disease or Spinal Muscular Atrophy Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.45	Chronic Respiratory Failure Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.46	Chronic Respiratory Failure Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.47	Chronic Respiratory Failure Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.48	Ventilator Therapy Qualifying Condition	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.49	Ventilator Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.5	Chronic Obstructive Lung Disease SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.50	Fixed Height Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.51	Variable Height Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.52	Semi electric Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.53	Heavy Duty Extra Wide Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.54	Extra Heavy Duty Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.55	Hospital Bed Trapeze Accessory Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.56	Hospital Bed Cradle Accessory Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.57	Hospital Bed Side Rail or Safety Enclosure Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.58	Hospital Bed Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.59	Intermittent Urinary Catheter or Urological Supply for Intermittent Urinary Catheter Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.6	Chronic Obstructive Lung Disease (COPD)	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.60	Indwelling Urinary Catheter Supply or Urological Supply for Indwelling Urinary Catheter Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.61	Urinary Collection and Irrigation System Device or Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.62	External Catheter or Urinary Collection Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.63	Miscellaneous Urinary Catheter Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.64	Urinary Incontinence Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.65	Urinary Incontinence ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.66	Urinary Incontinence Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.67	Chronic Urinary Retention Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.68	Urinary Retention Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.69	Chronic Urinary Retention Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.7	Hypoxemia Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.70	Urinary Incontinence or Chronic Urinary Retention Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.72	Portable Compressed Gas Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.73	Stationary Oxygen Concentrator Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.74	Compressed Gas Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.75	Stationary Compressed Gas Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.76	Portable Oxygen Concentrator Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.77	Liquid Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.78	Oxygen Concentrator Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.79	Portable Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.8	Hypoxemia Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.80	Stationary Oxygen Therapy Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.81	Organ Transplant History Significant to Immunosuppressive Therapy	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.82	Immunosuppressive Medication HCPCS	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.83	Medication Supporting Immunosuppressive Medication HCPCS	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.84	Home Blood Glucose Monitor Device	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.85	Insulin Medication	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.86	Hyperglycemia or Hypoglycemia Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.87	Hyperglycemia or Hypoglycemia Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.88	Hyperglycemia or Hypoglycemia Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.89	Diabetic Test Strip or Lancet Supply	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.9	Hypoxemia Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.90	Organ Transplant Procedure Significant to Immunosuppressive Therapy	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.91	Pulmonary Hypertension Disorder SNOMEDCT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.92	Pulmonary Hypertension Disorder ICD10CM	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.93	Pulmonary Hypertension Disorder	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.94	Laboratory Test for Home Glucose Monitor Evaluation	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.95	Physical Therapy Procedure SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.96	Occupational Therapy Procedure SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.97	Speech Language Therapy Procedure SNOMED CT	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.98	Physical Therapy Procedure HCPCS	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.99	Physical Therapy Procedure	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.135	Last Menstrual Period (LMP)	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.146	Abortion, All (ICD 10 CM)	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.149	Abortion, All (SNOMED CT)	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.150	Abortion, All	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.151	Abortion, All (CPT)	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.152	Abortion, 1st Trimester	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.153	Abortion, 2nd Trimester	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.154	Abortion, 2nd Trimester	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.155	Abortion, 3rd Trimester	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.156	Abortion, Elective	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.157	Abortion, Elective	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.158	Abortion, Failed Attempt	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.159	Abortion, Induced	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.160	Abortion, Induced	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.161	Abortion, Induced	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.162	Abortion, Medical Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.163	Abortion, Medical Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.164	Abortion, Medical Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.165	Abortion, Elective	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.166	Abortion, Surgical Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.167	Abortion, Surgical Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.168	Abortion, Surgical Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.169	Abortion, Spontaneous / Miscarriage	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.170	Abortion, Spontaneous / Miscarriage	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.171	Abortion, Spontaneous / Miscarriage	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.172	Contraception, Counseling	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.173	Contraception, Counseling	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.174	Contraception, Counseling	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.175	Contraception, Counseling	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.176	Methotrexate Injection	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.177	Mifepristone	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.178	Misoprostol	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.179	Abortion Medications	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.180	Contraception, Surveillance	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.181	Contraception, Surveillance	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.182	Contraception, Surveillance	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.183	Clomiphene (Selective Estrogen Receptor Modulator / SERM)	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.184	Letrozole (Aromatase inhibitor)	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.185	Infertility, Female Medications	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.186	Infertility, Female	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.187	Infertility, Female	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.188	Infertility, Female	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.189	Infertility, Male	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.190	Infertility, Male	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.191	Infertility, Male	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.192	Infertility, All	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.193	Gender Dysphoria	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.194	Gender Identity	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.195	Intersex Surgery, History	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.196	Intersex Surgery, Non specific	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.197	Intersex Surgery, Female to Male	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.198	Intersex Surgery, Female to Male	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.199	Intersex Surgery, Female to Male	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.200	Intersex Surgery, Male to Female Sex	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.201	Intersex Surgery, Male to Female Sex	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.202	Intersex Surgery, Male to Female Sex	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.203	Intersex Surgery, All	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.204	Pregnancy Labs, Blood/Serum/Plasma/Urine	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.205	Stillbirth	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.206	Stillbirth	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.208	Sexual Orientation	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.209	Transfeminine Regimens, Antiandrogens	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.210	Transfeminine Regimens, Estrogens	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.211	Transfeminine Regimens, GnRH Agonists	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.212	Transfeminine Regimens, All	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.213	Transmasculine Regimens, Testosterone, Transdermal	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.214	Transmasculine Regimens, Testosterone, Parenteral	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.215	Transmasculine Regimens, All	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.216	Abortion, 1st Trimester	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.100	Sleep Apnea Disorders SCT	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1005	Sexual Satisfaction	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.101	Sleep Apnea Disorders ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1015	Substance Use	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1016	Tobacco Use	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.102	Sleep Apnea Disorders	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1020	Screen Time	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1022	Fluid Management	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1023	Fat Intake	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1024	Unsaturated Fat Intake	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1025	Saturated Fat Intake	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1026	Carbohydrate Intake	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1027	Salt Intake	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1028	Vegetable Intake	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1029	Fruit Intake	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103	PostTraumatic Stress Disorder PTSD	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1030	English Proficiency	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.104	PostTraumatic Stress Disorder PTSD ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1042	Neglect	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1048	Current or Former Occupation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105	PostTraumatic Stress Disorder PTSD SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1050	Work Productivity	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1053	Income Level	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1057	Caregiver Characteristics	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1058	Caregiver Availability	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1060	Living Situation	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1064	Marital or Spousal Status	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1065	Dependents in Home	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1068	Physical Activity Level	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1069	Leisure Activity Engagement	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1075	Exposure to Environmental Hazards	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1076	Neighborhood Safety	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1080	Experiences of Discrimination	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1082	Criminal Justice Involvement or Incarceration	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1083	Immigration Status	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.111	Creatinine in blood, serum or plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.113	Blood Urea Nitrogen	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.114	Hemoglobin	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.118	Iron Saturation (Transferrin Saturation/TSAT)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.119	Hemoglobin A1C	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1197	Sleep Behavior	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.120	Potassium in blood, serum or plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203	Medication Literacy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213	Elder and Child Abuse SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.122	Corrected Calcium	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229	Education Level SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.123	Phosphorus in blood, serum or plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.126	Vitamin D Levels	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.128	KT/V Hemodialysis Ratio	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281	Elder and Child Abuse	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.129	Intact Parathyroid Hormone	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.130	Bicarbonate in blood, serum or plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.131	Sodium in blood, serum or plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.132	Chloride in blood, serum or plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1336	Elder and Child Abuse ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.135	High Density Lipoprotein	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.137	Triglyceride in blood, serum or plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1375	Tinnitus	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1377	Brain Fog	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1378	Depression Symptoms	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1379	Mood Swings	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.138	Cystatin C	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1380	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1381	Lightheadedness	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1382	Stress	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1383	Grief and Suffering	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1384	Insomnia and Other Sleep Difficulties	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1385	Impaired Sense of Taste	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1386	Pink Eye Diagnosis SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1387	Pink Eye Diagnosis ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1388	Pink Eye Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.139	Total Cholesterol	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1392	Lymphadenopathy Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1393	Lymphadenopathy Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1394	Lymphadenopathy Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1395	Visual Changes	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1396	Impaired Sense of Smell	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1398	Fatigue	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1399	Chills	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.140	Ferritin	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1400	Fever	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1401	Functional and Mobility Impairment	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1403	Orthostatic Intolerance	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1405	Cough	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1406	Dyspnea	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1409	Wheezing	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.141	Red Blood Cell Count (Erythrocytes)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1413	Sinonasal Congestion	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1414	Respiratory Distress	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1415	Edema	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1419	Weight Changes	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.142	White Blood Cell (Leukocytes) Count	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1422	Immunologic Changes	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1424	Pain	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1425	Arthralgia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1426	Chest Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1427	Headache	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1428	Myalgia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1429	Back Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.143	Hematocrit	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1430	Pain in Extremities	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1431	Pain in Throat	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1432	Palpitations	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1433	Tachycardia	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1434	Bleeding	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1435	Abdominal Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1436	Diarrhea	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1437	Gastroesophageal Reflux	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1438	Nausea	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1439	Vomiting	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.144	Mean Corpuscular Volume	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1440	Constipation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1441	Difficulty Swallowing	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1442	Bronchiectasis Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1443	Loss of Appetite	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1444	Paresthesia	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1445	Rash	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1446	Covid Toes (Toes and/or Fingers)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1447	Itching	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1448	Menstrual Cycle Irregularities	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1449	Lower Urinary Tract Symptoms	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.145	Mean Corpuscular Hemoglobin Concentration	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1450	Urinary Incontinence	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1451	Dizziness	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1453	Hair Loss	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1455	Disability Severity	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1456	Hypercoagulability	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1457	Post Exertional Malaise	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1458	Chronic Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1459	Neurogenic Pain	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.146	Platelet Count	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1460	Impaired Hearing	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1461	Parkinsonia Like Symptoms	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1462	Bronchiectasis Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1463	Bronchiectasis Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1464	Chronic obstructive pulmonary disease (COPD) Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1465	Chronic obstructive pulmonary disease (COPD) Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1466	Chronic obstructive pulmonary disease (COPD) Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1467	Interstitial lung disease Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1468	Interstitial lung disease Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1469	Interstitial lung disease Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.147	Erythrocyte Distribution Width	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1470	Asthma Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1471	Asthma Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1472	Asthma Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1473	Fibromyalgia Diagnosis SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1474	Fibromyalgia Diagnosis ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1475	Fibromyalgia Diagnosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1476	Herpes zoster Diagnosis ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1477	Herpes zoster Diagnosis SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1478	Herpes zoster	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1479	Pulmonary embolism Diagnosis SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.148	Platelet Distribution Width	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1480	Pulmonary embolism Diagnosis ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1481	Pulmonary embolism Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1482	Hypertension, Pulmonary Hypertension SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1483	Hypertension, Pulmonary Hypertension Diagnosis ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1484	Hypertension, Pulmonary Hypertension	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1485	Language and Speech Problems	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1486	Postural tachycardia syndrome (POTS) Diagnosis SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1487	Postural tachycardia syndrome (POTS) Diagnosis ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1488	Postural tachycardia syndrome (POTS) Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1489	Functional disorder of gastrointestinal tract Diagnosis SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.149	Platelet Mean Volume	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1490	Functional disorder of gastrointestinal tract Diagnosis ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1491	Functional disorder of gastrointestinal tract Diagnosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1492	Autonomic dysfunction	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1496	Mast Cell Activation Syndrome (MCAS) Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1497	Mast Cell Activation Syndrome (MCAS) Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1498	Mast Cell Activation Syndrome (MCAS) Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.150	Estimated Average Glucose	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1500	Debility or Frailty SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1501	Debility or Frailty ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1502	Debility or Frailty	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1503	Ehlers Danlos syndrome (EDS) Diagnosis SCT	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1504	Ehlers Danlos syndrome (EDS) Diagnosis ICD10	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1505	Ehlers Danlos syndrome (EDS) Diagnosis	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1506	Malnutrition Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1507	Malnutrition Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1508	Narcolepsy Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1509	Narcolepsy Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.151	Albumin in Blood, Plasma, or Serum	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1510	Narcolepsy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1514	Small Fiber Neuropathy Diagnosis SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1515	Small Fiber Neuropathy Diagnosis ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1516	Small Fiber Neuropathy Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1517	Malnutrition Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1518	Neuropathy Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1519	Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1520	Multisystem Inflammatory Syndrome in Adults (MIS A) ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1521	Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1522	Congestive heart failure Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1523	Congestive heart failure Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1524	Congestive heart failure Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1525	Cognitive disorder Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1526	Cognitive disorder SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1527	Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1529	Post Acute Sequelae of Sars Cov 2 infection (PASC) ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.153	Anion Gap	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1530	Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1531	Hypertension, Persistent SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1532	Acute Renal Failure Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1533	Acute Renal Failure Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1534	Acute Renal Failure Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1535	Complication due to Diabetes Mellitus Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1536	Complication due to Diabetes Mellitus Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1537	Complication due to Diabetes Mellitus Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1538	Coronary Revascularization History SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1539	Coronary Revascularization History ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.154	Urine Urea Nitrogen	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1540	Coronary Revascularization History	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1541	Heart Failure Diagnosis SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1542	Heart Failure Diagnosis ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1543	Heart Failure Diagnosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1547	Hypertension, Primary and Secondary Diagnosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1548	Cerebrovascular Disease Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1549	Cerebrovascular Disease Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.155	Bone Density	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1550	Migraine Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1551	Migraine Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1552	Migraine Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1553	Chronic Tension type Headache Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1554	Chronic Tension type Headache Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1555	Chronic Tension type Headache Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1556	Low Back Pain SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1557	Low Back Pain ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1558	Low Back Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1559	Metabolic Syndrome Diagnosis SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.156	Bone Survey X Rays	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1560	Metabolic Syndrome Diagnosis ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1561	Metabolic Syndrome Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1562	Hypertension, Persistent ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1563	Hypertension, Persistent	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1564	Pregnancy SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1565	Pregnancy ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1566	Pregnancy	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1568	Low Density Lipoprotein	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1569	Physical findings of the abdomen	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.157	Chronic Kidney Disease All Stages (1 through 5) SNOMED	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1571	Chest US	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1572	Sleep Disorder Assessment	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1573	Cerebral Spinal Fluid (CSF) Analysis	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1574	Comprehensive Metabolic Panel (CMP)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1575	Arterial Blood Gas (ABG)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1576	Coagulation Assay (PT, aPTT, Fibrinogen)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1577	D Dimer Test	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1578	Procalcitonin in Blood, Serum, or Plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1579	Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.158	Chronic Kidney Disease All Stages (1 through 5) ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1580	COVID 19 (SARS CoV 2), SARS CoV, Influenza virus A and B Tests	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1581	Microorganisms Detection by Blood Culture	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1582	Microorganisms Detection by Sputum Culture	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1583	Cystography	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1584	Cognitive Health Related Questionnaire Panel Codes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1585	Alcohol Use Related Questionnaire Panel Codes	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1586	Functional Status Related Questionnaire Panel Codes	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1587	Kidney Disease Related Questionnaire Panel Codes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1588	Long Covid Related Questionnaire Panel Codes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1589	Nutrition Status Related Questionnaire Panel Codes	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.159	Chronic Kidney Disease All Stages (1 through 5)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1590	Pain Perception Related Questionnaire Panel Codes	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1591	Patient Goal Related Questionnaire Panel Codes	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1592	Social Determinant of Health Related Questionnaire Panel Codes	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1593	Covid 19 Related Health Questionnaire Panel Codes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1594	Caregiver Considerations Related Questionnaire Panel Codes	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1595	Acute COVID 19 Diagnosis SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1597	Drugs of Abuse Screen	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1598	Criminal Justice Involvement or Incarceration History	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1599	Cardiomyopathy Diagnosis SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1600	Cardiomyopathy Diagnosis ICD10	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1601	Atherosclerotic Cardiovascular Disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1602	Neuropathy Diagnosis ICD10	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1603	Neuropathy Diagnosis SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1605	Left Ventricular Hypertrophy ICD10	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1606	Left Ventricular Hypertrophy	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1607	Alanine Aminotransferase (ALT) in Blood, Plasma, or Serum	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1608	Aspartate Aminotransferase (AST) in Blood, Plasma, or Serum	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1609	Erythrocyte Sedimentation Rate (ESR) in Blood	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1610	Oxygen Saturation in Blood	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.176	Urine Sediment	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.179	Estimated Glomerular Filtration Rate (eGFR)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.22	Alcohol Use Disorder SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.23	Alcohol Use Disorder ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.24	Alcohol Use Disorder	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.25	Peripheral Vascular Disease SCT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.26	Peripheral Vascular Disease ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.27	Peripheral Vascular Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.28	Hepatitis C Condition SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.30	Hepatitis C Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.31	Diabetic Neuropathy SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.32	Diabetic Neuropathy ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.33	Diabetic Neuropathy Conditions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.35	Obesity ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.36	Obesity Conditions	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.37	Obesity SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.4	Chronic Kidney Disease Type or Cause SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.41	Tuberculosis (Disorders) SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.417	Prediabetes (Borderline Diabetes)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.418	Prediabetes (Borderline Diabetes)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.419	Prediabetes (Borderline Diabetes)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.420	Maturity Onset Diabetes of the Young (MODY)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.43	Tuberculosis Disorders	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.44	Tuberculosis (Disorders) Ext	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.45	Hypoalbuminemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.450	CKD Progression Risk	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.46	Hypoalbuminemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.47	Hypoalbuminemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.48	Hyperkalemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.480	Diabetic Coma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.481	Diabetic Coma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.482	Diabetic Coma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.49	Hyperkalemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.490	Diabetic Peripheral Angiopathy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.491	Diabetic Peripheral Angiopathy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.492	Diabetic Peripheral Angiopathy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.496	Cataract of the Eye	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.497	Cataract of the Eye	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.498	Cataract of the Eye	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.499	Rubeosis Iridis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.5	Chronic Kidney Disease Type or Cause ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.50	Hyperkalemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.500	Rubeosis Iridis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.501	Rubeosis Iridis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.502	Rubeosis Iridis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.506	Emotional Distress caused by Chronic Condition	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.507	Emotional Distress caused by Chronic Condition	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.508	Emotional Distress caused by Chronic Condition	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.51	Anemia Conditions SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.510	Hypoglycemic Event	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.512	Hypoglycemic Event	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.513	Hypoglycemic Event	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.514	Hypoglycemia Unawareness	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.515	Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.516	Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.517	Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.518	Ketoacidosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.519	Ketoacidosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.52	Anemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.520	Ketoacidosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.521	Diabetic Foot	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.522	Diabetic Foot	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.523	Diabetic Foot	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.524	Diabetic Foot Ulcer	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.525	Diabetic Foot Ulcer	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.526	Diabetic Foot Ulcer	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.529	Charcot Foot	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.53	Anemia Conditions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.530	Charcot Foot	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.531	Charcot Foot	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.533	Cellulitis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.535	Diabetic Hand or Diabetic Cheiroarthropathy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.538	Necrobiosis Lipoidica (Skin Lesions)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.539	Necrobiosis Lipoidica (Skin Lesions)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.540	Necrobiosis Lipoidica (Skin Lesions)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.541	Gangrene	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.542	Gangrene	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.543	Gangrene	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.544	Dupuytren's Contracture	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.545	Dupuytren's Contracture	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.546	Dupuytren's Contracture	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.547	Scleroderma or Thick Skin Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.548	Scleroderma or Thick Skin Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.549	Scleroderma or Thick Skin Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.554	Acanthosis Nigricans	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.555	Acanthosis Nigricans	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.556	Acanthosis Nigricans	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.557	Eruptive Xanthomatosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.558	Periodontitis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.559	Periodontitis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.560	Periodontitis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.561	Amputated Limb (Not Traumatic)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.562	Amputated Limb (Not Traumatic)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.563	Amputated Limb (Not Traumatic)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.564	Hypertension, Essential or Primary ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.565	Hypertension, Essential or Primary SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.567	Hypertension, Secondary ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.568	Hypertension, Secondary SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.571	Hypertension Stage	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.579	Cardiomyopathy	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.58	Hypercalcemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.580	NYHA Heart Failure Functional Classifications	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.581	American Heart Association Heart Failure Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.582	Framingham Risk Assessments	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.583	American College of Cardiology or American Heart Association Ascvd Risk Score (acc/aha Ascvd Risk)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.584	Atherosclerotic Cardiovascular Disease	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.586	Gout	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.587	Psoriatic Arthritis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.588	Reactive Arthritis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.59	Hypercalcemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.590	Experience of Traumatic Events	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.591	Cannabis Use	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.592	Hearing Impairment	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.6	Chronic Kidney Disease Type or Cause	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.60	Hypercalcemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.606	Angina	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.607	Angina	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.608	Angina	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.609	Unstable Angina	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.61	Hypocalcemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.610	Unstable Angina	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.611	Unstable Angina	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.613	Ischemic Heart Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.614	Ischemic Heart Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.615	Left Ventricular Hypertrophy SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.616	Stroke History	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.618	Stroke	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.619	Transient Ischemic Attack	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.62	Hypocalcemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.620	Transient Ischemic Attack	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.621	Transient Ischemic Attack	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.625	Aneurysm	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.626	Aneurysm	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.627	Aneurysm	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.63	Hypocalcemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.634	Aortic Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.635	Aortic Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.636	Aortic Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.637	Carotid Stenosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.638	Carotid Stenosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.639	Carotid Stenosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.64	Hyperphosphatemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.640	Intracranial Stenosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.641	Intracranial Stenosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.642	Intracranial Stenosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.643	Pulmonary Edema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.644	Pulmonary Edema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.645	Pulmonary Edema	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.646	Osteoarthritis (Oa)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.647	Osteoarthritis (Oa)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.648	Osteoarthritis (Oa)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.649	Rheumatoid Arthritis (Ra)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.65	Hyperphosphatemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.650	Rheumatoid Arthritis (Ra)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.651	Rheumatoid Arthritis (Ra)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.652	Infectious Arthritis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.653	Infectious Arthritis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.654	Infectious Arthritis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.656	Temporomandibular Disorder Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.658	Irritable Bowel Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.659	Irritable Bowel Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.66	Hyperphosphatemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.660	Irritable Bowel Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.661	Neuropathic Pain (Neuralgia)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.662	Neuropathic Pain (Neuralgia)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.663	Neuropathic Pain (Neuralgia)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.664	Neuromas	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.665	Neuromas	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.666	Neuromas	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.667	Phantom Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.668	Phantom Pain	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.669	Phantom Pain	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.67	Hematuria Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.670	Entrapment Neuropathy	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.671	Entrapment Neuropathy	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.672	Entrapment Neuropathy	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.673	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.674	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.675	Myalgic Encephalomyelitis or Chronic Fatigue Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.676	Psychotic Depression	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.677	Psychotic Depression	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.678	Psychotic Depression	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.679	Post Partum Depression	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.68	Hematuria Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.680	Post Partum Depression	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.681	Post Partum Depression	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.682	Seasonal Affective Disorder	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.683	Seasonal Affective Disorder	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.684	Seasonal Affective Disorder	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.685	Psychological Trauma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.686	Psychological Trauma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.687	Psychological Trauma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.688	Grief or Loss	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.689	Grief or Loss	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.69	Hematuria Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.690	Grief or Loss	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.691	Suicide Risk	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.692	Suicide Risk	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.693	Suicide Risk	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.694	Vaping	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.695	Vaping	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.696	Vaping	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.697	Tobacco Use or Exposure	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.699	Tobacco Use or Exposure	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.70	Metabolic Acidosis Conditions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.701	Binge Drinking	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.702	Binge Drinking	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.703	Binge Drinking	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.704	Drug Misuse	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.705	Drug Misuse	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.706	Drug Misuse	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.707	Drug Misuse	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.708	Sensory Status	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.709	Sensory Status	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.71	Metabolic Acidosis Conditions ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.711	Fall Risk	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.713	Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.714	Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.715	Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.716	Urinary Incontinence	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.717	Urinary Incontinence	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.718	Urinary Incontinence	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.719	Urinary Urgency	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.72	Metabolic Acidosis Conditions SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.720	Urinary Urgency	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.721	Urinary Urgency	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.722	Urinary Frequency	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.723	Urinary Frequency	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.724	Urinary Frequency	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.725	Nocturia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.726	Nocturia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.727	Nocturia	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.728	Pelvic Organ Prolapse	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.729	Pelvic Organ Prolapse	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.73	Hyperlipidemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.730	Pelvic Organ Prolapse	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.731	Erectile Dysfunction	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.732	Erectile Dysfunction	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.733	Erectile Dysfunction	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.734	Interstitial Cystitis or Bladder Pain Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.735	Interstitial Cystitis or Bladder Pain Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.736	Interstitial Cystitis or Bladder Pain Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.737	Recurrent Urinary Tract Infections	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.738	Recurrent Urinary Tract Infections	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.739	Recurrent Urinary Tract Infections	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.74	Hyperlipidemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.740	Hypertriglyceridemia	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.741	Hypertriglyceridemia	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.742	Hypertriglyceridemia	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.743	Hypothyroidism	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.744	Hypothyroidism	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.745	Hypothyroidism	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.746	Menopause	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.747	Menopause	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.748	Menopause	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.749	Testicular Hypofunction	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.75	Hyperlipidemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.750	Testicular Hypofunction	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.751	Testicular Hypofunction	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.752	Primary Aldosteronism	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.753	Primary Aldosteronism	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.754	Primary Aldosteronism	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.755	Restless Leg Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.756	Restless Leg Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.757	Restless Leg Syndrome	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.759	Claudication	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.76	Chronic Pain Conditions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.760	Claudication	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.761	Claudication	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.762	Angioedema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.763	Angioedema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.764	Angioedema	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.768	Nonalcoholic Fatty Liver Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.769	Nonalcoholic Fatty Liver Disease	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.77	Chronic Pain ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.770	Nonalcoholic Fatty Liver Disease	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.771	Thalassemia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.772	Thalassemia	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.773	Thalassemia	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.78	Chronic Pain SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.79	Arthritis Disorders SCT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.790	Urine Protein to Creatinine Ratio (UPCR)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.791	24 Hour Urine Volume	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.792	24 Hour Urine Protein Excretion	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.793	Total Carbon Dioxide or Bicarbonate in blood, serum or plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.794	Calcium (Not Corrected for Serum Albumin) in Blood, Plasms, or Serum	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.795	B Type Natriuretic Peptide [Bnp] in Blood, Serum or Plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.797	N Terminal Pro_B_Type Natriuretic Peptide [Nt_Probnp] in blood, serum or plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.799	Temporomandibular Disorder Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.80	Arthritis Disorders ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.800	Temporomandibular Disorder Diagnosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.801	High Sensitivity Troponin	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.804	Aspartate Transaminase or Alanine Aminotransferase Ratio	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.805	Alkaline Phosphatase (Alp) in Blood, Serum or Plasma	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.806	Gamma Glutamyl Transpeptidase (Ggt) in blood, serum or plasma	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.807	Triiodothyronine in serum or plasma	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.808	Fasting Blood Glucose	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.809	Random Blood Glucose Test	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.81	Arthritis Disorders	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.810	Uric Acid (Urate) in blood, serum or plasma	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.811	Aldosterone/Renin Ratio	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.812	Serum Rheumatoid Factor	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.813	Blood Ethanol Level	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.814	Drugs of Abuse Screen in Hair	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.815	Drugs of Abuse Screen in Urine	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.816	Drugs of Abuse Screen in Blood	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.817	Drugs of Abuse Screen in Tissue	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.818	Drugs of Abuse Screen in Body Fluid	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.819	Urea Reduction Ratio	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.82	Preeclampsia Disorders SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.822	Bowel Sounds	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.823	Uroflowmetry	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.826	Gait Quality	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.828	Balance Assessments	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.83	Preeclampsia Disorders ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.836	Sit to Stand Ability	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.84	Preeclampsia Disorders	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.840	Spinal Cord Compression	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.841	Spinal Cord Compression	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.842	Alcohol Use (Revised 2021)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.843	Alcohol Use (Revised 2021)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.844	Alcohol Use (Revised 2021)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.845	Alcohol Use	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.85	Hyperuricemia Conditions	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.86	Hyperuricemia Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.864	Kidney Biopsy Report	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.867	Skin Biopsy Report	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.868	Muscle Biopsy Report	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.869	Gastric Tissue Biopsy Report	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.87	Hyperuricemia Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.870	Bone Biopsy Report	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.873	Echocardiogram	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.88	Vitamin D Deficiency Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.880	Spinal or Back CT	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.881	Chest CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.882	Abdominal or Pelvic CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.883	Limb CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.884	Heart Calcium Score	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.885	Coronary CT Angiogram	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.886	Limb CT Angiogram	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.888	Chest CT Angiogram	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.889	Head and Neck CT Angiogram	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.89	Vitamin D Deficiency Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.891	Gastrointestinal Tract X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.892	Gallbladder X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.893	Kidney X Ray	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.894	Abdomen X Ray	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.895	Pelvis X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.896	Hand X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.897	Wrist X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.898	Forearm X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.899	Elbow X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.90	Vitamin D Deficiency Conditions	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.900	Upper Arm X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.901	Shoulder X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.902	Upper Extremity X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.903	Foot X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.904	Ankle X Ray	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.905	Shin X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.906	Knee X Ray	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.907	Thigh X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.908	Hip X Ray	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.909	Lower Extremity X Ray	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.91	Alkaline Phosphatase Deficiency Conditions SCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.910	Abdominal MRI	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.911	Adrenal Gland MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.912	Kidney MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.913	Pancreas MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.915	Kidney MRA	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.916	Chest Region MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.917	Pulmonary MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.918	Cardiac MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.92	Alkaline Phosphatase Deficiency Conditions ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.920	Spine MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.921	Head and Neck MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.922	Brain MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.923	Pelvic Region MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.924	Knee MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.925	Foot MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.927	Shoulder MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.928	Lower Extremity MRA	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.93	Alkaline Phosphatase Deficiency Conditions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.930	Spine X Ray	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.933	Hip MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.934	Thigh or Femur MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.935	Ankle MRI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.936	Lower Extremity MRI	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.937	Forearm MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.938	Elbow MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.939	Wrist MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.94	Uremic Pruritus Conditions ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.940	Hand MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.942	Upper Extremity MRI	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.943	Abdominal MRA	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.944	Chest MRA	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.945	Upper Extremity MRA	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.947	Head and Neck MRA	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.948	Pelvic Region MRA	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.949	Functional MRI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.95	Uremic Pruritus Conditions SCT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.951	Optical Coherence Tomography	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.954	Bathing or grooming/hygiene (ADL/IADL)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.955	Dressing (ADL or IADL)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.956	Toileting (ADL or IADL)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.957	Transferring (ADL or IADL)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.958	Walking or ambulation/locomotion (ADL/IADL)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.96	Uremic Pruritus Conditions	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.960	Domestic Duties or Household Tasks (ADL/IADL)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.961	Telephone Use (ADL or IADL)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.962	Bed Mobility (ADL or IADL)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.963	Stair Use (ADL or IADL)	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.964	Medication Management (ADL or IADL)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.967	Electromyography	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.968	Electroencephalogram	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.969	Exercise Stress Test	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.97	Insomnia Disorders	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.976	Sleep Duration, Device	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.977	Steps Per Time, Device	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.978	Physical Activity Level, Device	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.979	Cognitive Function Clinician Interpretation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.98	Insomnia Disorders ICD10	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.987	Psychosis	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.99	Insomnia Disorders SCT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.991	Suicidal Ideation and Behaviors	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.994	Sleep Duration	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.996	Pain Intensity or Severity	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.997	Pain Quality	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.4	Glaucoma ICD10	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1225.5	Glaucoma SNOMED	active	2022-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.1	Scleritis	active	2021-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.2	Scleritis	active	2021-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1226.3	Scleritis	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.1	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography	active	2021-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.2	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Non Diagnostic or Non CT	active	2021-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.3	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography Nuclear Medicine With CT	active	2021-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.4	Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography CT Without Specified Body Region	active	2021-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.6	Outpatient Encounter Locations	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1228.7	Outpatient Activity Codes	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.6	Anaphylaxis, ICD10CM codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.60	Guillain Barre Syndrome, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.61	Febrile seizure, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.62	Encephalomyelitis and encephalitis, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.63	Disseminated Intravascular Coagulation, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.64	Deep Vein Thrombosis, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.65	Bells Palsy, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.66	Appendicitis, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.67	Anaphylaxis, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.68	Acute Myocardial Infarction, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.69	Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.7	Anaphylaxis, SNOMED codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.70	Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.71	Transfusion CPT codes for exposure identification	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.72	Transfusion ICD9 codes for exposure identification	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.73	Transfusion ICD10PCS codes for exposure identification	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.74	Transfusion CPT, ICD9, ICD10PCS codes for exposure identification	active	2021-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75	COVID19 vaccine ICD10PCS codes for exposure identification	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.8	Appendicitis, SNOMED codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.9	Appendicitis, ICD10CM codes for AE reporting	active	2021-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.1	Test Diabetes codes	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.100	Cardiomyopathy Hypertrophic Condition	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.12	Metabolic Syndrome LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.15	MetabolicSyndromeCondition	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.16	Annual Physical ICD9 CN5	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.164	Diabetic Retinal Screening HD CPT for Tax Pair	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.165	Optometrist and Ophthalmologist Taxonomy HD Taxonomy	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.167	End Stage Renal Disease (ESRD)_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.168	End Stage Renal Disease (ESRD)_HD_ICD9	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.169	End Stage Renal Disease (ESRD)_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.17	Annual Physical ICD10 CN5	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.170	End Stage Renal Disease (ESRD)_HD_HCPCS	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.171	End Stage Renal Disease (ESRD)_HD_LOINC	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.172	End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.173	Systolic Blood Pressure_HD_SNOMED	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.174	Systolic Blood Pressure_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.175	Systolic Blood Pressure_HD_LOINC	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.176	Systolic Blood Pressure_HD	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.177	Diastolic Blood Pressure_HD_SNOMED	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.178	Diastolic Blood Pressure_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.179	Diastolic Blood Pressure_HD_LOINC	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.18	Annual Physical SNOMED CN5	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.180	Diastolic Blood Pressure_HD	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.181	Remote Blood Pressure_HD_SNOMED	active	2023-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.182	Remote Blood Pressure_HD	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.183	Remote Blood Pressure_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.184	Acute Inpatient_CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.185	Acute Inpatient_CN_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.186	Acute Inpatient_HD_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.187	ED Visit_CN_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.188	ED Visit_CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.19	Annual Physical Taxonomy CN5	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.190	Pregnancy_HD_Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.191	Pregnancy_CN_HD_SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.192	Pregnancy_CN_HD_ICD10	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.193	ED Visit_HD_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.194	Lipid Panel_Event_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.195	Lipid Panel_Event_HCPCS	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.196	Lipid Panel_Event_LOINC	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.197	Lipid Panel_Event_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.198	Lipid Panel_Event_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.199	Unknown Glucose_Event_ICD9	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.20	Annual Physical CN5	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.200	Unknown Glucose_Event_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.201	Unknown Glucose_Event_LOINC	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.202	Unknown Glucose_Event_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.203	Unknown Glucose_Event_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.204	Unknown Glucose_Lab_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.205	Bone Marrow Transplant CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.206	Bone Marrow Transplant CN_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.207	Bone Marrow Transplant_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.208	Immunocompromising Conditions CN_HD_ICD9	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.209	Immunocompromising Conditions CN_HD_ICD10PCS	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.21	Annual Physical CPT CN5	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.210	Immunocompromising Conditions CN_HD_ICD10CM	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.211	Immunocompromising Conditions_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.212	Immunocompromising Conditions CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.213	Cerebrospinal Fluid Leak CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.214	Cerebrospinal Fluid Leak CN_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.215	Cerebrospinal Fluid Leak_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.216	Anatomic or Functional Asplenia CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.217	Anatomic or Functional Asplenia CN_HD_ICD9	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.218	Anatomic or Functional Asplenia CN_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.219	Anatomic or Functional Asplenia_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.22	Annual Physical HCPCS CN5	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.220	Sickle cell Anemia and HB S Disease CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.221	Sickle cell Anemia and HB S Disease CN_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.222	Sickle cell Anemia and HB S Disease_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.223	Pneumococcal Vaccine CN_HD_SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.224	Pneumococcal Vaccine CN_HD_HCPCS	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.225	Pneumococcal Vaccine CN_HD_CVX	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.226	Pneumococcal Vaccine CN_HD_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.227	Pneumococcal Vaccine_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228	Influenza Vaccine CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.229	Influenza Vaccine CN_HD_HCPCS	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.23	Annual Physical CPT for Tax Pair CN5	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.230	Influenza Vaccine CN_HD_CVX	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231	Influenza Vaccine CN_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232	Influenza Vaccine_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.233	Cochlear Implant CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.234	Cochlear Implant CN_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.235	Cochlear Implant CN_HD_HCPCS	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.236	Cochlear Implant CN_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.237	Cochlear Implant_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.238	Chemotherapy CN_HD_SNOMED	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.239	Chemotherapy CN_HD_ICD10	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.24	Annual Physical ICD9 for Tax Pair CN5	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.240	Chemotherapy CN_HD_CPT	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.241	Chemotherapy_HD_CN_Grouping	active	2023-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.244	Fasting Blood Glucose_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.245	Chronic Heart Failure (CHF)_ICD9	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.246	Chronic Heart Failure (CHF)_ICD10	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.251	Asthma_LOINC	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.253	Asthma_Clinical Condition Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.254	Pregnancy Loss_HD_SNOMED	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.255	Pregnancy Loss_HD_ICD10	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.257	Pregnancy Loss_HD_Clinical Condition Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.258	Heart Failure (CHF)_ICD9	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.259	Heart Failure (CHF)_ICD10	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.260	Heart Failure (CHF)_SNOMED	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.261	Heart Failure (CHF)_HCPCS	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.262	Heart Failure (CHF)_LOINC	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.263	Heart Failure (CHF)_CPT	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.264	Heart Failure (CHF)_RxNorm	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265	Heart Failure (CHF)_Clinical Condition Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.270	Triglyceride_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.274	Total Cholesterol_CPT	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.275	Total Cholesterol_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.276	LDL_SNOMED	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.280	LDL_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.284	HDL_LOINC	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.285	HDL_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.286	Colectomy_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.288	Colectomy_ICD9	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.29	Hospice Exclusions Grouping	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.290	Colectomy_Event_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.291	CT Colonography_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.292	CT Colonography_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.294	CT Colonography_Event_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.295	FIT DNA_LOINC	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.296	FIT DNA_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.297	FIT DNA_HCPCS	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.298	FIT DNA_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.299	FIT DNA Test_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.30	Annual Physical Codes for Tax Pair CN5	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.300	Sigmoidoscopy_CPT	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.302	Sigmoidoscopy_ICD9	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.303	Sigmoidoscopy_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.304	Sigmoidoscopy_Event_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.305	Colonoscopy_CPT	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.306	Colonoscopy_HCPCS	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.307	Colonoscopy_ICD9	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.308	Colonoscopy_SNOMED	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.309	Colonoscopy_Event_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.310	FOBT Lab_CPT	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.311	FOBT Lab_HCPCS	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.312	FOBT Lab_LOINC	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.313	FOBT Lab_SNOMED	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.314	FOBT Lab Test_Lab_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.315	Colorectal Cancer_HD_ICD10	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.316	Colorectal Cancer_HD_ICD9	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.317	Colorectal Cancer_HD_SNOMED	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.318	Colorectal Cancer_HD_Grouping	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.319	Absence of Cervix Diagnosis_HD_ICD10	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.320	Absence of Cervix Diagnosis_HD_ICD9	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.321	Absence of Cervix Diagnosis_HD_SNOMED	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.322	Absence of Cervix Diagnosis_HD_Grouping	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.323	Hysterectomy With No Residual Cervix_HD_CPT	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.324	Hysterectomy With No Residual Cervix_HD_ICD10	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.325	Hysterectomy With No Residual Cervix_HD_ICD9	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.326	Hysterectomy With No Residual Cervix_HD_SNOMED	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.327	Hysterectomy With No Residual Cervix_HD_Grouping	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328	High Risk HPV Test_HD_CPT	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329	High Risk HPV Test_HD_HCPCS	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330	High Risk HPV Test_HD_LOINC	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331	High Risk HPV Test_HD_SNOMED	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332	High Risk HPV Test_HD_Grouping	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.333	Cervical Cytology_HD_CPT	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.334	Cervical Cytology_HD_HCPCS	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.335	Cervical Cytology_HD_LOINC	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.336	Cervical Cytology_HD_SNOMED	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.337	Cervical Cytology_HD_Grouping	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.338	AFib (Atrial Fibrillation)_ICD9	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.339	AFib (Atrial Fibrillation)_ICD10	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.340	AFib (Atrial Fibrillation)_SNOMED	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.341	AFib (Atrial Fibrillation)_LOINC	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342	AFib (Atrial Fibrillation)_RxNORM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.343	AFib (Atrial Fibrillation)_CPT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.344	AFib (Atrial Fibrillation)_Clinical Condition Grouping	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.345	COVID19 Vaccine_CPT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.346	COVID19 Vaccine_HCPCS	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348	COVID19 Vaccine_RxNorm	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.349	COVID19 Vaccine_CVX	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350	COVID19 Vaccine_Event Clinical Grouping	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.351	Coronary Artery Disease (CAD)_ICD9	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.352	Coronary Artery Disease (CAD)_ICD10PCS	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.353	Coronary Artery Disease (CAD)_ICD10CM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.354	Coronary Artery Disease (CAD)_CPT	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.355	Coronary Artery Disease (CAD)_HCPCS	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.356	Coronary Artery Disease (CAD)_LOINC	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.357	Coronary Artery Disease (CAD)_SNOMED	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.358	Coronary Artery Disease (CAD)_CUI_UMLS	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.359	Coronary Artery Disease (CAD)_Clinical Condition Grouping	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.360	Allergy List_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.361	Allergy List_ICD10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.362	Allergy List_Clinical Grouping Event	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.363	Statin Use_RxNorm	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.364	Other Revascularization_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.365	Other Revascularization_CPT	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.366	Other Revascularization_Grouping	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.367	Ischemic Vascular Disease (IVD)_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.368	Ischemic Vascular Disease (IVD)_ICD10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.369	Ischemic Vascular Disease (IVD)_Grouping	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.370	Muscular Pain and Disease_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.371	Muscular Pain and Disease_ICD10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.372	Muscular Pain and Disease_Grouping	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.373	Cirrhosis_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.374	Cirrhosis_ICD10	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.375	Cirrhosis_Grouping	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.376	IVF_SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.377	IVF_HCPCS	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.378	IVF_Grouping	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.379	Estrogen Agonists Medications_RXNORM	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.382	Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.384	Family History Hypertension (HTN)_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.385	Family History Hypertension (HTN)_Clinical Condition Grouping	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.386	Obesity_Condition_UMLS	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.387	Podiatry_Taxonomy	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.388	Cardiology _Taxonomy	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.393	BMI >=40_Event_Clinical Condition Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.400	Smoker Status_Event_Clinical Condition Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.401	First Trimester_ICD10	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.402	First Trimester_SNOMED	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.403	First Trimester_LOINC	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.404	First Trimester_CPT	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.405	First Trimester_UMLS CUI	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.406	First Trimester_Clinical Grouping Event	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.408	Birth Event_ICD10	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.409	Birth Event_SNOMED	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.413	Birth Event_Clinical Grouping Event	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.414	Obesity_Condition_SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.415	Obesity_Condition_ICD10	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.416	Obesity_Condition_ICD9	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.417	Obesity_Clinical Grouping Condition	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.418	Pre_Hypertension (Pre_HTN)_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.419	Pre_Hypertension (Pre_HTN)_ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.420	Pre_Hypertension (Pre_HTN)_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.424	BMI >=30_Event_Clinical Condition Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.427	Obesity_Condition_LOINC	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.428	Vitals Body Height LOINC	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.429	Vitals Body Height SnoMed	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.430	Vitals Body Height	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.431	bwell_Vital_Blood Glucose_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.432	Anxiety_Clinical Grouping Condition_ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.433	Anxiety_Clinical Grouping Condition_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.434	Anxiety_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.435	Anxiety_Clinical Grouping Condition_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.436	Anxiety_Clinical Grouping Condition	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.437	bwell_Vital_Blood Oxygen_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.438	bwell_Vital_Systolic Blood Pressure_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.439	bwell_Vital_Diastolic Blood Pressure_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.440	bwell_Vital_Heart Rate_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.441	bwell_Vital_BMI_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.442	bwell_Vital_Body Fat_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.443	bwell_Vital_Body Temperature_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.444	bwell_Vital_Body Height_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.445	bwell_Vital_Body Weight_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.446	bwell_Vital_Respiratory Rate_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.447	bwell_Vital_Waist Circumference_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.448	bwell_Vital_Blood Glucose_Clinical Grouping Lab	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.449	bwell_Vital_Blood Oxygen_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.450	bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.451	bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.452	bwell_Vital_Heart Rate_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.453	bwell_Vital_BMI_Clinical Grouping Event	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.454	bwell_Vital_Body Fat_Clinical Grouping Event	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.455	bwell_Vital_Body Temperature_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.456	bwell_Vital_Body Height_Clinical Grouping Event	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.457	bwell_Vital_Body Weight_Clinical Grouping Event	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.458	bwell_Vital_Respiratory Rate_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.459	bwell_Vital_Waist Circumference_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.460	Pregnancy_CN_HD_LOINC	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.461	Pregnancy_CN_HD_CPT	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.462	Pregnancy_CN_HD_UMLS	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.463	Second Trimester_ICD10	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.464	Second Trimester_SNOMED	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.465	Second Trimester_Clinical Grouping Event	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.466	Third Trimester_SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.467	Third Trimester_ICD10	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.468	Third Trimester_Clinical Grouping Event	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.469	Pregnancy Due Date_LOINC	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.470	Second Trimester_LOINC	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.472	OGTT_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.473	OGTT_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.475	OGTT_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.476	OGTT_Grouping	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.477	Second Trimester_CPT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.479	Prostate Cancer Screening_HD_ICD9	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.482	Prostate Cancer Screening_HD_Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.484	Prostate Dysplasia_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.486	Prostate Dysplasia_Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.487	Prostectomy_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.488	Prostectomy_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.490	Prostectomy_Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.494	PSA Testing _LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.495	PSA Testing_Grouping	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.496	Active Pregnancy_CPT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.497	Active Pregnancy_ICD10	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.498	Active Pregnancy_LOINC	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.499	Active Pregnancy_SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.5	ADD/ADHD Condition	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.500	Active Pregnancy_Clinical Grouping Event	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.501	Abnormal PSA Testing _SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.502	Prediabetes_Clinical Grouping Condition_ICD10	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.503	Prediabetes_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.504	Prediabetes_Clinical Grouping Condition	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.505	Third Trimester_CPT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.506	Third Trimester_LOINC	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.508	bwell_Vital_Waist Circumference_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.509	bwell_Vital_Blood Oxygen_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.510	bwell_Vital_Body Temperature_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.511	bwell_Vital_Diastolic Blood Pressure_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.512	bwell_Vital_Systolic Blood Pressure_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.513	bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.514	bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.515	bwell_Vital_Heart Rate_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.516	bwell_Vital_Respiratory Rate_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.517	Lupus_Clinical_Condition_ICD10	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.519	Lupus_Clinical_Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.520	Lupus_Clinical Condition Grouping	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.523	UTI_Clinical_Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.524	UTI_Clinical Condition Grouping	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.525	Postpartum_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.526	Postpartum_HCPCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.527	Postpartum_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.528	Postpartum_ICD9CM	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.529	Postpartum_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.530	Postpartum_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.531	Postpartum_Clinical Grouping Event	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.532	bwell_Vital_Head Circumference_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.533	bwell_Vital_Head Circumference_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.534	bwell_Vital_Head Circumference_Clinical Grouping Event	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.535	bwell_Vital_Body Surface Area_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.536	bwell_Vital_Body Surface Area_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.537	bwell_Vital_Body Surface Area_Clinical Grouping Event	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.538	bwell_Vital_Vital Signs Panel_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.539	bwell_Vital_Vital Signs Panel_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.540	bwell_Vital_Vital Signs Panel_Clinical Grouping Event	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.541	bwell_Vital_Blood Pressure Panel_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.542	bwell_Vital_Blood Pressure Panel_Clinical Grouping Event	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.543	Depression_Clinical Grouping Condition_CPT	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.544	Depression_Clinical Grouping Condition_HCPCS	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.545	Depression_Clinical Grouping Condition_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.546	Depression_Clinical Grouping Condition_ICD9	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.547	Depression_Clinical Grouping Condition_LOINC	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.548	Depression_Clinical Grouping Condition_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.549	Depression_Clinical Grouping Condition	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.550	MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.551	MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.552	MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.553	MI (Myocardial Infarction)_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.554	CABG_Clinical Grouping Condition_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.555	CABG_Clinical Grouping Condition_HCPCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.556	CABG_Clinical Grouping Condition_ICD10PCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.557	CABG_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.558	CABG_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.559	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.56	Diabetic Retinal Screening HD CPT	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.560	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.561	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.562	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.563	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.564	PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.565	Essential HTN_HD_Clinical Grouping Condition_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.566	Essential HTN_HD_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.567	Essential HTN_HD_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.568	Total and Partial Neph_HD_Clinical Grouping Condition_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.569	Total and Partial Neph_HD_Clinical Grouping Condition_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.570	Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.571	Total and Partial Neph_HD_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.572	Kid Trans and Hx_HD_Clinical Grouping Condition_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.573	Kid Trans and Hx_HD_Clinical Grouping Condition_HCPCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.574	Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10CM	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.575	Kid Trans and Hx_HD_Clinical Grouping Condition_ICD10PCS	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.576	Kid Trans and Hx_HD_Clinical Grouping Condition_ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.577	Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.578	Kid Trans and Hx_HD_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.579	HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.580	HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.581	Systolic Less than 140_HD_Clinical Grouping Event_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.582	Diastolic Less than 90_HD_Clinical Grouping Event_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.583	Systolic Less than 140_HD_Clinical Grouping Event	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.584	Diastolic Less than 90_HD_Clinical Grouping Event	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.585	COPD_Clinical_Grouping_Condition_ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.586	COPD_Clinical_Grouping_Condition_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.587	COPD_Clinical_Grouping_Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.588	COPD_Clinical Condition Grouping	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.589	Polypharmacy_Clinical_Grouping_Condition_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.590	Polypharmacy_Clinical_Grouping_Condition_ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.591	Polypharmacy_Clinical_Grouping_Condition_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.592	Polypharmacy_Clinical_Grouping_Condition_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.593	Polypharmacy_Clinical Condition Grouping	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.595	Thyroid Cancer_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.596	Thyroid Cancer_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.597	Thyroid Cancer_Grouping	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.598	Allergy Iodine_SNOMED	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.599	Allergy to contrast_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.600	Allergy to contrast_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.601	Allergy to contrast_Grouping	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.602	Contrast induced nephropathy_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.603	Contrast induced nephropathy_ICD10	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.604	Contrast induced nephropathy_Grouping	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.605	Systolic Blood Pressure_Compliant	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.606	Diastolic Blood Pressure_Compliant	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.607	Diastolic Blood Pressure_Compliant_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.608	Systolic Blood Pressure_Compliant_CPT	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.609	bwell Systolic Blood Pressure Vitals_UI_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.610	bwell Systolic Blood Pressure Vitals_UI_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.611	bwell Diastolic Blood Pressure Vitals_UI_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.612	bwell Diastolic Blood Pressure Vitals_UI_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.613	bwell Combo Blood Pressure Vitals_UI_LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.614	bwell Combo Blood Pressure Vitals_UI_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.615	bwell Systolic Blood Pressure_UI	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.616	bwell Diastolic Blood Pressure_UI	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.617	bwell Combo Blood Pressure_UI	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.618	b.well Herpes Zoster Vaccine CN_HD	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.619	b.well Herpes Zoster Vaccine CN_HD_SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.620	b.well Herpes Zoster Vaccine CN_HD_CVX	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.621	b.well Herpes Zoster Vaccine CN_HD_CPT	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.622	b.well Herpes Zoster Vaccine CN_HD_2dose	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.623	b.well Herpes Zoster Vaccine CN_HD_2dose_CPT	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.624	b.well Herpes Zoster Vaccine CN_HD_2dose_CVX	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.625	b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.626	b.well Herpes Zoster Vaccine CN_HD_Exclusions	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.627	b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.628	b.well Adult RSV Vaccine CN_CVX	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.629	b.well Adult RSV Vaccine CN_CPT	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.630	b.well Adult RSV Vaccine CN_HCPCS	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.631	b.well Adult RSV Vaccine CN_SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.633	Lp(a) Test_SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.634	Lp(a) Test_LOINC	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.635	LP(a) Test_ICD	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.636	Lp(a) Test_CPT	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.637	LP(a) Test	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.638	b.well Adult Tetanus Vaccine CN	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.639	BWellAdultTetanusVaccineCN_SNOMED	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.640	b.well Adult Tetanus Vaccine CN_CPT	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.641	b.well Adult Tetanus Vaccine CN_CVX	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.642	b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.643	b.well Adult Tetanus Vaccine CN_Exclusions	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.644	BWellAdultTetanusVaccineCN_RxNorm	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.645	Pneumococcal Vaccine HD_CN_ Allergy	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.646	bwell COVID Vaccine CN_Allergy	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.647	bwell Covid Vaccine CN_Allergy_SNOMED	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.648	bwell COVID Vaccine CN_Met	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.9	Metabolic Syndrome ICD10	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.91	Cardiomyopathy Dilated ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.92	Cardiomyopathy Dilated ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.93	Cardiomyopathy Dilated SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.94	Cardiomyopathy Dilated Condition	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.95	Cardiomyopathy Dilated LOINC	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.96	Cardiomyopathy Hypertrophic ICD9	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.97	Cardiomyopathy Hypertrophic ICD10	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.98	Cardiomyopathy Hypertrophic SNOMED	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.99	Cardiomyopathy Hypertrophic LOINC	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.12	SNOMEDFindingValuesQualifierValue	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.13	SNOMED Organism from LOINC Answer List	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.18	Medication Prescribable Brand Name	active	2021-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.2	SNOMED Organisms	active	2021-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.22	Medicinal Ingredients RXNORM	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.1	Mental Status Observation	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.10	Other Unknown Nulls	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.11	Sexual Orientation Including nulls and Data Absent Reason	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.12	Pregnancy Status Observation	active	2024-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.2	No Healthcare Agent Included Reason	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.3	Sex	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.4	Asked Declined Data Absent Reason	active	2023-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.5	Act Encounter Codes	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.6	Completed or Nullified Act Status	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.7	Data Absent Reason Types of Unknown	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.8	Medication Adherence	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.2	Sickle Cell Disease	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1242.4	Depression	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.1	Food Insecurity Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.100	Intimate Partner Violence Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.101	Less Than High School Education Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.102	Less Than High School Education Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.103	Less Than High School Education Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.106	Transportation Insecurity Interventions SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.107	Financial Insecurity Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.108	Financial Insecurity Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.109	Financial Insecurity Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.11	Food Insecurity Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.110	Medical Cost Burden Goals SNOMED CT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.111	Health Insurance Coverage Status Goals SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.112	Health Literacy Diagnoses SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.113	Health Literacy Diagnoses ICD10CM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.114	Health Literacy Goals SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.115	Health Literacy Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.116	Health Literacy Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.117	Health Literacy Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.118	Health Literacy Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.119	Health Literacy Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.120	Medical Cost Burden Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.121	Health Insurance Coverage Status Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.122	Medical Cost Burden Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.123	Medical Cost Burden Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.124	Health Insurance Coverage Status Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.125	Health Insurance Coverage Status Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.126	Social Determinants of Health Screening Assessments	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.127	Food Insecurity Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.128	Transportation Insecurity Screening Assessments	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.129	Homelessness Screening Assessments	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.13	Homelessness Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.130	Housing Instability Screening Assessments	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.131	Inadequate Housing Screening Assessments	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.132	Less Than High School Education Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.133	Unemployment Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.134	Veteran Status Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.135	Social Connection Screening Assessments	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.136	Stress Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.137	Cognitive disorder Diagnosis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.138	Financial Insecurity Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.139	Material Hardship Screening Assessments	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.14	Homelessness Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.140	Intimate Partner Violence Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.141	Health Literacy Screening Assessments	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.142	Medical Cost Burden Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.143	Health Insurance Coverage Status Screening Assessments	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.144	Elder Abuse Screening Assessments	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.145	Less Than High School Education Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.146	Financial Insecurity Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.147	Health Insurance Coverage Status Diagnoses ICD10CM	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.148	Health Insurance Coverage Status Diagnoses	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.149	Health Insurance Coverage Status Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.15	Food Insecurity Interventions CPT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.150	Material Hardship Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.151	Medical Cost Burden Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.152	Medical Cost Burden Diagnoses SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.153	Medical Cost Burden Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.154	Medical Cost Burden Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.157	Transportation Insecurity Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.158	Homelessness Goals SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.159	Homelessness Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.16	Food Insecurity Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.160	Housing Instability Goals SNOMED CT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.161	Housing Instability Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.162	Transportation Insecurity Goals SNOMED CT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.163	Transportation Insecurity Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.164	Veteran Status Interventions SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.167	Inadequate Housing Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.168	Material Hardship Screening Assessments Questions	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.169	Stress Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.17	Food Insecurity Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.170	Transportation Insecurity Screening Assessments Questions	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.171	Unemployment Screening Assessments Questions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.172	Veteran Status Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.173	Financial Insecurity Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.174	Food Insecurity Screening Assessments Answers	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.175	Health Literacy Screening Assessments Answers	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.176	Homelessness Screening Assessments Answers	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.177	Housing Instability Screening Assessments Answers	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.178	Inadequate Housing Screening Assessments Answers	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.179	Less Than High School Education Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.18	Homelessness Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.180	Material Hardship Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.181	Stress Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.182	Transportation Insecurity Screening Assessments Answers	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.183	Unemployment Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.184	Veteran Status Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.185	Health Insurance Coverage Status Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.186	Health Insurance Coverage Status Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.187	Medical Cost Burden Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.188	Medical Cost Burden Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.189	Elder Abuse Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.19	Homelessness Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.190	Elder Abuse Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.191	Elder Abuse Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.192	Veteran Status Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.193	Financial Insecurity Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.194	Food Insecurity Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.195	Health Literacy Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.196	Homelessness Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.197	Housing Instability Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.198	Intimate Partner Violence Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.199	Less Than High School Education Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.20	Homelessness Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.200	Material Hardship Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.201	Medical Cost Burden Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.202	Social Connection Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.203	Stress Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.204	Transportation Insecurity Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.205	Unemployment Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.206	Social Determinants of Health Screening Assessments And Questions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.207	Social Determinants of Health Screening Assessments Questions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.208	Social Determinants of Health Screening Assessments Answers	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.209	Intimate Partner Violence Screening Assessments Answers	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.21	Homelessness Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.210	Social Connection Screening Assessments Answers	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.211	Intimate Partner Violence Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.212	Social Connection Screening Assessments Questions	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.213	Health Insurance Coverage Status Diagnoses SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.214	Veteran Status Goals	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.215	Veteran Status Goals SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.217	Digital Literacy Diagnoses SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.218	Digital Literacy Diagnoses ICD10CM	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.219	Digital Literacy Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.22	Housing Instability Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.220	Digital Literacy Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.224	Digital Literacy Diagnoses	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.225	Digital Literacy Goals	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.226	Digital Literacy Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.227	Digital Literacy Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.229	Digital Access Diagnoses SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.23	Housing Instability Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.230	Digital Access Diagnoses ICD10CM	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.231	Digital Access Diagnoses	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.232	Digital Access Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.233	Digital Access Goals	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.234	Digital Access Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.235	Digital Access Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.236	Digital Access Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.237	Digital Access Screening Assessments	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.238	Digital Access Screening Assessments Questions	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.239	Digital Access Screening Assessments Answers	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.24	Housing Instability Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.240	Digital Access Screening Assessments And Questions	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.241	Utility Insecurity Diagnoses SNOMED CT	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.242	Utility Insecurity Diagnoses ICD10CM	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.243	Utility Insecurity Diagnoses	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.244	Utility Insecurity Goals SNOMED CT	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.245	Utility Insecurity Goals	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.246	Utility Insecurity Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.247	Utility Insecurity Procedures	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.248	Utility Insecurity Screening Assessments	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.249	Utility Insecurity Screening Assessments Questions	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.25	Transportation Insecurity Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.250	Utility Insecurity Screening Assessments Answers	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.251	Utility Insecurity Screening Assessments And Questions	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.252	Utility Insecurity Service Requests	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.253	Social Determinants of Health General Interventions HCPCS	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.254	Incarceration Status Diagnoses ICD10CM	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.255	Incarceration Status Diagnoses SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.256	Incarceration Status Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.257	Incarceration Status Goals	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.258	Incarceration Status Diagnoses	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.259	Incarceration Status Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.26	Transportation Insecurity Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.260	Incarceration Status Procedures	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.261	Incarceration Status Service Requests	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.262	Language Access Diagnoses	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.263	Language Access Diagnoses ICD10CM	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.264	Language Access Diagnoses SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.265	Language Access Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.266	Language Access Goals	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.267	Language Access Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.268	Language Access Procedures	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.269	Language Access Service Requests	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.27	Transportation Insecurity Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.270	Language Access Screening Assessments	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.271	Language Access Screening Assessments Answers	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.272	Language Access Screening Assessments Questions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.273	Language Access Screening Assessments And Questions	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.28	Transportation Insecurity Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.29	Financial Insecurity Goals SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.3	Food Insecurity Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.30	Financial Insecurity Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.31	Financial Insecurity Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.32	Financial Insecurity Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.33	Material Hardship Diagnoses ICD10CM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.34	Material Hardship Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.35	Material Hardship Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.36	Material Hardship Goals SNOMED CT	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.37	Material Hardship Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.38	Material Hardship Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.39	Material Hardship Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.4	Food Insecurity Goals SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.40	Unemployment Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.41	Unemployment Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.42	Unemployment Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.43	Housing Instability Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.44	Housing Instability Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.45	Housing Instability Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.46	Inadequate Housing Diagnoses SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.47	Inadequate Housing Diagnoses ICD10CM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.48	Inadequate Housing Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.49	Inadequate Housing Goals SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.5	Social Determinants of Health General Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.50	Inadequate Housing Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.51	Inadequate Housing Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.52	Inadequate Housing Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.53	Inadequate Housing Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.54	Less Than High School Education Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.55	Less Than High School Education Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.56	Less Than High School Education Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.57	Less Than High School Education Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.58	Unemployment Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.59	Unemployment Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.6	Food Insecurity Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.60	Unemployment Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.61	Elder Abuse Diagnoses ICD10CM	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.62	Elder Abuse Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.63	Elder Abuse Diagnoses	active	2022-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.64	Elder Abuse Goals SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.65	Elder Abuse Goals	active	2022-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.66	Elder Abuse Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.67	Elder Abuse Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.68	Elder Abuse Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.69	Unemployment Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.7	Food Insecurity Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.70	Unemployment Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.71	Social Determinants of Health Goals	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.72	Stress Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.73	Stress Interventions SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.74	Stress Diagnoses ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.75	Stress Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.76	Veteran Status Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.77	Veteran Status Diagnoses ICD10CM	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.78	Veteran Status Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.79	Social Connection Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.8	Social Determinants of Health General Interventions CPT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.80	Social Connection Diagnoses ICD10CM	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.81	Social Connection Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.82	Intimate Partner Violence Diagnoses SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.83	Intimate Partner Violence Diagnoses ICD10CM	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.84	Intimate Partner Violence Diagnoses	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.85	Stress Goals SNOMED CT	active	2023-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.86	Stress Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.87	Stress Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.88	Social Connection Goals SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.89	Social Connection Goals	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.9	Food Insecurity Interventions HCPCS	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.90	Veteran Status Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.91	Veteran Status Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.92	Stress Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.93	Social Connection Interventions SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.94	Social Connection Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.95	Social Connection Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.96	Intimate Partner Violence Interventions SNOMED CT	active	2024-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.97	Intimate Partner Violence Procedures	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.98	Intimate Partner Violence Service Requests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.99	Intimate Partner Violence Goals SNOMED CT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.105	Mechanical Ventilation Procedures	active	2022-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.106	Mechanical Ventilation	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.107	Mechanical Ventilation	active	2022-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.109	aPTT Tests	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119	Opioid Antagonist	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.12	High Risk Diagnosis for AKI	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.120	Opioids	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.124	Immune Modulators	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.130	Suicide Attempt	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.134	Central Nervous System Depressants	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.136	Leukemia or Lymphoma	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.137	Liver Disease Moderate to Severe	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.138	COVID19	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.139	COVID 19	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.14	Hemolytic Uremic Syndrome (HUS)	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.140	COVID 19	active	2022-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.162	Obesity	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.163	Antidepressants	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.164	Antihypertensives	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.165	Delirium	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.166	Dementia	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.167	Psychosis	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.168	Delirium or Dementia and Other Psychoses	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.169	Depression	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.170	Diuretics	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.171	Epilepsy	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.172	Neurologic Movement Disorders	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.173	Neurologic Disorders, Other	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.174	Neurologic Movement and Related Disorders	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.175	Peripheral Neuropathy	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.176	Stroke	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.177	Abnormal Weight Loss and Malnutrition	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.178	Intubation	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.179	Intubation	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.180	Tracheostomy Procedures	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.181	Tracheostomy Procedures	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.182	Head and Neck Surgeries with High Risk Airway Compromise	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.185	Spinal Surgery	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.187	Routes of Administration for Opioid Antagonists	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.19	High Risk Procedures for AKI	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.197	Hospital Based Dialysis Services	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.198	Hospital Based Dialysis Services	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.199	Hospital Based Dialysis Services	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.200	Nephrectomy	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.201	Thrombotic Thrombocytopenic Purpura	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204	VTE Prophylaxis	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.205	Moderate Injuries	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.206	General and Neuraxial Anesthesia	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.207	General and Neuraxial Anesthesia	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.208	General and Neuraxial Anesthesia	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.209	Non Invasive Oxygen Therapy by Nasal Cannula or Mask	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.21	Creatinine Mass Per Volume	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.210	Continuous and Bilevel Positive Airway Pressure	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.211	Continuous and Bilevel Positive Airway Pressure	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.213	Non Invasive Oxygen Therapy	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.214	Non Invasive Oxygen Therapy Devices	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.216	Procedural Hospital Locations	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.217	ASA physical status class	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.218	Blood urea nitrogen lab test	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.219	Hemoglobin lab test	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.22	Anticoagulants for All Indications	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.220	Smoking status	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.221	Albumin lab test	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.222	Leukocyte count lab test	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.223	Bilirubin lab test	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.224	Aspartate transaminase lab test	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.226	Cardiac Arrest	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.23	Coagulation Disorders	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.230	PO Antibacterials	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.231	Injectable Antifungals	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.238	Neuromuscular Disorder	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.239	Neuromuscular Disorder	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.24	Malignant Bone Disease	active	2022-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.240	Degenerative Neurological Disorder	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.241	Degenerative Neurological Disorder	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.242	Heart and Lung Transplants	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.243	Heart and Lung Transplants	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.245	Lung Resections and Excisions	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.246	Lung Resections and Excisions	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.247	Chest Wall Procedures	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.248	Chest Wall Procedures	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.249	Maxillary Procedures	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.250	Maxillary Procedures	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.251	Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.252	Anesthesia Requiring Monitored Care	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.253	Anesthesia Requiring Monitored Care	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.255	Anesthesia Requiring Monitored Care	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.256	Osteoporosis	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.260	Rivaroxaban Anticoagulant	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.262	Fondaparinux Anticoagulant	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.263	Dalteparin Anticoagulant	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.264	Heparin	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.268	Enoxaparin Anticoagulant	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.271	Undetectable Lab Result Value	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.272	Undetectable Lab Result Value	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.274	Dietary Recommendations	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.275	Bariatric Procedures	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.276	Telemedicine Services	active	2025-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.277	Prostate Cancer Treatment	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.28	Traumatic Avulsion of Kidney	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.29	Rapidly Progressive Nephritic Syndrome	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.301	LDL Cholesterol	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.33	Obstetrics and VTE Obstetrics	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.34	Glucose Lab Test Mass Per Volume	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.349	Tuberculosis for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.350	Tuberculosis for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351	Tuberculosis for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.352	Androgen Deprivation Therapy for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353	Bacillus Calmette Guerin for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354	Bladder Cancer for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355	Chemotherapy Agents for Advanced Cancer	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.356	Cystectomy for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.357	Cystectomy for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358	Cystectomy for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.359	DEXA Bone Density for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360	Hospital Services for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.361	Immunocompromised Conditions	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.362	Immunocompromised Conditions	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363	Immunocompromised Conditions	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364	Immunosuppressive Drugs for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365	Mixed Histology Urothelial Cell Carcinoma for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.366	Morbid Obesity	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.367	Morbid Obesity	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368	Morbid Obesity	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.369	Unavailability of Bacillus Calmette Guerin for Urology Care	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.370	Urinary Retention	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.371	Urinary Retention	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372	Urinary Retention	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.374	Face to Face Interaction	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.375	Face to Face Interaction	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.376	HIV Viral Load Tests	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.377	HIV Viral Load Tests	active	2025-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.389	Syphilis Tests	active	2025-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.4	Nephrectomy	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.79	Acute Brain or Spinal Injury or Hemorrhage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.8	Large Body Surface Area (BSA) Burns	active	2022-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.80	Pulmonary Arterial Thrombectomy	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.81	Extracorporeal Membrane Oxygenation	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.85	Elective Inpatient Encounter	active	2023-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.86	Intubation	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.88	Acute Respiratory Failure	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.89	Tracheostomy Diagnoses	active	2022-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.90	Tracheostomy Procedures	active	2023-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.91	Neuromuscular Disorder	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.92	Degenerative Neurological Disorder	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.93	Head and Neck Surgeries with High Risk Airway Compromise	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.94	Oxygen Partial Pressure in Arterial Blood	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.95	Carbon Dioxide Partial Pressure in Arterial Blood	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.96	Arterial Blood pH	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.2	Psychological Neuropsychological or Neurobehavioral Testing	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1250.3	Psychological or Neuropsychological Testing	active	2023-11	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.10	Tricuspid Valve Regurgitation	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.12	Hypertension	active	2022-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.2	Valvular Heart Disease	active	2022-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.22	Acute Kidney Injury	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.23	Anemia	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.24	Cardiac Arrhythmias	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.25	Attention Deficit and Hyperactivity Disorder	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.26	Cerebrovascular Disease	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.27	Seizure Disorder	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.28	Proteinuria	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.29	Thyroid Hormone Disorder	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.30	Thromboembolic Disease	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.31	Parkinson's Disease and Parkinsonism	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.32	Upper GI Diseases	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.33	Failure to Thrive	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.34	Osteoporosis	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.35	Mood Disorders	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.36	Dyslipidemia	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.37	Heart Failure	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.38	Coronary Artery Disease	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.39	Chronic Kidney Disease	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.40	Chronic Obstructive Pulmonary Disease	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1251.41	Diabetes Mellitus	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.1	EventTiming-TimingEvent	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1254.2	EventTiming-EventTiming	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.1	Gonorrhea Screening	active	2025-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1258.2	Abnormal Weight Loss	active	2024-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.2	Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.3	Prescribable brand and generic insulins and analogues	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.4	eGFR Using 2021 Race Free Formulas	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.5	Fructosamine in Serum or Plasma	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.6	Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.7	Creatinine in serum/plasma	active	2023-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.9	IgE Agonists, prescribable	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.10	Estrogen Receptor Testing for Orserdu	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.100	MMR Proficient	active	2024-01	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.101	Systemic Cancer Directed Therapy	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.102	Face To Face Interaction	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.104	Erdafitinib	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.107	Chemotherapy Encounter	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.108	Urothelial Cancers ICD9	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.109	Urothelial Cancer ICD10	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.11	Estrogen Receptor Test for Orserdu	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.110	Urothelial Cancers	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.111	Prior Therapies for Erdafitinib	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.112	Urothelial Cancer Histologies	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.113	Malignant Tumor Behavior	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.114	Localized Bladder Cancer Stage SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.116	Localized Bladder Cancer Staging	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.117	Advanced Bladder Cancer Stage	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.118	Localized Bladder Cancer T Stage	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.119	Localized Bladder Cancer T Stage	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.12	Negative	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.120	Localized Bladder Cancer N Stage	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.121	Localized Bladder Cancer M Stage	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.122	Advanced Bladder Cancer M Stage	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.124	Locoregional Urothelial Cancer ICD9	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.125	Locoregional Urothelial Cancer ICD10	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.126	Locoregional Urothelial Cancer SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.127	Locoregional Urothelial Cancer	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.128	FGFR3 Gene	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.129	FGFR3 Gene Interpretation Positive SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.13	HER2 Negative	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.130	FGFR3 Gene Interpretation Positive LOINC	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.131	FGFR3 Gene Interpretation Positive NCI	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.133	FGFR3 Gene Interpretation Positive	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.134	FGFR3 Gene Interpretation Negative SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.135	FGFR3 Gene Interpretation Negative NCI	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.137	FGFR3 Gene Interpretation Negative	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.138	FGFR3 Molecular Variants	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.139	Tumor Behavior	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.14	Endocrine Therapy	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.140	Physcological Support for Cancer	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.141	Referral For Pain From Cancer	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.142	Cancer Pain Education	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.143	Telehealth Encounters	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.144	Pain Assessment Score	active	2024-02	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.146	Telehealth Encounters SNOMEDCT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.147	Telehealth Encounters CPT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.148	Telehealth Encounters HCPCS	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.149	Telehealth Encounters All	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.15	All Metastatic Sites	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.150	Chemo Admin SNOMEDCT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.151	Chemo Admin CPT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.152	Chemo Admin HCPCS	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.153	Chemotherapy Administration All	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.154	Radiation Treatment CPT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.155	Radiation Treatment HCPCS	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.156	Radiation Treatment SNOMEDCT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.157	Radiation Treatment All	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.158	Bipolar Diagnosis Codes	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.159	Telephone Visits SNOMED	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.16	All Metastatic Sites	active	2023-10	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.160	Telephone Visit CPT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.161	Telephone Visits All	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.162	Adolescent depression screening assessment	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.163	Adult depression screening assessment LOINC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.165	Referral for Depression Adult	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.166	Referrals for Adolescent Depression	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.167	Follow Ups for Adolescent Depression	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.168	FollowUps for Adult Depression	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.169	Depression Screen Declined for Medical Reason	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.17	Metastatic Breast Cancer	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.170	Physical Therapy Evaluations SNOMEDCT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.171	Physical Therapy Evaluation CPT	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.172	Physical Therapies Evaluations	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.173	Non Opioid Analgesics	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.174	Adjuvant Analgesics	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.176	Lung Cancer ICD9	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.177	Lung Cancer ICD10	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.178	Lung Cancer	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.179	Prior Therapies for Osimertinib	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.18	Stage IA	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.181	Plan of Care for Pain	active	2024-03	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.182	All Antineoplastic Agents	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.183	Locally Advanced NSCLC Stage Group	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.185	Localized NSCLC Stage Group SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.186	Radiation Treatment Management	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.187	Plan of Care	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.188	Documentation of Plan of Care	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.189	Pain Present	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.19	Stage IB	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.190	Localized NSCLC Stage Group NCIM	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.192	Localized NSCLC Stage Group	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.193	Advanced NSCLC Stage Group	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.194	NSCLC M Stage (metastatic)	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.195	NSCLC T Stage	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.196	NSCLC N Stage	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.197	SCLC and rarer lung cancer histology	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.198	EGFR Gene	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.199	EGFR Gene Interpretation Positive SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.20	Stage IIA	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.200	EGFR Gene Interpretation Positive LOINC	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.201	EGFR Gene Interpretation Positive	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.202	EGFR Osimertinib Molecular Variants	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.203	EGFR Generic Molecular Variant NCIM	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.204	EGFR Generic Molecular Variant SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.205	EGFR Generic Molecular Variant LOINC	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.206	EGFR Molecular Variants Osimertinib PM	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.207	Osimertinib	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.208	Pemetrexed	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.209	Radiation Treatment Management SNOMEDCT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.21	Stage IIB	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.210	Radiation Treatment Management Codes	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.211	Radiation Treatment Delivery CPT	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.212	77427 Management Code	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.213	Radiation Treatment Delivery HCPCS	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.214	Radiation Treatment Delivery NCIM	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.215	Radiation Treatment Delivery SNOMED	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.216	Radiation Treatment Delivery	active	2024-04	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.217	MET Gene Test	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.219	Tepotinib	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.22	Stage IIIA	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.220	MET Positive gene interpretation	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.227	MET Exon 14 skipping molecular variant	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.23	Stage IIIB	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.230	All Cancer Directed therapies	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.231	EGFR Amivantamab Molecular Variants	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.232	EGFR Molecular Variants Amivantamab PM	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.233	test43	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.234	ROS1 Molecular Variants Repotrectinib PM	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.235	ROS1 Repotrectinib Molecular Variants	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.236	ROS1 Negative (geneinterpretation) SNOMEDCT	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.237	ROS1 Negative (geneinterpretation) NCI	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.238	ROS1 Negative (geneinterpretation) SNOMEDCT,NCI	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.239	ROS1 Positive (geneinterpretation)	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.24	Stage IIIC	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.240	ROS1 results (HGNC)	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.241	ROS1 Gene Rearrangement	active	2024-05	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.242	RET Test (HGNC)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.243	RET Positive (Genei interpretation )	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.244	RET Gene Rearrangement	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.245	RET Negative (geneinterpretaion) SNOMED	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.246	RET Negative (geneinterpretaion) NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.247	RET Negative (geneinterpretaion) SNOMEDCT,NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.248	RET Fusion Molecular Variants	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.249	pralsetinib	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.25	ESR1 Gene Test	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.250	Repotrectinib Value set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.251	Amivantamab	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.252	Alectinib Drug	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.253	Gemcitabine Drug Value set	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.254	vinorelbine Drug	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.255	NSCLC_Tumor_resection SNOMEDCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.256	NSCLC_Tumor_resection CPT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.257	NSCLC_Tumor_resection SNOMEDCT CPT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.258	ALK results (HGNC)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.259	ALK Positive (geneinterpretation) SNOMED	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.26	ESR1 Genetic Mutation	active	2023-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.260	ALK Positive (geneinterpretation) NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.261	ALK Positive (geneinterpretation) SNOMEDCT NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.262	ALK Negative (geneinterpretation) SNOMEDCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.263	ALK Negative (geneinterpretation) NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.264	ALK Negative (geneinterpretation) SNOMEDCT NCI	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.265	Locoregional Sites	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.266	NSCLC N2 Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.267	NSCLC N1 Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.268	NSCLC N0 Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.269	NSCLC T3_T4 Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.27	Genetic Test Finding	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.270	NSCLC T2 Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.271	NSCLC T1 Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.272	Locally_Advanced_Metastatic_NSCLC Stage Group	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.273	Localized_Inclusion_NSCLC Stage Group	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.274	Localized_Exclusion_NSCLC Stage Group	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.275	tarlatamab dlle	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.276	Extensive SCLC Stage Group SNOMEDCT	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.277	Extensive SCLC Stage Group NCIM	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.278	Extensive SCLC Stage Group	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.279	Localized SCLC Stage Group	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.28	Her2 Negative	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.280	SCLC M Stage (metastatic)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.281	SCLC T Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.282	SCLC N Stage	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.283	SCLC histology (to include those patients)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.284	Binimetinib	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.285	Encorafenib	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.286	Encorafenib PM Molecular variant	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.288	BRAF Positive (geneinterpretation)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.289	BRAF test (HGNC)	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.29	HER2 Positive	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.292	Prior therapy for Amivantamab	active	2024-06	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.293	ENHERTU Drug	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.294	Metastatic_Solid_Cancer_Stage Group SNOMED CT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.295	Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.296	Localized_Solid_Cancer_Stage Group SNOMED CT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.297	Solid cancer M Stage (metastatic)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.298	Solid Cancer T Stage	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.299	Solid Cancer N Stage	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.30	HER2 Positive	active	2023-12	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.302	HER2_IHC_Positive	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.303	HER2 Negative (geneinterpretation/Labtestvalue) SNOMED	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.304	HER2 Negative (geneinterpretation/Labtestvalue) LOINC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.305	HER2 Negative (geneinterpretation/Labtestvalue) NCI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.307	HER2 Negative (geneinterpretation/Labtestvalue)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.308	Solid Cancer Diagnosis ICD 9	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.309	Solid Cancer Diagnosis SNOMED CT	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.31	HER2 Positive	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.310	Solid Cancer Diagnosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.311	Localized_Solid_Cancer_Stage Group NCIM	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.313	Localized_Solid_Cancer_Stage Group	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.314	Locally_Advanced_Solid_Cancer_Stage Group NCIM	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.315	Locally_Advanced_Solid_Cancer_Stage Group	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.316	Metastatic_Solid_Cancer_Stage Group NCIM	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.317	Metastatic_Solid_Cancer_Stage Group	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.318	Solid Cancer T Stage LOINC	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.319	Solid Cancer T Stage NCI	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.32	HER2 Positive	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.320	Solid Cancer T Stage codes	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.321	Prior_Systemic_therapy_Enhertu	active	2024-08	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.322	RET test_Solid_cancer (HGNC)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.323	RET Positive_Solid_Cancer (geneinterpretation)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.324	RET Negative_Solid_Cancer (geneinterpretation)	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.325	RET fusion Molecular Variants_Solid_Cancer	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.326	Prior_systemic_therapy_Retevmo	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.327	Selpercatinib (Retevmo) Drug	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.328	Breast Cancer Diagnosis ICD9	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.329	Breast Cancer Diagnosis ICD10	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.33	Metastatic Breast Cancer	active	2023-09	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.330	Breast Cancer Diagnosis	active	2024-07	hl7
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.331	Metastatic_Breast_Cancer_Stage Group	active	2024-07	hl7